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Summary 
 
The intestinal tract is home of trillions of bacteria which are essential for our health as they 
provide us with nutrients, are important for a balanced and mature immune system and 
protect us from enteric pathogens. The majority of the bacteria in the gut are obligate 
anaerobes which are fastidious and not easy to isolate or even culture. Though much 
progress has been made in the field of microbiome research in the past decade, still, our 
knowledge on lifestyle and functions of the mammalian gut bacteria is insufficient today. 
While many insights on the role of the microbiota for human health have been gained from 
comparative microbiome analyses in humans, the causative role of individual microbes in 
health and disease can only be addressed using gnotobiotic animal models. We can follow 
changes in the microbiota composition and distribution in the intestine, as well as resulting 
metabolic changes and the influence on the host immune system. Furthermore, the 
protective effect of specific microbiota alterations during enteric infections can be monitored. 
In this thesis I investigated the impact of Mucispirillum schaedleri ASF457 on Salmonella 
enterica serovar Typhimurium (S. Tm), a major cause of human gastroenteritis. S.Tm is 
transmitted via ingestion of contaminated food or via the fecal-oral route. After ingestion, 
S.Tm colonizes the intestinal tract, invades the intestinal epithelial cells and triggers 
inflammation by employing its type three secretion system (T3SS) encoded on Salmonella 
pathogenicity island 1 (SPI-1) (SPI1-T3SS). S.Tm is recognized by the innate immune 
system and induces a self-limiting gastroenteritis accompanied with diarrhea, fever, nausea 
and abdominal pain in healthy individuals. In a previous study with mucus-deficient Agr2-/- 
mice it was reported that Agr2-/- mice were protected from S. Tm colitis compared to 
littermate Agr2+/- control mice (Brugiroux, 2016). M. schaedleri was identified by comparative 
microbiome analysis as a candidate bacterium for protection from S. Tm colitis (Brugiroux, 
2016). 
Employing a gnotobiotic mouse model with a low complex microbiota consisting of 3 different 
bacterial species (Clostridium sp., Parabacteroides goldsteinii and Lactobacillus murinus) I 
could show that the mouse-derived bacterium M. schaedleri is localized in close proximity to 
the epithelium. While M. schaedleri had no effect on S. Tm gut colonization, it protected mice 
efficiently against S. Tm induced gut inflammation. This protective phenotype could be 
recapitulated in another gnotobiotic mouse model with a more complex microbiota, the 
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OligoMM12 mouse model. The microbial consortium of those mice consists of 12 different 
species representing the main 5 phyla inhabiting the murine gut (Firmicutes, Bacteroidetes, 
Verrucomicrobia, Proteobacteria and Actinobacteria) (Brugiroux et al., 2016).  
Microarray analysis revealed that M. schaedleri had no effect on suppression of the pro-
inflammatory host response (Loy et al., 2017). Further tissue invasion of S. Tm was 
drastically reduced in protected mucus-deficient Agr2-/- mice (Brugiroux, 2016). However, 
M. schaedleri did not block access to the epithelium. Finally, I could show that in the 
presence of M. schaedleri the S. Tm SPI1-T3SS is downregulated utilizing a gfp-reporter 
strain for SPI1-T3SS expression. Transcriptome data from S. Tm in gnotobiotic mice with 
and without M. schaedleri confirmed this result and further suggested a potential role of 
nitrate in SPI1-T3SS regulation in vivo.  
Expression of S. Tm SPI1-T3SS is regulated by a complex network of transcription factors, 
two-component regulatory systems and environmental stimuli. Using a luciferase reporter 
strain for S. Tm SPI1-T3SS expression I could identify nitrate as a previously unknown 
stimulus for SPI1-T3SS induction under anaerobic conditions in vitro. This is an important 
finding as nitrate is formed from NO, a product of the gut epithelium by oxidation and reaches 
the gut lumen by diffusion. 
Previously it was found that M. schaedleri is able to utilize alternative electron acceptors like 
nitrate, nitrite, trimethylamin-N-oxide (TMAO) and dimethyl S-oxide (DMSO) (Loy et al., 
2017) indicating competition with S. Tm. Employing S. Tm mutants unable to perform nitrate 
respiration (S. TmΔnr3) or anaerobic respiration of nitrate, TMAO, DMSO, tetrathionate and 
fumarate (S. TmΔmoaA), I showed that the protective effect of M. schaedleri is independent of 
utilization of those alternative electron acceptors by S. Tm, suggesting that other 
environmental factors like nitrite or O2 could be involved in regulation of SPI1-T3SS. 
M. schaedleri was described as a mucus dwelling bacterium and protection of Agr2-/- mice 
from S. Tm colitis was attributed to M. schaedleri (Brugiroux, 2016). So far the role of mucus-
deficiency on M. schaedleri colonization and function is unclear. Employing mucus-deficient 
gnotobiotic mice (OligoMM12 Agr2-/-) I found that M. schaedleri colonized OligoMM12 Agr2-/- 
mice and protected mice from S. Tm colitis independently of the host genotype.  
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With this study I identified M. schaedleri, a low abundant member of the murine microbiota, 
as a protective bacterium against S. Tm infection. The S. Tm SPI1-T3SS was found to be 
downregulated in the presence of M. schaedleri, suggesting that M. schaedleri directly 
affects SPI1-T3SS regulation or alters the environmental conditions which are important for 
SPI1-T3SS expression. Competition for nitrate, oxygen and H2 may be involved in virulence 
interference by M. schaedleri. Currently, genetic manipulation of M. schaedleri is not 
possible which limited further mechanistic analysis of the protective phenotype. 
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Zusammenfassung 
 
Der Magen-Darm-Trakt beherbergt eine Vielzahl an Mikroorganismen – die Mikrobiota. Sie 
erfüllt essentielle Aufgaben wie den Aufschluss von Nährstoffen, die Entwicklung eines 
gesunden Immunsystems und den Schutz vor Krankheitserregern. Die Darm-Mikrobiota 
setzt sich vor allem aus obligat anaeroben Bakterien zusammen, welche komplexe 
Anforderungen an die Kultivierung und Isolierung stellen. In den letzten zehn Jahren wurden 
große Fortschritte im Bereich der Mikrobiom-Forschung gemacht, allerdings ist unser 
Wissen über die Lebensweise und Funktionen der einzelnen Darmbakterien bis heute sehr 
begrenzt. Die vergleichende Mikrobiom-Analyse gewährt uns erste Einblicke auf die 
wichtige Rolle der Darm-Mikrobiota im Zusammenhang mit der menschlichen Gesundheit. 
Die kausalen Zusammenhänge einzelner Bakterien auf den Schutz vor Krankheiten kann 
allerdings nur mit Hilfe gnotobiotischer Modelle untersucht werden. In diesen können 
Veränderungen der Mikrobiota-Zusammensetzung als auch die daraus resultierenden 
Auswirkungen auf das Metabolom sowie auf das Immunsystem des Wirts betrachtet 
werden. Zusätzlich kann der Beitrag einzelner Bakterien auf den Schutz vor 
Krankheitserregern analysiert werden. In dieser Doktorarbeit wurde der Einfluss des 
Bakteriums Mucispirillum schaedleri ASF457 auf die Infektion mit Salmonella enterica 
serovar Typhimurium (S. Tm) untersucht. Eine Infektion mit S. Tm erfolgt durch die 
Aufnahme verunreinigten Essens und ist die Hauptursache für Gastroenteritis beim 
Menschen. S. Tm besiedelt den Darm und wandert in die Epithelzellen ein wofür ein Typ-3-
Sekretionssystem (T3SS) genutzt wird, welches auf der Salmonella Pathogenitätsinsel-1 
(SPI1) codiert ist. Das angeborene Immunsystem erkennt S. Tm und löst eine 
selbstbegrenzende Gastroenteritis aus, welche sich durch Durchfall, Fieber, Erbrechen und 
Bauchschmerzen kennzeichnet. Eine Studie mit Mucus-defizienten Agr2-/- Mäusen zeigte, 
dass Agr2-/- Mäuse vor einer S. Tm induzierten Gastroenteritis geschützt waren (Brugiroux, 
2016). Vergleichende Mikrobiom-Analyse identifizierte M. schaedleri als potentielles 
Bakterium, welches Schutz vor S. Tm Kolitis vermittelt (Brugiroux, 2016). 
In gnotobiotischen Mäusen mit einer minimalen Mikrobiota bestehend aus drei Spezies 
(Clostridium sp.; Parabacteroides goldsteinii und Lactobacillus murinus) konnte gezeigt 
werden, dass M. schaedleri sich nahe des Darmepithels ansiedelt. Bei einer Infektion mit 
S.Tm verhindert M. schaedleri nicht die Besiedlung von S. Tm, allerdings schützte es vor 
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einer Entzündung des Zökums. Die Protektion von M. schaedleri gegenüber S. Tm Kolitis 
konnte zusätzlich in einem weiteren gnotobiotischen Model, der OligoMM12 Maus, gezeigt 
werden. Die OligoMM12 setzt sich aus 12 verschiedenen Bakterienarten zusammen, welche 
den fünf Hauptphyla (Firmicutes, Bacteroidetes, Verrucomicrobia, Proteobacteria und 
Actinobacteria) der Mausmikrobiota angehören (Brugiroux et al., 2016).  
Durch Microarray Analysen konnte gezeigt werden, dass M. schaedleri keinen Einfluss auf 
die pro-inflammatorische Immunantwort ausübt (Loy et al., 2017). Weiterhin wurde 
festgestellt, dass in geschützte mucus-defizienten Agr2-/- Mäuse weniger S. Tm in das 
Epithel eindrangen (Brugiroux, 2016). Allerdings blockiert M. schaedleri nicht den Zugang 
zum Epithel. Mit Hilfe eines gfp-Reporters für SPI1-T3SS Expression konnte ich zeigen, 
dass S.Tm in der Gegenwart von M. schaedleri das SPI1-T3SS herunter reguliert. In vivo 
Transkriptom Daten von S.Tm bestätigen die verringerte Expression von SPI1-T3SS in 
Mäusen mit M. schaedleri.  
Die Expression von S. Tm SPI1-T3SS ist durch ein komplexes Netzwerk von 
Transkriptionsfaktoren, Zweikomponentensystem und Umwelteinflüssen reguliert. Mittels 
eines Luziferase-Reportersystems für SPI1-T3SS Expression konnte gezeigt werden, dass 
Nitrat unter anaeroben Bedingungen eine induzierende Wirkung auf das SPI1-T3SS ausübt.  
M. schaedleri besitzt die Fähigkeit alternative Elektronenakzeptoren wie Nitrat, Nitrit, 
Trimethylamin-N-oxid (TMAO) und Dimethylsulfoxid (DMSO) zu nutzen (Loy et al., 2017). 
Dies könnte zu einer Kompetition mit S. Tm führen. Mit Hilfe von S. Tm Mutanten, welche 
keine funktionelle Nitratatmung besitzen (S. TmΔnr3) oder keine anaerobe Atmung von Nitrat, 
DMSO, TMAO, Tetrathionat und Fumarat betreiben können (S. TmΔmoaA), wurden für in vivo 
Infektionsstudien genutzt. Dadurch konnte gezeigt werden, dass der protektive Effekt von 
M. schaedleri unabhängig von diesen alternativen Elektronakzeptoren ist und weiter 
Umweltfaktoren wie O2 und Nitrit eine wichtige Rolle spielen könnten. 
In mucus-defizienten Agr2-/- Mäusen wurde M. schaedleri eine schützende Wirkung vor 
S. Tm Kolitis zugeschrieben (Brugiroux, 2016). Allerdings ist die Bedeutung der 
Mucusschicht auf die Besiedlung und Funktion von M. schaedleri im Darm noch nicht 
erforscht. Mittels gnotobiotischer mucus-defizienter Mäuse (OligoMM12 Agr2-/-) konnte ich 
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zeigen, dass M. schaedleri auch OligoMM12 Agr2-/- Mäuse kolonisiert und diese Mäuse 
unabhängig ihres Genotypes vor S. Tm induzierten Gastroenteritis schützt. 
Mit dieser Arbeit konnte gezeigt werden, dass das Bakterium M. schaedleri protektiv 
gegenüber S. Tm Kolitis ist. Das S. Tm SPI1-T3SS ist in der Gegenwart von M. schaedleri 
herunter reguliert, was darauf hindeutet, dass M. schaedleri entweder direkt die SPI1-T3SS 
Regulation beeinflusst oder aber die Umweltbedingungen verändert welche für die SPI1-
T3SS Expression essentiell sind. Kompetition um Nitrat, Sauerstoff und Wasserstoff 
könnten eine wichtige Rolle einnehmen. Zurzeit ist es nicht möglich M. schaedleri genetisch 
zu verändern, was weiter mechanistische Analysen erschwert. 
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1 Introduction 
1.1 The intestinal microbiota: keeper of homeostasis and health  
Our intestine is the natural habitat for trillions of bacteria with which we maintain a mutualistic 
relationship beginning directly at birth. Those bacteria provide us with nutrients such as 
vitamins and short chain fatty acids (SCFA) essential for the metabolism and protect us from 
invading pathogens. Studies showed that antibiotic intake disrupts the microbiota and 
increases the susceptibility to intestinal pathogens like Salmonella enterica serovar 
Typhimurium (S.Tm), Clostridium difficile and vancomycin-resistant Enterococcus (Buffie et 
al., 2012; Ubeda et al., 2010) which can have severe outcomes. 
Therefore it is of enormous importance that we study and understand how individual 
commensal bacteria and pathogens interact with each other and with their host. 
1.1.1 Mechanisms of colonization resistance (CR) 
The intestinal microbiota confers protection against enteric pathogens which is called 
colonization resistance (CR) (Buffie & Pamer, 2013; Stecher et al., 2013). This is mediated 
by multiple mechanisms. Direct CR is conferred by secretion of harmful bacteriocins or 
attacking other bacteria with a type 6 secretion system (T6SS) (Corr et al., 2007; Donohoe 
et al., 2011; Hecht et al., 2016; Sassone-Corsi et al., 2016). It was also shown that bacteria 
can compete for the same nutrients, and therefore limit colonization (Deriu et al., 2013; 
Leatham et al., 2009) (Fig. 1B). Furthermore, the microbiota modulates the host’s immune 
system by enhancing secretion of antimicrobial peptides like RegIIIγ and strengthens our 
epithelial barrier (Cash et al., 2006; Rakoff-Nahoum et al., 2004) which is termed indirect or 
immune-mediated colonization resistance (Buffie & Pamer, 2013) (Fig. 1A). Further, 
Clostridium scindens was shown to be a secondary bile acid producer. Those secondary 
bile acids prevent vegetative growth of C. difficile (Buffie et al., 2015; Studer et al., 2016) 
(Fig. 1A). 
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Fig. 1. Mechanisms of colonization resistance. A) Indirect (immune-mediated) CR. a) The commensal 
bacterium Clostridium scindens can convert primary bile acids in secondary bile acids. Those inhibit the 
vegetative growth of the pathogen Clostridium difficile. b) Commensal bacteria stimulate continuously the innate 
immune system via flagellin or LPS leading to the secretion of antimicrobial peptides (e.g. RegIIIγ) by paneth 
and epithelial cells. This leads to pore formation in Gram positive bacteria (e.g. Vancomycin resistant 
Enterococcus or Listeria monocytogenes). c) Pathogens like C. difficile lead to disruption of the epithelial barrier. 
The microbiota induces the NF-κB pathway in epithelial cells via TLR5 signaling. This pathway leads to induction 
of anti-apoptotic factors which results in cell proliferation and enhancement of tight junctions. The recruitment of 
innate immune cells further stabilizes epithelial integrity. B) Direct colonization resistance. d) The probiotic E. 
coli Nissle 1917 can secrete bacteriocins which reduce colonization of pathogenic bacteria like Salmonella 
enterica serovar Typhimurium and therefore leads to lower intestinal inflammation. e) The commensal bacteria 
can compete with invading pathogens for essential nutrients like iron or carbohydrates and therefore limit 
colonization. f) Commensal Bacteroides spp. can employ their T6SS and deliver toxic effector proteins in a 
contact dependent manner to pathogenic Bacteroides spp.. This leads to reduced intestinal inflammation. 
Adapted from (Buffie & Pamer, 2013; Kim et al., 2017). 
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1.1.2 SCFAs are important for our intestinal health 
The majority of the intestinal bacteria are obligate anaerobes which meet their energy 
demands by fermentation of indigestible carbohydrates, thereby producing SCFA like 
butyrate, acetate, propionate, succinate, formate and lactate (Macfarlane & Macfarlane, 
2003; Macfarlane et al., 1998; Miller & Wolin, 1996). These SCFAs have extremely diverse 
and pivotal functions for the host. They serve as an energy source for colonocytes (Donohoe 
et al., 2011), play an important role in immune regulation (Calo et al., 2015; Furusawa et al., 
2013; Trompette et al., 2014), improve barrier integrity via tight junctions and regulate the 
pH of the intestine (den Besten et al., 2013; Peng et al., 2009). 
1.1.3 Host produced bile acids are modified by the intestinal microbiota 
Another important group of metabolites in the gut are bile acids. They are produced in the 
liver from cholesterol were they are conjugated to taurine or glycine to primary bile acids. 
Mice and humans harbor a different set of bile acids. Primary bile acids in mice are α-
muricholic acid (MCA) and β-MCA. Both in mouse and human we find cholic acid (CA) as 
well as chenodeoxycholic acid (CDCA)). Those primary bile acids are secreted into the 
gallbladder and released into the intestine upon ingestion of food (Falany et al., 1994; 
Vessey, 1978; Wahlstrom et al., 2016). They are needed to facilitate the uptake of lipids and 
fat-soluble vitamins. The gut microbiota has the capacity to modify the primary bile acids by 
deconjugation using bile salt hydrolases (BSH) or form secondary bile acids by 
dehydroxylation. Secondary bile acids in mouse and human are lithocholic acid (LCA) and 
deoxycholic acid (DCA) whereas only in mouse hyodeoxycholic acid (HDCA) and ω-MCA 
are present. Bile acids recirculate to the liver via the enterohepatic route (de Aguiar Vallim 
et al., 2013). BSHs are found in a variety of different bacterial species belonging to the 
genera Bacteroides, Clostridium, Lactobacillus and Bifidobacterium (Chand et al., 2017; 
Moser & Savage, 2001). Bile acids can directly harm sensitive bacteria by membrane 
disruption and DNA damage (Begley et al., 2005; Devlin & Fischbach, 2015; Merritt & 
Donaldson, 2009; Sung et al., 1993), but plenty of enteric pathogens evolved mechanisms 
to survive bile salt exposure and even managed to use them as signals for virulence gene 
expression (Sistrunk et al., 2016). For example, S. Tm employs several efflux pumps to fend 
off intracellular bile acids (Buckley et al., 2006; Nishino et al., 2006) and uses DNA adenine 
methylase to cope with bile acid induced DNA damage (Prieto et al., 2004). On the other 
hand, S. Tm responds to bile acids by regulating its virulence factors. Its SPI1-T3SS and 
flagella biosynthesis are downregulated in the presence of a mixture of bile acids which 
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could be an adjustment to decreasing bile salt concentrations along the intestinal tract 
(Prouty & Gunn, 2000; Sistrunk et al., 2016; Wohlgemuth et al., 2011). 
1.2 Mucispirillum schaedleri, a commensal bacterium in the murine gut 
Mucispirillum schaedleri, a member of the family Deferribacteraceae (Robertson et al., 2005) 
is Gram-, flagellated, spiral shaped and a obligate anaerobic bacterium (Robertson et al., 
2005). It is a common member of the mouse gut microbiota (Rosshart et al., 2017) and also 
found in the intestine of several different species like turkey, pigs, lizards and occasionally 
also in humans (Harrell et al., 2012; He et al., 2016; Rausch et al., 2011; Scupham et al., 
2008; Zhang et al., 2018). Interestingly, in the family Deferribacteraceae, M. schaedleri is 
the only species known to inhabit the intestine, whereas the other members were isolated 
from waste water, hot springs and sediments (Loy et al., 2017). M. schaedleri is enriched in 
mice suffering from acute colitis (Berry et al., 2012; Rooks et al., 2014; Selvanantham et al., 
2016; Song et al., 2018) and is also elevated in obese mice (Ravussin et al., 2012; Serino 
et al., 2012). Recently, genome and transcriptome analysis gave us a deeper insight into 
the lifestyle of M.schaedleri (Loy et al., 2017). Several genes important for anaerobic 
respiration of nitrate, fumarate, TMAO or tetrathionate are present (Loy et al., 2017). Its 
capacity to use nitrate as electron acceptor and perform full dissimilatory nitrate reduction 
to ammonia (DNRA) was verified in in vitro cultures (Fig. 2B) (Loy et al., 2017). Furthermore, 
this bacterium occupies a niche close to the epithelium and genes for the defense against 
oxidative stress (e.g. catalase, superoxide reductase and cytochrome c peroxidase) were 
found (Loy et al., 2017). Despite M.schaedleri was shown to colonize close to the mucus 
layer no enzymes for mucus degradation were found (Loy et al., 2017). Predicted genomic 
features are visualized in (Fig. 2A) (Loy et al., 2017). 
M. schaedleri (ASF457) is also a component of the Altered Schaedler Flora (ASF). The ASF 
is a bacterial consortium established in 1965 by Russel W. Schaedler and consisted initially 
of five bacterial isolates from the murine gut (Schaedler et al., 1965). Later this consortium 
was revised by Roger Orcutt to enclose eight different species (Orcutt et al., 1987), two 
lactobacilli (L. intestinalis ASF360 and L. murinus ASF361), Parabacteroides goldsteinii 
(ASF519), Eubacterium plexicaudatum (ASF492), Pseudoflavonifactor sp. (ASF500), 
M. schaedleri (ASF457) and two Clostridium spp. (ASF356 and ASF502) (Dewhirst et al., 
1999; Wymore Brand et al., 2015).  
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Fig. 2. Genomic features of M. schaedleri, based on prediction from genome annotations (Loy et al., 
2017). A) Model of metabolic features of M. schaedleri. Abbreviations: Cat: Catalase; CCO: Cytochrome c 
oxidase; CCP: Cytochrome c peroxidase; DNRA: Dissimilatory nitrate reduction to ammonium; EMP: Embden-
Meyerhof-Parnas; FR: Fumarate reductase; GCK: Glucokinase; GK: Glycerol kinase; GLDH; Glutamate 
dehydrogenase; Glp: Sn-glycerol-3-phosphate dehydrogenase; GP: Glycerolphosphodiester 
phosphodiesterase; GS: Glutamine synthetase; HK: Histidine kinase; HYD: Hydrogenase; Hyb: Hydrogenase 2; 
MCP: Methyl-accepting chemotaxis protein; NapA: Periplasmic nitrate reductase; NrfA: Cytochrome c nitrite 
reductase; PolyP: Polyphosphate; Rbr: Rubrerythin; Rnf: Ferredoxin:NAD+ oxidoreductase; SOR: Superoxide 
reductase; TMAO: Trimethylamine-N-oxide reductase; TrxR: Thioredoxin reductase; TCA: Tricarboxylic acid. B) 
Growth of M.schaedleri under anaerobic conditions in the presence of either 10 mM nitrate and 8 % H2 (red); 
only 8 % H2 (light green); 10 mM formate and 10 mM nitrate (dark green); 10 mM formate and 10 mM fumarate 
(blue) or only 10 mM formate (violet) monitored by OD600 measurement. M. schaedleri can use nitrate as electron 
acceptor and H2 as electron donor under anaerobic conditions (Loy et al., 2017). Figures from (Loy et al., 2017). 
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1.3 Salmonella enterica serovar Typhimurium (S.Tm) 
1.3.1 S.Tm is a major cause of gastroenteritis 
The non-typhoidal Salmonella Typhimurium (S.Tm), a Gram- rod shaped bacterium of the 
family Enterobacteriaceae, is the cause of foodborne Salmonellosis. It is transmitted via 
ingestion of contaminated food but can also be passed directly person-to-person via the 
fecal-oral route (WHO, 2018). After ingestion, S. Tm induces a localized and self-limiting 
gastroenteritis, accompanied with diarrhea, fever, nausea and abdominal pain in healthy 
individuals (Coburn et al., 2006). Immunocompromised people can suffer from an invasive 
disease resulting in high mortality (Gordon, 2008; Uche et al., 2017). To establish disease, 
S. Tm needs to colonize the intestinal tract and invade the epithelium where it is recognized 
by the immune system which subsequently triggers inflammation (Hapfelmeier et al., 2005; 
Lawley et al., 2008). When S. Tm is close to the epithelial barrier it employs a needle like 
structure, its type 3 secretion system, encoded on the Salmonella Pathogenicity Island 1 
(SPI1-T3SS), to invade the epithelial cells (Laughlin et al., 2014; Lorkowski et al., 2014). 
Once inside a host cell, S. Tm uses its second T3SS, located on the Salmonella 
Pathogenicity Island 2 (SPI2), to survive and multiply intracellularly (Hensel et al., 1998; 
Laughlin et al., 2014; Ochman et al., 1996).  
1.3.2 Experimental models for studying S.Tm induced colitis 
 The streptomycin mouse model 
For a long time it has been challenging to decipher mechanisms important for S.Tm 
pathogenesis in vivo, as the most common experimental model, the mouse, is resistant to 
S.Tm induced gastroenteritis. Instead mice develop systemic disease resembling the course 
of human typhoid fever (Santos et al., 2001). Studies by Barthel and colleagues found that 
this protection is dependent of the microbiota and established the streptomycin mouse 
model (Barthel et al., 2003). The antibiotic streptomycin disrupts the colonization resistance 
against S. Tm. Mice treated with a high dose of streptomycin one day prior to infection are 
efficiently colonized by S. Tm and develop gastroenteritis one day post infection (p.i.) with 
symptoms resembling human disease (diarrhea, submucosal edema, epithelial ulceration, 
infiltration of polymorphonuclear cells (PMNs) and loss of goblet cells) (Barthel et al., 2003; 
Day D et al., 1978).  
Introduction 
7 
 
 Gnotobiotic low complex microbiota models 
Another possibility to study S. Tm infection is the use of gnotobiotic mouse models, 
harboring a microbiota with reduced complexity which does not confer colonization 
resistance to S. Tm. One of these mouse models are mice colonized with the ASF (1.2) 
consisting of 8 bacterial species. This consortium does not confer colonization resistance to 
S. Tm and the mice develop colitis without disruption of the microbiota by antibiotic 
pretreatment (Stecher et al., 2010). A more complex consortium consisting of 12 bacterial 
species (OligoMM12; Table 22, Fig. 3A) was recently published (Brugiroux et al., 2016). This 
consortium maintains a stable composition over mouse generations and confers 
intermediate colonization resistance (Brugiroux et al., 2016) which is ideal to study the 
different stages of S. Tm colonization and onset of inflammation. The use of this model 
makes it possible to explore S. Tm induced microbiota changes over time (Beutler, 2016). 
Onset of inflammation is observed at day 3 post infection and severe colitis is established 
one day later, 4 days post infection (Fig. 3C) (Beutler, 2016).  
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Fig. 3. The gnotobiotic OligoMM12 mouse microbiota model. A) Images of Gram stainings from each 
individual strain of the OligoMM12 microbiota. Actinobacteria: YL2, Bifidobacterium longum subsp. animalis; 
Bacteroidetes: I48, Bacteroides caecimuris; YL27, Muribaculum intestinale; Proteobacteria: YL45, Turicimonas 
muris; Verrucomicrobia: YL44, Akkermansia muciniphila; Firmicutes: KB1, Enterococcus faecalis; I49, 
Lactobacillus reuteri; YL32, Clostridium clostridioforme; YL58, Blautia coccoides; YL31, Flavonifractor plautii; 
KB18, Acutalibacter muris; I46, Clostridium innocuum; scale bar: 10 µm. Picture from (Brugiroux et al., 2016). B) 
Colonization of an attenuated S.Tmavir (blue dots) and a virulent S.Tmwt (red dots) over time in mice associated 
with the OligoMM12 consortium (Beutler, 2016). C) Histopathological score of cecal tissue after infection with an 
attenuated S.Tmavir  and a virulent  S.Tmwt over time. S.Tmwt induces inflammation at day 3 p.i. (Beutler, 2016). 
The degree of submucosal edema, neutrophil infiltration, loss of goblet cells and epithelial damage was scored 
in a double-blinded manner. 0-3: no pathological changes; 4-7: moderate inflammation; above 8: severe 
inflammation. Each dot represents one mouse. Kruskal-Wallis test with Dunn’s multiple comparison test, no 
significant difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. Adapted from (Beutler, 2016). 
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1.3.3 The Salmonella pathogenicity island 1 type 3 secretion system (SPI1-
T3SS) 
For full pathogenicity, S. Tm requires its major virulence factor, the SPI1-T3SS (Hapfelmeier 
et al., 2005). The SPI1-T3SS consists of a multitude of structural proteins that form a needle 
like structure. With this apparatus, S. Tm can deliver a cocktail of effector proteins into host 
cells and facilitate pathogen uptake by rearrangement of the host cell’s cytoskeleton 
(Burkinshaw & Strynadka, 2014). Furthermore, by invasion into host cells, the innate 
immune response is triggered and a pro-inflammatory milieu is established (cf. 1.3.4.3). As 
SPI1-T3SS fulfills an essential role, it was already studied extensively, but due to its complex 
regulatory networks little is known on the environmental factors influencing its expression. 
Induction of SPI1-T3SS under laboratory conditions is extremely influenced by osmolarity of 
the medium, oxygen concentration and growth phase (Bajaj et al., 1996; Galan & Curtiss, 
1990; Lee & Falkow, 1990; Steele-Mortimer et al., 1999; Tartera & Metcalf, 1993). Standard 
SPI1-inducing conditions are reported as high salt (0.3 M NaCl) and microaerobic growth 
(1 % O2) (Lee & Falkow, 1990; Song et al., 2004). In contrast, highest invasiveness was 
reached when S.Tm was grown in fully aerated cultures to late exponential phase (Ibarra et 
al., 2010). Under oxygen limiting conditions (1 % oxygen) highest invasion was observed 
when bacteria reach the stationary phase but where still reduced in their invasive capacity 
compared to fully aerated cultures (Ibarra et al., 2010). Furthermore, Gunn and Poutry 
showed that S. Tm is reduced in its invasiveness in the presence of bile salts which could 
give an insight for the regulation in vivo (Prouty et al., 2004; Prouty & Gunn, 2000). Another 
family of metabolites shown to regulate SPI1-T3SS expression are SCFAs. Acetate induces 
SPI1-T3SS expression whereas butyrate and propionate show an inhibitory effect (Durant 
et al., 2000; Lawhon et al., 2002).  
The SPI1-T3SS is expressed in a bistable manner. In the gut, two subpopulations are found, 
a slow growing SPI1-T3SS+ population, important for induction of inflammation, and a fast 
growing SPI1-T3SS- population which can colonize effectively the intestine (Diard et al., 
2013). The exact mechanism of SPI1-T3SS regulation and the influence of the microbiota 
and the host remains still elusive and needs further consideration. 
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1.3.4  The gut is an oxygen limited environment  
 Sensing of environmental oxygen by S.Tm 
As S. Tm is a facultative anaerobic bacterium it can cope with changes of the available 
oxygen in the environment. When oxygen is present, S. Tm uses preferentially O2 as 
terminal electron acceptor as it is the most potent to drive efficient ATP production and rapid 
growth (Barrow et al., 2015; Unden & Dunnwald, 2008). In the gastrointestinal tract S. Tm 
faces an oxygen limited environment (Albenberg et al., 2014) and has to switch to an 
anaerobic lifestyle, which is mainly regulated by the aerobic respiratory control two-
component system (ArcBA) and the global fumarate nitrate reduction regulator (FNR) 
(Evans et al., 2011; Fink et al., 2007; Wallace et al., 2016). When oxygen concentrations 
are low ArcA acts as a repressor of aerobic metabolism, energy generation, amino acid and 
fatty acid transport (Evans et al., 2011). On the other hand, it is an activator of flagella 
biosynthesis, motility, chemotaxis and anaerobic metabolism (ethanolamine and 
propanediol utilization, nitrite reductase) (Evans et al., 2011). FNR is a transcription factor 
which is inactive under aerobiosis due to its oxidized iron-sulfur cluster. Anaerobic conditions 
result in formation of FNR dimers and DNA binding (Lazazzera et al., 1996) which leads to 
upregulation of genes which are essential for anaerobic respiration (DMSO reductase, 
ethanolamine utilization), flagella biosynthesis and the SPI1-T3SS (Fink et al., 2007). It also 
acts as a repressor of aerobic metabolism (cytochrome c-oxidase, NADH-dehydrogenase, 
cytochrome cd-complex) (Fink et al., 2007). Using these sensors, S. Tm can efficiently adapt 
its metabolism to changing oxygen environments. 
 Utilization of alternative electron acceptors during inflammation: advantage 
of S. Tm over the commensal microbiota 
Under anaerobic conditions S. Tm can undergo fermentative metabolism of complex 
carbohydrates and produce energy by substrate-level phosphorylation. This is not 
energetically favorable for S. Tm as it only yields two ATP per mol glucose (Gunsalus & 
Park, 1994). S. Tm adopts several different pathways to utilize alternative electron acceptors 
(in order of preference: nitrate, nitrite, DMSO, TMAO, tetrathionate and fumarate) in an 
anaerobic environment which increases energy yield (Unden & Dunnwald, 2008). S. Tm 
possesses three nitrate reductases, the constitutively produced NarZYV, the high affinity 
periplasmic NapABCGH and the low affinity cytosolic NarGHI, which reduce nitrate to nitrite. 
Nitrite is then further reduced to ammonia by the nitrite reductase NrfABCD (Unden & 
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Dunnwald, 2008). For DMSO, TMAO, fumarate and tetrathionate, S. Tm encodes the 
respective reductases in the dmsABC, torCAD, frdABCD and ttrBCA operons (Unden & 
Dunnwald, 2008). All these reductases contain a molybdopterin co-factor which is essential 
for their function (Hille, 1996). Therefore by deletion of moaA, an essential gene for 
molybdopterin synthesis, anaerobic respiration is prevented (Mehta et al., 2014). Winter and 
colleagues showed that a moaA E. coli mutant exhibits a growth disadvantage with nitrate, 
TMAO and DMSO in an anaerobic co-culture assay (Rivera-Chavez et al., 2013).  
As mentioned above, most obligate anaerobic bacteria ferment complex carbohydrates to 
meet their energy demands. Instead, M. schaedleri is able to use nitrate as alternative 
electron acceptor for anaerobic respiration (Loy et al., 2017) (Fig. 2B). Further, a putative 
TMAO reductase, tetrathionate reductase and DMSO reductase were found by genome 
analysis (Loy et al., 2017). As those are all metabolites which are more abundant in the 
inflamed gut (Winter, Lopez, et al., 2013; Winter, Winter, et al., 2013), it is not astonishing 
that M. schaedleri is found in increased abundance in mouse models associated with acute 
colitis (cf. 1.2), but also in a dementia mouse model which is associated with inflammation 
in the brain cortex (Gao et al., 2018). 
 S. Tm creates a favorable environment by induction of an inflammatory 
response 
When S. Tm enters the gut it has to compete with the commensal microbiota and reach a 
critical density to induce inflammation and allow further transmission via the fecal-oral route 
(Lawley et al., 2008). Compared to the resident microbiota, S. Tm has a growth advantage 
in the presence of anaerobic electron acceptors (nitrate, nitrite, DMSO, TMAO, tetrathionate 
and fumarate) (1.3.4.2). Those metabolites are increased in the inflamed gut, due to the 
host’s immune response (Winter, Lopez, et al., 2013). After S. Tm is ingested, it can attach 
to the epithelial cells via adhesins and the SPI1-T3SS which facilitates invasion into the host 
cells (Gerlach et al., 2007; Hapfelmeier et al., 2005). S.Tm triggers the intracellular 
NAIP/NLRC4 inflammasome which elicits IL18, a proinflammatory cytokine (Muller et al., 
2016; Sellin et al., 2014). This leads to epithelial damage, submucosal edema and attraction 
of cells of the innate immune system like macrophages and neutrophils (Barthel et al., 2003). 
Those cells release harmful reactive oxygen species (ROS) (Winterbourn et al., 2016). 
Further the inducible nitric oxide synthase (iNOS) of intestinal epithelial cells and 
macrophages produce nitric oxide (NO) which reacts with ROS to form reactive nitrogen 
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species (RNS) which creates an antibacterial environment (Aviello & Knaus, 2017). Reactive 
oxygen / nitrogen species lead to DNA damage, lipid peroxidation and protein modification 
which are mechanisms of the innate immune system to prevent spread of pathogenic 
bacteria (Maier et al., 2014; Tharmalingam et al., 2017). In addition these ROS/RNS boost 
also the formation of alternative electron acceptors by oxidation. Microbial released 
hydrogen sulfide (H2S), trimethylamine and NO react with the present ROS and form the 
alternative electron acceptors tetrathionate, TMAO, nitrate and nitrite respectively (Rivera-
Chavez & Baumler, 2015). Recently, it was shown that during S. Tm infection, Clostridia 
spp. are depleted in a SPI1-T3SS dependent manner which leads to reduced butyrate 
concentration and subsequently to oxygenation of the intestinal epithelium. Therefore, 
oxygen becomes available, which can be readily consumed by S. Tm and reinforces its 
colonization (Rivera-Chávez et al., 2016). Taken together S. Tm establishes a beneficial 
milieu for its growth by induction of gut inflammation which allows efficient replication in the 
gut.  
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1.4 Role of the intestinal mucus layer: protection and supply of 
nutrients 
1.4.1 Architecture of the intestinal mucus layer 
The epithelial border of the intestine is lined with a layer of mucus that protects from 
environmental challenges. This intestinal mucus layer consist mainly of the mucin MUC2, 
which is heavily O-glycosylated in the endoplasmatic reticulum of goblet cells and is secreted 
into the lumen (Arike & Hansson, 2016). In the large intestine, mucus consists of two distinct 
layers, the outer loosely attached and the inner firm layer strongly attached to the epithelium. 
The outer layer is permeable to bacteria whereas the inner layer is densely packed and 
devoid of bacteria (Johansson et al., 2008).This mucus protects the epithelium from 
pathogens and bacterial derived products but also serves as a nutrient source (e.g. sialic 
acid, fucose, galactose, amino acids). Commensal bacteria such as Bacteroides 
thetaiotaomicron or Akkermansia muciniphila, harbor multiple glycoside hydrolases which 
they employ to forage the mucus layer (Derrien et al., 2004; Sonnenburg et al., 2005). The 
released nutrients can not only be used by themselves but also by other co-localized 
bacteria by cross-feeding (Backhed et al., 2005; Belzer et al., 2017; Derrien et al., 2004; 
Sonnenburg et al., 2005). Although M.schaedleri colonizes the outer mucus layer it does not 
possess any known genes for mucus degradation (Loy et al., 2017). To summarize, the 
intestinal mucus layer is essential for human health and offers a complex niche for the 
microbiota. 
1.4.2 Agr2-/- mice, lacking secreted MUC2, are protected against S. Tm 
induced colitis 
Previous work in the group employed the Agr2-/- mouse model to study the role of the mucus 
layer in S. Tm infection (Brugiroux, 2016). Agr2-/- mice lack the protein disulfide isomerase 
anterior gradient homolog 2 (AGR2) which is important for correct folding and secretion of 
MUC2. Mice deficient in AGR2 (Agr2-/-) lack MUC2 in the intestine but exhibit no adverse 
health effects during the early life stages (up to 4 months) (Bergström et al., 2014; Park et 
al., 2009). Histology and microarray data showed that the intestine of Agr2-/- mice harbors 
an increased amount of mast cells and proinflammatory cytokines (Park et al., 2009). Still, 
mice do not develop spontaneous colitis but are more susceptible to chemically induced 
DSS colitis (Park et al., 2009). 
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Agr2-/- mice, pretreated with the antibiotic streptomycin, showed reduced inflammation after 
one day of infection with S. Tm, compared to Agr2+/- mice (Brugiroux, 2016). On the contrary, 
when mice are pretreated with ampicillin instead of streptomycin, S. Tm colitis was induced 
in Agr2-/- as well as Agr2+/- mice (Brugiroux, 2016) (Fig. 4A). Microbiota analysis revealed, 
that M. schaedleri is enriched in the protected Agr2-/- streptomycin treated mice compared 
to the three unprotected groups (Brugiroux, 2016) (Fig. 4B). Thus it was hypothesized that 
M. schaedleri is protective against S.Tm induced colitis. The aim of my PhD thesis was to 
further investigate the protective effect of M. schaedleri in S. Tm colitis.  
 
Fig. 4. Streptomycin treated Agr2-/- mice are protected from S.Tm induced colitis (Brugiroux, 2016). Agr2-
/- and Agr2+/- mice were treated with streptomycin or ampicillin one day before infection with S.Tm and LCN2 
levels at day 1 post infection is shown as a measure of intestinal inflammation. Mann–Whitney U test; ns, no 
significant difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. B) DNA from cecal samples was extracted, 
sequenced and bioinformatic analysis on the 16S rRNA genes was performed. The cladogram shows indicator 
species, which are enriched in the protected mice compared to all other three unprotected groups using LEfSe 
algorithm (Segata et al., 2011). Adapted from (Brugiroux, 2016). 
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2 Aims of this PhD thesis 
 
To identify the causal role of one bacterial species and its contribution to or protection from 
disease is still a challenging task. In a previous study Mucispirillum schaedleri, a member of 
the Deferribacteres, was identified by comparative microbiome analysis as a candidate 
bacterium for protection from S. Tm colitis (Brugiroux, 2016). 
In order to investigate, if M. schaedleri plays a protective role in S. Tm infection, I plan to 
employ gnotobiotic mouse models colonized with different microbial consortia, associated 
in addition with M. schaedleri or control, where the impact of M. schaedleri on the 
microbiome, the host and S. Tm infection can be causally addressed.  
Streptomycin treated mucus-deficient Agr2-/- mice exhibit increased levels of M. schaedleri 
and are protected from S. Tm colitis (Brugiroux, 2016). So far the role of mucus-deficiency 
on M. schaedleri colonization and function is unclear. By generating gnotobiotic Agr2-/- mice 
I want to analyze if protection of conventional streptomycin treated Agr2-/- mice is mediated 
by the microbiota or the host’s genotype. 
Last, I want to elucidate the protective mechanism of M. schaedleri in S.Tm colitis by using 
metabolite analysis and infection studies with S.Tm mutants defective in different pathways 
which may be involved in competition with M. schaedleri. 
Materials and Methods 
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3 Materials and Methods 
3.1 Materials 
3.1.1 Media and buffer 
 
Table 1. Luria-Bertani (LB) medium 
Components Per liter 
NaCl 5 g 
Yeast extract  5 g 
Tryptone  10 g 
All components were dissolved in dH2O. 
Table 2. LB agar 
Components Per liter 
NaCl 5 g 
Yeast extract  5 g 
Tryptone  10 g 
Agar 15 g 
All components were dissolved in dH2O. 
Table 3. LB 0.3 M NaCl 
Components Per liter 
NaCl 17.53 g 
Yeast extract  5 g 
Tryptone  10 g 
All components were dissolved in dH2O. 
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Table 4. Peptone-glycerol broth (P/G) 
Components Per liter 
Peptone  20 g 
Glycerol 50 ml 
All components were dissolved in dH2O. 
Table 5. 10 x Phosphate Buffered Saline (PBS) 
Components Per liter  
NaCl  80 g 
KCl 2 g 
Na2HPO4  6.1 g 
KH2PO4 2.4 g 
All components were dissolved in dH2O. 
Table 6. Akkermansia medium (AAM) without mucin, supplemented with NaNO3 
Components Per liter medium 
Brain Heart Infusion  18.5 g 
Trypticase soy broth 15 g 
Yeast extract 5 g 
K2HPO4 2.5 g 
Hemin 1 mg 
Glucose 0.5 g 
NaNO3 0.85 g 
Autoclave and add the following components under sterile conditions: 
Na2CO3¤ 0.4 g 
Cysteine hydrochloride# 0.5 g 
Menadione# 0.5 g 
Complement inactivated FCS# 3 % 
Hemin, resuspended in ethanol p.a. and supplemented with NaOH until dissolved; menadione, was 
resuspended in ethanol p.a.; Cysteine hydrochloride and Na2CO3 were dissolved in dH2O. After 
addition of supplements, the still warm media was imported under the anaerobic tent. 
¤ Autoclaved. # Sterile filtered. 
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Table 7. 4 % Paraformaldehyde (PFA) 
Components Per liter 
ddH2O 300 ml 
PFA 40 g 
1 M NaOH 100 µl 
10 x PBS in ddH2O, pH 7.4 100 ml 
Components were heated up to 60 °C and stirred vigorously until PFA is dissolved. ddH2O (Ampuwa) 
was filled up to 1 l, pH was adjusted, afterwards sterile filtered and stored at -20 °C. 
Table 8. 50 x TAE buffer 
Components Per 5 l 
Tris 1,210 g 
Glacial acetic acid 285.5 ml 
0.5 M EDTA pH 8.0 500 ml 
dH2O ad 5 l 
 
Table 9. 10 x loading dye 
Components Final concentration 
Sucrose 40 % 
Bromphenol blue 0.25 % 
Xylene Cyanol 0.25 % 
 
Table 10. SOC medium 
Components Per 250 ml 
Tryptone 5 g 
Yeast extract 1.25 g 
NaCl 0.125 g 
250 mM KCl 2.5 ml 
Ad 250 ml with ddH2O (Ampuwa), adjust pH to 7.0 with 5 M NaOH 
and autoclave. 
1 M glucose (sterile filtered) 5 ml 
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Table 11. 20 % glycerol-palladium solution 
Components Per 50 ml 
100 % glycerol 10 ml 
Palladium crystals Tip of spatula 
ddH20 40 ml 
After autoclaving, the warm solution (60 °C) was imported in the anaerobic tent. 
Table 12. PBT 
Components Per 200 ml 
BSA fraction V 200 mg 
TM 10 tergitol 200 µl 
1 x PBS ad 200 ml 
Solution was sterile filtered and stored at -20°C. 
Table 13. Lysis buffer for DNA extraction (Stool kit, Qiagen) 
Components Final concentration 
Tris 20 mM 
EDTA 2 mM 
Triton X 100 1 % 
Adjust pH to 8.0 with HCl, autoclave and add: 
Lysozyme 20 mg/ml 
Components were dissolved in ddH2O (Ampuwa). 
Table 14. CTAB/NaCl 
Components Final concentration 
CTAB 10 % 
NaCl 0.7 M 
All components were dissolved in Ampuwa water. 
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Table 15. TE buffer 
Components Final concentration 
Tris-Cl 10 mM 
EDTA 1 mM 
All components were dissolved in ddH2O (Ampuwa) and pH was adjusted to pH 8.0 with HCl 
Table 16. Extraction buffer for DNA extraction (Turnbaugh/Ubeda) 
Components Final concentration 
Tris  200 mM 
NaCl 200 mM 
EDTA 20 mM 
Components were dissolved in ddH20 (Ampuwa). pH was adjusted to 8.0 using HCl and the solution 
was finally autoclaved. 
Table 17. Hybridization buffers (HB) for FISH 
Component Volume 
5 M NaCl 180 µl 
1 M Tris / HCl 20 µl 
ddH2O 449 µl 
Formamide 350 µl 
10 % SDS 1 µl 
 
Table 18. Washing buffer (WB) for FISH 
Component Volume 
5 M NaCl 0.7 ml 
1 M Tris / HCl 1 ml 
0.5 M EDTA 0.5 ml 
ddH2O To 50 ml 
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Table 19. Lysis buffer (Luciferase assay) 
Component Final concentration 
K2HPO4   100 mM 
KH2PO4  100 mM 
EDTA  2 mM 
Triton X-100 1 % 
BSA (PAA) 5 mg/ml 
Solution was sterile filtered (0.22µm) and stored at -20 °C. Following 
ingredients were added freshly per 10 ml: 
PIC 100µl of 5x Protease inhibitor 
cocktail 
DTT 1 mM 
Lysozyme 5 mg/ml 
All components were dissolved in ddH2O (Ampuwa). 
Table 20. Luciferase reagent 
Component Final concentration 
Tricine  20 mM 
(MgCO3)4Mg(OH)25H2O 1 mM 
EDTA 0.1 M 
D(-) Luciferin  470 µM 
DTT  33 mM 
Li3-Coenzym A  270 µM 
Mg-ATP  530 µM 
Glycylglycin  125 µM 
Tricine  5 mg/ml 
All components were dissolved in ddH2O (Ampuwa) and stored at -20 °C. 
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3.1.2 Strains and plasmids 
 Strains  
Table 21. S. Tm and C. rodentium strains  
Strain 
Lab-internal 
strain 
designation 
Genotype Resistances Reference 
S. Tmwt SB300 S. Tm strain SL1344  Strep 
(Hoiseth & Stocker, 
1981) 
S. Tmavir M2702 SL1344 ΔinvG; ΔssaV Strep (Maier et al., 2013) 
S. TmSPI1 SB161 SL1344 ΔinvG Strep (Kaniga et al., 1994) 
S. TmavirpsicAgfp M2702_pM974 S. Tmavir with plasmid pM974 Strep; Amp (Brugiroux, 2016) 
S. TmavirpM1419 M2702_pM1419 S. Tmavir with plasmid pM1419 Strep; Amp This study 
S. Tmavir hyd3 M3087 ΔSL1467‐SL1468, SL1714‐
SL1715::aphT, SL3121‐
SL3124::cat ΔinvG; ΔssaV 
Strep; Cm; Kan (Maier et al., 2013) 
S. Tm∆narZ MBE1 SL1344 narZ::cat Strep; Cm (Beutler, 2016) 
S. Tm∆narG MBE2 SL1344 narG::cat Strep; Cm (Beutler, 2016) 
S. Tm∆napA MBE3 SL1344 napA::aphT Strep; Kan (Beutler, 2016) 
S. Tm∆nr3 MBE7 ΔnarZ; narG::cat; napA::aphT Strep; Cm; Kan (Beutler, 2016) 
SHE1 SHE1 ΔinvG; ΔssaV 
narZ::cat (P22-phage lysate of 
MBE1 on M2702) 
Strep; Cm This study 
SHE2 SHE2 ΔnarZ (pCP20 in SHE1) 
Strep This study 
SHE3 SHE3 ΔnarZ; narG::cat (P22-phage 
lysate of MBE2 on SHE2) 
Strep; Cm This study 
S. Tmavir ∆nr3  SHE4 ΔnarZ; narG::cat; napA::aphT 
(P22-phage lysate of MBE3 on 
SHE3) 
Strep; Cm; Kan This study 
S. Tm avir ∆nr3 sicA-luc SHE5 ΔnarZ; narG::cat; napA::aphT 
pagC::pM1471 (PsicA-luc) 
(P22-phage lysate of M971 on 
SHE4) 
Strep; Cm; Kan; 
Amp 
This study 
S. TmsicA-luc M971 pagC::pM1471 (PsicA-luc) Strep; Amp (Häberli, 2005) 
S. Tmavir sicA-luc SHE11 pagC::pM1471 (PsicA-luc) 
(P22-phage lysate of M971 on 
M2702) 
Strep; Amp This study 
SHE13 SHE13 moaA::aphT Strep; Kan This study 
S. Tm∆moaA SHE14 moaA::aphT  (P22-phage 
lysate of SHE13 on SB300) 
Strep; Kan This study 
C. rodentium DBS100   
(Schauer & Falkow, 
1993) 
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Table 22. Mouse derived bacterial strains  
Strain Taxonomy (species level) DSM No. Reference 
OligoMM12 
YL2 
Bifidobacterium longum  
subsp. animalis 
26074 (Brugiroux et al., 2016) 
YL27 Muribaculum intestinale 28989 (Brugiroux et al., 2016) 
YL31 Flavonifractor plautii 26117 (Brugiroux et al., 2016) 
YL32 Clostridium clostridioforme 26114 (Brugiroux et al., 2016) 
YL44 Akkermansia muciniphila 26127 (Brugiroux et al., 2016) 
YL45 Turicimonas caecimuris 26109 (Brugiroux et al., 2016) 
YL58 Blautia coccoides 26115 (Brugiroux et al., 2016) 
I46 Clostridium innocuum 26113 (Brugiroux et al., 2016) 
I48 Bacteroides caecimuris 26085 (Brugiroux et al., 2016) 
I49 Lactobacillus reuteri 32035 (Brugiroux et al., 2016) 
KB1 Enterococcus faecalis 32036 (Brugiroux et al., 2016) 
KB18 Acutalibacter muris 26090 (Brugiroux et al., 2016) 
ASF3 
ASF356 Clostridium sp.  Charles River Laboratories 
ASF519 Parabacteroides. goldsteinii  Charles River Laboratories 
ASF361 Lactobacillus murinus  Charles River Laboratories 
ASF457 Mucispirillum schaedleri  Charles River Laboratories 
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 Plasmids 
 
Table 23. Plasmids in S. Tm 
Plasmid Genotype Reference 
pM974 
T3SS-1 (SPI-1) promotor of the sicAsipBCDA operon coupled with 
GFPmut2 coding sequence AmpR 
(Ackermann et al., 2008)  
pM1419 
Temperature sensitive plasmid, variant of pHSG422 lacking KmR 
CmR resistances; AmpR 
(Stecher et al., 2008) 
 
Table 24. Plasmids for lambda Red recombination in S. Tm 
Plasmid Function Genotype Reference 
pKD3 Harbors a chloramphenicol resistance gene 
(cat) 
cat with FRT sites, 
AmpR 
(Datsenko & Wanner, 
2000) 
pKD4 Harbors a kanamycin resistance gene 
(aphT) 
aphT with FRT sites, 
AmpR 
(Datsenko & Wanner, 
2000) 
pKD46 Harbors 2,154 nt (31088–33241) of phage 
λ, enzymes for recombination 
araC, ParaB γ, β and 
exo, repA101ts, AmpR 
(Datsenko & Wanner, 
2000) 
pCP20 Harbors FLP-recombinase FLP+, λ cI857+, λ pR 
Repts, AmpR, CmR 
(Cherepanov & 
Wackernagel, 1995) 
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3.1.3 Oligonucleotides 
 
Table 25. Oligonucleotides and hydrolysis probes for qPCR 
Primers and 
corresponding probe 
(targeted strain) 
Sequence 5’ - 3’ Reference 
Isol46_Exonucl.2_fwd CGGATCGTAAAGCTCTGTTGTAAG (Brugiroux et al., 2016) 
Isol46_Exonucl.3_rev GCTACCGTCACTCCCATAGCA  
Probe3_Isol46 
(Clostridium innocuum I46) 
FAM-AAGAACGGCTCATAGAGG-BHQ1  
Isol49_Exonucl._fwd GCACTGGCTCAACTGATTGATG (Brugiroux et al., 2016) 
Isol49_Exonucl._rev CCGCCACTCACTGGTGATC  
Probe_Isol49 
(Lactobacillus reuteri I49) 
HEX-CTTGCACCTGATTGACGA-BHQ1  
YL58_Exonucl._fwd GAAGAGCAAGTCTGATGTGAAAGG (Brugiroux et al., 2016) 
YL58_Exonucl._rev CGGCACTCTAGAAAAACAGTTTCC  
Probe_YL58 
(Blautia coccoides YL58) 
FAM-TAACCCCAGGACTGCAT-BHQ1  
YL27_Exonucl.2_fwd TCAAGTCAGCGGTAAAAATTCG (Brugiroux et al., 2016) 
YL27_Exonucl.2_rev CCCACTCAAGAACATCAGTTTCAA  
Probe2_YL27 
(Muribaculum intestinale YL27) 
HEX-CAACCCCGTCGTGCC-BHQ1  
YL31_Exonucl.2_fwd AGGCGGGATTGCAAGTCA (Brugiroux et al., 2016) 
YL31_Exonucl.3_rev CCAGCACTCAAGAACTACAGTTTCA  
Probe2_YL31 
(Flavonifractor plautii YL31) 
FAM-CAACCTCCAGCCTGC-BHQ1  
YL32_Exonucl.2_fwd AATACCGCATAAGCGCACAGT (Brugiroux et al., 2016) 
YL32_Exonucl.2_rev CCATCTCACACCACCAAAGTTTT  
Probe2_YL32 
(Clostridium clostridioforme YL32) 
HEX-CGCATGGCAGTGTGT-BHQ1  
KB1_Exonucl._fwd CTTCTTTCCTCCCGAGTGCTT (Brugiroux et al., 2016) 
KB1_Exonucl._rev CCCCTCTGATGGGTAGGTTACC  
Probe_KB1 
(Enterococcus faecalis KB1) 
FAM-CACTCAATTGGAAAGAGGAG-
BHQ1 
 
YL2_Exonucl._fwd GGGTGAGTAATGCGTGACCAA (Brugiroux et al., 2016) 
YL2_Exonucl._rev CGGAGCATCCGGTATTACCA  
Probe_YL2 
(Bifidobacterium longum subsp. 
animalis YL2) 
HEX-CGGAATAGCTCCTGGAAA-BHQ1  
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Primers and 
corresponding probe 
(targeted strain) 
Sequence 5’ - 3’ Reference 
KB18_Exonucl.2_fwd TGGCAAGTCAGTAGTGAAATCCA (Brugiroux et al., 2016) 
KB18_Exonucl.2_rev TCACTCAAGCTCGACAGTTTCAA  
Probe2_KB18 
(Acutalibacter muris KB18) 
FAM-CTTAACCCATGAACTGC-BHQ1  
YL44_Exonucl._fwd CGGGATAGCCCTGGGAAA (Brugiroux et al., 2016) 
YL44_Exonucl._rev GCGCATTGCTGCTTTAATCTTT  
Probe_YL44 
(Akkermansia muciniphila YL44) 
HEX-TGGGATTAATACCGCATAGTA-
BHQ1 
 
YL45_Exonucl._fwd AGACGGCCTTCGGGTTGTA (Brugiroux et al., 2016) 
YL45_Exonucl._rev CGTCATCGTCTATCGGTATTATCAA  
Probe_YL45 
(Turicimonas caecimuris YL45) 
FAM-ACCACTTTTGTAGAGAACGA-BHQ1  
Isol48_Exonucl._fwd GGCAGCATGGGAGTTTGCT (Brugiroux et al., 2016) 
Isol48_Exonucl._rev TTATCGGCAGGTTGGATACGT  
Probe_Isol48 
(Bacteroides caecimuris I48) 
HEX-CAAACTTCCGATGGCGAC-BHQ1  
ASF356_Exonucl.2_fwd CGGCAAGGTAAGCGATATGTG (Brugiroux et al., 2016) 
ASF356_Exonucl.2_rev CGCTTTCCTCTCCTGTACTCTAGCT  
Probe2_ASF356 
(Clostridium sp. ASF356) 
FAM-TAACTTAAGGATAGCATAACGAAC 
T-BHQ1 
 
ASF361_Exonucl._fwd TCGGATCGTAAAACCCTGTTG (Brugiroux et al., 2016) 
ASF361_Exonucl._rev ACCGTCGAAACGTGAACAGTT  
Probe_ASF361 
(Lactobacillus murinus ASF361) 
HEX-TAGAGAAGAAAGTGCGTGAGAG-
BHQ1 
 
ASF457_Exonucl._fwd GACTGGAACAACTTACCGAAAGGT (Brugiroux et al., 2016) 
ASF457_Exonucl._rev CAGGTCTCCCCAACTTTTCCT  
Probe_ASF457 
(Mucispirillum schaedleri 
ASF457) 
FAM-TAATGCCGGATGAGTTATA-BHQ1  
ASF519_Exonucl._fwd TGTGGCTCAACCATAAAATTGC (Brugiroux et al., 2016) 
ASF519_Exonucl._rev GCATTCCGCCTACCTCAAATAT  
Probe_ASF519 
(Parabacteroides goldsteinii 
ASF519) 
HEX-TTGAAACTGGTTGACTTGAG-BHQ1  
Salmo_Exonucl._fwd TGGGAAACTGCCTGATGGA (Brugiroux et al., 2016) 
Salmo_Exonucl._rev CTTGCGACGTTATGCGGTATT  
Probe_Salmo 
(Salmonella SL1344) 
FAM-ATAACTACTGGAAACGGTGGC-
BHQ1 
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Primers and 
corresponding probe 
(targeted strain) 
Sequence 5’ - 3’ Reference 
Univ_Exonucl.3_fwd TGCAYGGYYGTCGTCAGC (Brugiroux et al., 2016) 
Univ_Exonucl.3_rev CRTCRTCCYCRCCTTCCTC  
Probe2_Univ HEX-AACGAGCGCAACCC-BHQ1  
* FAM (6-carboxyfluoresceine); HEX (6-carboxyhexafluoresceine); BHQ1 (black hole quencher 1).  
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Table 26.  Primers used for construction of S. Tm mutants 
Designation Sequence 5’ - 3’ 
Construction 
of strain 
Amplicon 
size (bp) 
narZ-fwd-ko AATGGTTTAACGCCAAATCGACAGGATGGCGGA
AAATTTATCGAAGCAGGAGAAATGTCatatgaatatc
ctccttagtt 
  
narZ-rev-ko GGTGTGACAGCCAATACATTTATCGAGATTCAG
TACCATCCCAACCTGTGAGCGTATTTtgtgtaggctg
gagctgcttc 
MBE1 (narZ::cat)  
narZ fwd-check up GCGTCGTAAGCCTAAACA   
narZ rev-check up CCGGTCCAGACGTTTTTA  3948 
narG-fwd-ko CTTAGTTAAGCAATGTCGATTTATCAGAGAGCC
GTAAGGTTCCACACAGGAGAAACCCGatatgaatat
cctccttagtt 
  
narG-rev-ko GGTATGACAGCCGATGCACTTATCGAGATTCAG
CACCATGCCGACTTGTGAACGAATTTtgtgtaggctg
gagctgcttc 
MBE2 (narG::cat)  
narG fwd-check up TTCTCACGCCCATTCAGC   
narG rev-check up CCAGACGTTTTTACAGGT  3921 
napA-fwd-ko GGCGTACTGGCGGTGTCGCTGGTTTATCACCA
GCAGGATGAGCAAGGTGAGGAAACACCatatgaat
atcctccttagtt 
  
napA-rev-ko ACATCACGCAGGAAGCGGCGGCGGCCATTTTG
GGGTTTCGCTGTACGGGACATAACGCGtgtgtagg
ctggagctgcttc  
MBE3 (napA::aphT)  
napA fwd-check up ACAATTGAGTCAGTACGC   
napA rev-check up GCTGGCGAAGACATTTTC  2756 
moaA-fwd-ko CGTTTGCCACCAGGGCGCAGGAAGAAATGACT
CCGCCTCCCGTATTTGGAAAGGTGTACatatgaata
tcctccttagtt 
  
moaA-rev-ko ATGCGGGTCGGGATAAATTCAGCGCTGACCTG
ACTCATCTGAAATCTCCTTATTAAGGAtgtgtaggctg
gagctgcttc 
SHE13 
(moaA::aphT) 
 
moaA fwd-check up CACGTATTCTGTCGCTAAA   
moaA rev-check up CGGTTCTCTTTAACGATGG  1405 
Genes of interest were replaced by either chloramphenicol (cat) or kanamycin (aphT) resistance 
genes using the λ Red recombination system (Datsenko & Wanner, 2000). PCR products were 
generated with primers harboring a homology region adjacent to the gene of interest (capital letters) 
and a sequence targeting the plasmids pKD3 (cat) and pKD4 (aphT, small letters) (Table 24). Check-
up primers were used to verify correct insertion of the antibiotic cassette.  
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Table 27. Further oligonucleotides used in this study 
Designation Sequence 5’ - 3’ Purpose Reference 
fD1 CGATATCTCTAGAAGAGTTTGATCCTGG
CTCAG 
Amplification of bacterial 16S 
rRNA genes 
(Weisburg et al., 
1991) 
fD2 CGATATCTCTAGAAGAGTTTGATCATGG
CTCAG 
Amplification of bacterial 16S 
rRNA genes 
(Weisburg et al., 
1991) 
rP1 GATATCGGATCCACGGTTACCTTGTTAC
GACTT 
Amplification of bacterial 16S 
rRNA genes 
(Weisburg et al., 
1991) 
ssaV_check_fwd GGA GCT CTG GTT ACG ATT confirm ∆ssaV genotype in 
M2702 
(Nedialkova, 
2014) 
ssaV_check_rev ATA TTT CAG CCT CAG ACG confirm ∆ssaV genotype in 
M2702 
(Nedialkova, 
2014) 
pagC_pLB02_for GGTCCTGGGGGTCTAGAGAT confirm integration of 
pagC::pM1471 
(Häberli, 2005) 
pagC_chrom_rev AATTGTCGTTGTTGAGCGTTT confirm integration of 
pagC::pM1471 
(Häberli, 2005) 
 
Table 28. Probes for FISH 
Designation Sequence 5’ - 3’ Target Reference 
Msc487_correct 
(2xCy3) 
CAG TCA CTC CGA ACA ACG CT M. schaedleri (Loy et al., 
2017) 
Eub338 I (2xCy5) GCT GCC TCC CGT AGG AGT Most bacteria (Amann et al., 
1990) 
Eub338 III 
(2xCy5) 
GCT GCC ACC CGT AGG TGT Verrucomicrobiales (Daims et al., 
1999) 
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3.1.4  Chemicals and antibiotics 
 
Table 29. Chemicals used in this study 
Compound Supplier 
ABTS substrate  Merck (Darmstadt) 
Acetic acid Roth (Karlsruhe) 
Agar BD (Heidelberg) 
Agarose Bio&Sell (Feucht) 
L-(+)-arabinose Sigma-Aldrich (Munich) 
Brain Heart Infusion Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Bromphenol blue Sigma-Aldrich (Munich) 
Bovine serum albumin (BSA) PAA Laboratories GmbH (Austria) 
BSA fraction V Roth (Karlsruhe) 
CaCl2 Roth (Karlsruhe) 
CaCl2 · 2H2O Merck (Darmstadt) 
Chloroform Roth (Karlsruhe) 
CloneJETTM PCR Cloning kit Fermentas, Thermo Scientific (USA) 
CoCl2 · 6H2O Merck (Darmstadt) 
CuSO4 · 5H2O Merck (Darmstadt) 
Cysteine (-L) Hydrochloride Monohydrate Sigma-Aldrich (Munich) 
ddH2O (Ampuwa) Fresenius Kabi (Bad Homburg) 
ddH2O used for qPCR reactions Gibco, Life Technologies (UK) 
dNTPs Fermentas, Thermo Scientific (USA) 
DAPI Roth (Karlsruhe) 
DreamTaq PCR Master Mix (2x) Fermentas, Thermo Scientific (USA) 
DTPA Sigma-Aldrich (Munich) 
EDTA Biomol (Hamburg) 
EGTA Sigma-Aldrich (Munich) 
Eosin Y solution Sigma-Aldrich (Munich) 
Ethanol p.a. Roth (Karlsruhe) 
Ethidium bromide Sigma-Aldrich (Munich) 
FastStart Essential DNA Probes Master Roche (Mannheim) 
FastStart Taq polymerase Roche (Mannheim) 
FCS Biochrom AG (Berlin) 
FeCl3 · 6H2O Merck (Darmstadt) 
FeSO4 · 7H2O Roth (Karlsruhe) 
Formamide Sigma-Aldrich (Munich) 
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Compound Supplier 
GeneRuler 1kb DNA Ladder Thermo Fisher Scientific biosciences (St. Leon-Rot) 
GeneRuler DNA ladder mix (100bp) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
D-glucose Roth (Karlsruhe) 
Glycerol  Roth (Karlsruhe) 
HCl Roth (Karlsruhe) 
Hemin Sigma-Aldrich (Munich) 
Histidine Sigma-Aldrich (Munich) 
H2O2 Merck (Darmstadt) 
HRP-streptavidin  IBA (Göttingen) 
K2HPO4 Roth (Karlsruhe) 
KCl Fluka, Sigma-Aldrich (Munich) 
KH2PO4 Roth (Karlsruhe) 
Lipocalin-2 standard R&D Systems (Wiesbaden-Nordenstadt) 
Lysozyme from hen egg Sigma-Aldrich (Munich) 
MacConkey agar Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Menadione Sigma-Aldrich (Munich) 
MgSO4 Roth (Karlsruhe) 
MnSO4 · H2O Roth (Karlsruhe) 
MnCl2 · 4H2O Merck (Darmstadt) 
NaCl Roth (Karlsruhe) 
Na2CO3 Merck (Darmstadt) 
Na2HPO4 unhydrated  Roth (Karlsruhe) 
Na2HPO4 · 2H2O Roth (Karlsruhe) 
Na2MoO4 · 2H2O Merck (Darmstadt) 
NaNO2 Sigma-Aldrich (Munich) 
NaNO3 Roth (Karlsruhe) 
NaOH Roth (Karlsruhe) 
NaOH pellets Merck (Darmstadt) 
Na2O6S4 · 2H2O Sigma-Aldrich (Munich) 
Na2SeO3 Sigma-Aldrich (Munich) 
Na2SO4 Merck (Darmstadt) 
NH4Cl Merck (Darmstadt) 
N-naphthylethylenediamine dihydrochloride 
monomethanolate (NEDD) 
Sigma-Aldrich (Munich) 
Normal goat serum Biozol (Eching) 
O.C.T. Sakura Finetek (Torrance) 
Palladium chloride Sigma-Aldrich (Munich) 
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Compound Supplier 
Paraformaldehyde (PFA) Roth (Karlsruhe) 
Phenol:chloroform:isoamylalcohol (25:24:1) Roth (Karlsruhe) 
Potassium acetate Roth (Karlsruhe) 
Protease inhibitor cocktail Sigma-Aldrich (Munich) 
Oligonucleotides  Metabion (Martinsried) 
Peptone Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Q5Tm Hot Start High-Fidelity polymerase New England BioLabs (Frankfurt am Main) 
Rotimount Roth (Karlsruhe) 
Sabouraud dextrose agar Oxoid, Thermo Fisher Scientific Biosciences (St. Leon-Rot) 
Sodium acetate Roth (Karlsruhe) 
Sodium dodecyl sulfate (SDS) Serva (Heidelberg) 
Sucrose Sigma-Aldrich (Munich) 
Sulfanilamide  Merck (Darmstadt) 
Thiamine hydrochloride Roth (Karlsruhe) 
TM 10 tergitol Chemika (Australia) 
Tricine AppliChem (Darmstadt) 
Tris MP Biomedicals (Eschwege) 
Triton Roth (Karlsruhe) 
Trypticase soy broth Oxoid, Thermo Fisher Scientific biosciences (St. Leon-Rot)  
Tryptone  Roth (Karlsruhe) 
Tween Sigma-Aldrich (Munich) 
VCL3 Sigma-Aldrich (Munich) 
Vectashield Enzo life science (UK) 
Vector’s Hämalaun solution Roth (Karlsruhe) 
VirkonS V.P. Produkte (Schlüchtern) 
Xylene Roth (Karlsruhe) 
Xylene Cyanol Sigma-Aldrich (Munich) 
Yeast extract  MP Biomedicals (Eschwege) 
Yeast t-RNA Roche (Mannheim) 
ZnSO4 · 7H2O Merck (Darmstadt) 
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Table 30. Antibiotics used in this study 
Antibiotic Supplier Final concentration 
Ampicillin Roth (Karlsruhe) 100 µg/ml 
Chloramphenicol Roth (Karlsruhe) 30 µg/ml 
Kanamycin sulfate Roth (Karlsruhe) 15 or 30 µg/ml 
Streptomycin sulfate Roth (Karlsruhe) 50 or 100 µg/ml  
 
3.1.5 Antibodies 
 
Table 31. Antibodies used for lipocalin-2 ELISA (mouse lipocalin-2/NGAL detection kit (R&D, DY1857) 
Antibody Origin Supplier Dilution 
Lipocalin-2 capture antibody rat R&D, Part 842440 1:200 
Lipocalin-2 detection antibody (biotinylated) rat R&D, Part 842441 1:200 
 
Table 32. Antibodies used for immunofluorescence staining  
Antibody Origin Supplier Dilution 
α-Salmonella B test serum anti-O 
rabbit Becton Dickinson (New 
Jersey, US) 
1:400 
α-rabbit DyLight 649 
goat Jackson ImmunoResearch 
(Baltimore, US) 
1:400 
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3.1.6 Devices and specific materials 
Table 33. Devices and specific materials 
Items Supplier 
Acid washed glass beads (<106 µm) Sigma-Aldrich (Munich) 
Aluminum crimp seals (diam. 11 mm) Supelco (USA) 
Aluminum crimp seals (diam. 20 mm) Supelco (USA) 
Amp for agarose gels (Power Pac) Bio Rad (Munich) 
BioPhotometer Eppendorf (Wesseling-Berzdorf) 
BreatheEasy membrane Sigma-Aldrich (Munich) 
Butyl-rubber stoppers (diam. 11 mm) Supelco (USA) 
Butyl-rubber stoppers (diam. 20 mm) Geo-Mocrobial Technologies (USA) 
Cannulas B. Braun (Melsungen) 
Cell strainer (40 µm pore size) SPL Life Sciences (Korea) 
Crimper (diam. 11 mm) VWR (Darmstadt) 
Crimper (diam. 20 mm) VWR (Darmstadt) 
Confocal microscope (TCS SP5) Leica (Wetzlar) 
Cryotome Leica Biosystems (Wetzlar) 
Cryo-tubes Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Decrimper (diam. 20 mm) VWR (Darmstadt) 
Dialysis membrane (pore size: 0.025 µm) Merck, Millipore (Darmstadt) 
Diagnostic slides (10 wells, 76 x 25 x 1 mm) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
1.5 ml DNA loBind tubes Eppendorf (Wesseling-Berzdorf) 
Electroporation cuvette (1mm) Peqlab (Erlangen) 
Electroporation device (MicroPulser) Bio Rad (Munich)  
Epi Centrifuge (5430 R) Eppendorf (Wesseling-Berzdorf) 
ezDNase Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Filter Millex (0.22 µm; PES membrane) Merck (Darmstadt) 
Filter Millex (0.45 µm; PVDF membrane) Merck (Darmstadt) 
Gammex® Latex glove Ansell (Brussels) 
Gel documentation chamber Bio Rad (Munich) 
GeneJET RNA cleanup and Concentration Micro Kit  Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Glass slides (cover) Marienfeld Laboratory Glassware (Lauda-Königshofen) 
Gnoto cages Han, Bioscape (Emmendingen) 
Incubator (Heraeus oven) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Laminar flow (Safe 2020) Thermo Fisher Scientific biosciences (St. Leon-Rot) 
LightCycler96 Roche (Mannheim) 
40 µm mesh (cell strainer) BD FalconTM (USA) 
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Items Supplier 
Microplate reader (CLARIOstar ®) BMG LABTECH (Ortenberg) 
NanoDrop Thermo Fisher Scientific biosciences (St. Leon-Rot) 
NEBNext Ultra RNA library prep for Illumina New England Biolabs (Ipswich, MA) 
NucleoSpin gDNA Clean-up kit Macherey-Nagel (Düren) 
NucleoSpin Gel and PCR Clean-up kit Macherey-Nagel (Düren) 
NucleoSpin Plasmid kit Macherey-Nagel (Düren) 
Parafilm BEMIS (USA) 
Peqstar 2x gradient cycler Peqlab (Erlangen) 
Plasmid Plus Midi Kit Qiagen (Hilden) 
Screw cap plastic tubes A. Hartenstein (Würzburg) 
1.5 ml plastic tubes (PCR grade) Eppendorf (Wesseling-Berzdorf) 
2 ml plastic tubes (PCR grade) Eppendorf (Wesseling-Berzdorf) 
15 ml plastic tubes Greiner Bio-One (Frickenhausen) 
50 ml plastic tubes Greiner Bio-One (Frickenhausen) 
Petri dishes Greiner Bio-One (Frickenhausen) 
Qiagen DNA (fast) stool kit Qiagen (Hilden) 
Quant-iT™ RiboGreen™ RNA Assay Kit  Thermo Fisher Scientific biosciences (St. Leon-Rot) 
Ribo-Zero kit Illumina (San Diego, CA) 
Shaker (Certomat R) B. Braun Biotech international (Melsungen) 
Spectrophotometer (Sunrise) Tecan (Crailsheim) 
Stainless steel beads (5 mm) Hübsch Industrietechnik (Blaibach) 
Superfrost Plus slides (75 x 25 x 1 mm) A.Hartenstein (Wuerzburg) 
Syringes B. Braun (Melsungen) 
Tissue lyzer Qiagen (Hilden) 
Vortex Scientific industries (USA) 
96-well ELISA plates (Brandplates) Brand (Wertheim) 
96-well plate for standard assays TPP (Trasadingen) 
96-well plate black with white wells Porvair Sciences Ltd (King’s Lynn UK) 
Wheaton glass serum bottles (1.5 ml) Sigma-Aldrich (Munich) 
Wheaton glass serum bottles (100 ml) Sigma-Aldrich (Munich) 
Zirconia/silica beads (0.1 mm) Roth (Karlsruhe)  
Zirconia-beads (0.7 mm) Roth (Karlsruhe) 
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3.2 Methods  
3.2.1 Anaerobic cultivation of M. schaedleri (ASF457)  
All work was performed under anoxic conditions using an anaerobic chamber (3 % H2, rest 
N2) and all material was pre-reduced at least for two days in this environment. 10 ml of pre-
reduced AAM media (supplemented with 10 mM NaNO3) were distributed in 100 ml Wheaton 
serum bottles, inoculated with 1 ml of M. schaedleri (Table 22) cryostock (3.2.2) and sealed 
with butyl rubbers. The gas phase was exchanged by three times application of vacuum and 
gas atmosphere (7 % H2, 10 % CO2, rest N2). Cultures were grown statically for 48 h to 72 h 
at 37 °C.  
3.2.2 Preparation of cryostocks from anaerobic cultures 
Cryostocks were prepared by mixing fresh cultures (3.2.1) at a 1:1 ratio with a pre-reduced 
20 % glycerol solution containing palladium crystals (Table 11) directly in 1.5 ml glass vials 
and were frozen at -80 °C. Purity of cryostocks was checked by 16S rRNA gene sequencing 
of PCR fragments generated with primers fD1, fD2 and rP1 (Table 27). PCR fragments were 
purified (NucleoSpin Gel and PCR Cleanup kit, Macherey Nagel) and analyzed by Sanger 
sequencing (GATC Biotech, Konstanz). Sequences were compared to reference sequence 
of M. schaedleri (accession number: NR_042896) using CLC DNA Workbench 6.0.2.  
3.2.3 Construction of Salmonella enterica serovar Typhimurium (S. Tm) 
mutants by λ Red recombination   
 PCR fragment 
In frame deletions were performed by using the λ Red system (Datsenko & Wanner, 2000). 
PCR was performed in a Peqstar 2x gradient cycler using a FastStart Taq polymerase 
(Roche) with 10x MgCl2 reaction buffer, dNTPs (200 μM of each nucleotide), 5 - 50 ng of 
template DNA (plasmid pKD3, chloramphenicol resistance [cat] or pKD4, kanamycin 
resistance [aphT] (Table 24)) and oligonucleotides (200 nM each) (Table 26) in a total 
volume of 200 µl. The following cycling conditions were used: one initial denaturation step 
at 95 °C for 6 min followed by: (i) 15 cycles with one cycle at 95 °C for 30 s, 55 °C for 30 s 
and 72 °C for 2 min, (ii) 35 cycles 95 °C for 30 s, 65 °C for 30 s and 72 °C for 2 min and (iii) 
a final elongation step at 72 °C for 10 min. Oligonucleotides were designed to amplify the 
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antibiotic resistance cassette and the FRT sites essential for later removal of the antibiotic 
cassette by FLP recombinase using plasmid pCP20 (Table 24). Furthermore, sequences of 
59 bp homologous upstream to the adjacent start codon and downstream of the stop codon 
of the gene of interest, were attached to the oligonucleotides. PCR product was purified by 
ethanol precipitation. Therefore, 1/10 volume of 3 M NaAcetate and 2 volumes of ice cold 
96 % p. a. EtOH were added, mixed and centrifuged (14,000 rpm, 15 min, 4 °C). The pellet 
was washed in 500 µl of ice-cold 70% EtOH, centrifuged (14,000 rpm, 15 min, 4 °C) and the 
supernatant was discarded. The pellet was dried at 37 °C and resuspended in 22 µl H2O 
(Gibco). Dialysis against Ampuwa H2O was performed for desalting. Therefore, PCR product 
was placed for 60 min on a dialysis membrane (pore size: 0.025 μm (Millipore)) in Ampuwa 
H2O. The DNA was quantified by NanoDrop. 
 Electroporation of PCR product in S. Tm pKD46 
A liquid culture of S. Tm containing the plasmid pKD46 (encoding the λ Red recombinase) 
(Datsenko & Wanner, 2000) was set up by inoculating one colony in 20 ml LB (ampicillin 
100 µg/ml) and incubation for 12 h at 30 °C at 180 rpm. Overnight culture was diluted 1:200 
in 100 ml fresh LB (ampicillin 100 µg/ml) supplemented with 10 mM L-(+)-arabinose to 
induce expression of recombinase and was grown to an OD600 of app. 0.5 with constant 
shaking at 180 rpm at 30 °C. The culture was distributed in 50 ml conical tubes, centrifuged 
(4,500 rpm, 4 °C, 15 min) and supernatant was removed. Electrocompetent cells were 
prepared by resuspending bacteria in 1 ml 10 % glycerol solution, transferring the solution 
to a 1.5 ml tube and centrifugation at full speed 4 °C, 1 min. This washing step was repeated 
five times and after the last washing step bacteria were resuspended in 80 µl of ice-cold 
10 % glycerol solution. 5 - 10 µl of PCR product (3.2.3.1) was gently mixed with 
electrocompetent cells and added to precooled electroporation cuvettes (1 mm; Peqlab). 
Bacteria were electroporated with 1.8 kV for 5 ms (MicroPulser (Bio-Rad)), immediately 
recovered in 1 ml prewarmed SOC media (Table 10) and incubated for 1.5 h at 37 °C at 
500 rpm. 500 µl of bacterial suspension was spun down, plated on LB plates with selective 
antibiotics (kanamycin (100 µg/ml) or chloramphenicol (30 µg/ml)) and incubated o. n. at 
37 °C. Residual bacterial suspension was kept overnight at RT and was plated the next day. 
Colonies were picked and re-streaked, cryostocks were prepared and clones were checked 
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by PCR using Dreamtaq Mastermix (ThermoFisher) with 500 nM of each check-up primer 
(Table 26). Correct insert size was verified by agarose gel electrophoresis. 
 P22 phage transduction 
Phage lysates were produced by mixing 1 ml of an o. n. culture (3 ml LB, 5 mM CaCl2 and 
antibiotics (Table 30)) of the donor strain (3.2.3.2) with 10 µl of P22 stock solution, static 
incubation at 37 °C for 15 min and transfer in an Erlenmeyer flask containing 10 ml LB. This 
culture was grown for 6 h at 37 °C, 180 rpm and afterwards 50 µl of chloroform was added 
and incubated under constant shaking at RT for 30 min before it was filtered (0.45 µm; 
Merck). Sterility was checked by plating 50 µl on LB plates and phage lysate was stored at 
4 °C. For transduction, the generated phage lysate (1 - 10 µl) was mixed with 100 µl of an 
o. n. culture (3 ml LB, 5 mM CaCl2, antibiotics (Table 30)) of the recipient strain, statically 
incubated (15 min, 37 °C) to allow phage absorption before adding 900 µl of fresh LB 
supplemented with 10 mM EGTA and subsequent shaking for 1 h (500 rpm, 37 °C). Bacteria 
were centrifuged (10,000 rpm, 3 min), supernatant was reduced to app. 50 µl in which pellet 
was resuspended and all liquid was plated on selective LB plates supplemented with 10 mM 
EGTA. After incubation o. n. at 37 °C, colonies were picked and re-streaked three times on 
selective LB plates supplemented with 10 mM EGTA to remove phages. Clones were 
checked by PCR and stocked. 
 Generation of S.Tmavir∆nr3 
Single mutants of narZ::cat (MBE1), narG::cat (MBE2) and napA::apHT (MBE3) were 
generated by Dr. Markus Beutler in S. Tmwt background and P22 phage lysates were 
prepared (3.2.3.3). Subsequently, narZ::cat allele was transferred by P22 transduction 
(3.2.3.3) in an attenuated S. Tmavir strain background yielding SHE1. The chloramphenicol 
resistance gene was removed by electroporation of plasmid pCP20 (containing FLP 
recombinase) into SHE1, induction of recombinase at 43 °C and double picking on selective 
and non-selective plates to identify antibiotic sensitive clones (SHE2). In this strain, 
narG::cat and napA::apHT alleles were subsequently transferred by P22 transduction with 
lysate from strains MBE2 and then MBE3 (Table 21). This led to the generation of the triple 
mutant S. Tmavir∆nr3 (SHE4). 
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 Generation of S. Tm∆moaA 
The kanamycin resistance cassette was amplified from plasmid pKD4 (Table 24) using 
moaA_KO_fwd and moaA_KO_rev (Table 26) and PCR product was electroporated in 
S. Tmwt harboring pkD46 (3.2.3.2) from which S. Tm∆moaA (SHE13) was obtained. A P22 
lysate was prepared (3.2.3.3) and transduction of the moaA::apHT allele was performed into 
fresh S. Tmwt strain background yielding S. Tm∆moaA (SHE14). Cryostocks were done and 
clones were checked by PCR (Table 26).  
3.2.4 Fluorescence In Situ Hybridization (FISH) 
The distal part of the cecum was fixed in 4 % paraformaldehyde (PFA) (o. n at 4 °C), 
incubated in 20 % sucrose solution (o. n. 4 °C) and then embedded in tissue-tek O.C.T. 
(Sakura), flash frozen in liquid nitrogen and stored at -80 °C. 7 µm tissue sections were cut 
and dried o. n. at RT. Sections were dehydrated in 50 %, 80 % and 95 % ethanol for 3 min 
each. Hybridization buffer (Table 17) with 35 % formamide was prepared, fluorescently 
labelled probes (Table 28) were added to a final concentration of 5 ng/µl, pipetted on the 
sections and incubated at 46 °C for 3 h. Slides were washed in prewarmed wash buffer 
(Table 18) for 10 min at 48 °C, then dipped in ice-cold Ampuwa water and air-dried. 4',6-
diamidino-2-phenylindole (DAPI) staining was performed with a 1 µg/ml solution (in Ampuwa 
H2O) for 30 min at 4 °C. Before mounting with Vectashield and sealing with nail polish, slides 
were washed three times in ice-cold Ampuwa water and air dried. Afterwards, slides were 
kept at 4°C until analysis using a confocal TCS SP5 microscope (Leica). 
3.2.5 Immunofluorescence staining 
As described earlier (3.2.4), 7 µm cryosections were prepared and dried o. n.. Slides were 
washed one minute in PBS and afterwards blocked with 10% normal goat serum in PBS for 
60 min at RT. Blocking solution was removed and primary antibody (Table 32) in 10 % 
normal goat serum was added for another 60 min at RT. Slides were washed three times 
5 min in PBS and incubated for 30 min with secondary antibody (Table 32) and DAPI (final 
concentration of 1 µg/ml) in 10 % normal goat serum. Finally, slides were washed again 
three times 5 min, air dried, mounted with Vectashield and sealed with nail polish. Slides 
were stored at 4 °C until analysis with a TCS SP5 microscope (Leica). For analysis of GFP+ 
S. Tm (S.TmavirpsicAgfp), images with 2 x Zoom were made (1028 x 1028 resolution). These 
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were imported into ImageJ (Rasband, W.S., ImageJ 1.48v, U. S. National Institutes of 
Health, Bethesda, Maryland, USA, https://imagej.nih.gov/ij/, 1997-2016), inverted and the 
number of all α-Salmonella B test serum anti-O (Table 32) stained bacteria were determined. 
Afterwards, the number of all double positive bacteria (α-Salmonella and GFP+ bacteria) 
was determined and the percentage of GFP+ bacteria was calculated. 
3.2.6 Luciferase assay 
S.Tm, harboring a chromosomal luciferase reporter gene, were grown under anaerobic 
conditions in 100 ml serum glass bottles with 10 ml AAM (Table 6) supplemented with 0.3 M 
NaCl for 12 h at 37 °C and appropriate antibiotics. Cultures were removed from serum 
bottles with a sterile needle and syringe under laminar flow and imported into anaerobic tent 
where 96 well plates for anaerobic and microaerophilic conditions were prepared. Overnight 
cultures were directly diluted 1:20 in fresh LB media into 96 well plates in duplicates. Plates 
were sealed with BreatheEasy membrane (Sigma-Aldrich), placed in an anaerobic jar, 
exported from anaerobic tent and a vacuum / gas cycle was applied three times (anaerobic: 
7 % H2, 10 % CO2, rest N2; microaerophilic: 0.8 % O2, 5 % CO2, rest N2). For aerobic 
incubation, plates were prepared at ambient air with non-reduced media. All plates were 
incubated at 37 °C for 4 h, OD600 was measured (Sunrise Spectrophotometer, Tecan) and 
cultures were transferred in 1.5 ml plastic tubes, centrifuged (20 min, 14,000 rpm 2 °C), 
supernatant was discarded and pellet was stored at -80 °C. To measure luciferase activity, 
bacteria were lysed with Luc-lysis buffer (Table 19, 15 min at RT, vortexed every 2 min). 
Lysate was frozen for 1 hr at -20 °C and thawed again. Thereafter samples were briefly 
vortexed and centrifuged for 30 s to pellet cell debris. 25 µl of supernatant was pipetted in 
black 96 well plates with white wells (Porvair science) and luminescence was measured 
using Clariostar microplate reader (BMGLabtech). 50 µl of luc-reagent (Table 20) was 
directly injected before measurement to each well and luciferase signal was quenched with 
100 µl EtOH after each measurement. 
3.2.7 Hematoxylin and eosin staining (HE staining) 
Cecal tissue, directly frozen in O.C.T was cut in 5 µm sections by using a cryotome (Leica) 
and mounted onto Superfrost Plus glass slides (Hartenstein). Sections were dried o. n. and 
fixed for 30 s in Wollman solution (95 % ethanol, 5 % acetic acid), washed in flowing tap 
water (1 min) and rinsed in dH2O. Afterwards, slides were incubated for 20 min in Vectors’s 
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Hämalaun (Roth) washed in flowing tap water (5 min), dipped one time in de-staining 
solution (70 % ethanol with 1 % HCl), washed again in flowing tap water (5 min) and rinsed 
in dH2O with subsequent rinses in 70 % and 90 % ethanol. Slides were then dipped for 15 s 
in alcoholic eosin (90 % ethanol) with Phloxin (Sigma-Aldrich), rinsed in dH2O followed by 
dehydration in 90 % ethanol, 100 % ethanol and xylene. Sections were directly mounted with 
Rotimount and thoroughly dried. 
Histopathological scoring of cecal tissue was performed as described previously (Stecher et 
al., 2007). Submucosal edema (0-3), infiltration of polymorphonuclear neutrophils (PMNs) 
(0-4), loss of goblet cells (0-3) and epithelial damage (0-3) was evaluated and all individual 
scores were summed up to give a final pathology score: 0-3 no inflammation; 4-8 mild 
inflammation; 9-13 profound inflammation. For experiments with Agr2-/- mice, scoring was 
performed without taking into account loss of goblet cells as Agr2-/- mice do not possess 
goblet cells. 
3.2.8 Lipocalin-2 (LCN2) Elisa 
ImmunoGradeTM 96-well plates (Brand) were coated with 50 µl lipocalin-2 capture antibody 
(1:200 in PBS) (Table 31) over night at 4 °C in a humid chamber. Plates were washed three 
times in wash buffer (0.05 % Tween-20 in PBS) and blocked for one hour at RT with 100 µl 
blocking buffer (2 % BSA in PBS). Again, plates were washed three times and 50 µl of 
sample (undiluted (resuspended in PBT (Table 12)); 1:20 and 1:200 dilutions in PBS) were 
added in duplicates. For quantification a standard with a starting concentration of 50 ng/ml 
lipocalin-2 was added and serially diluted 1:3 in blocking buffer. After one hour of incubation 
at RT and six times washing, 50 µl of lipocalin-2 detection antibody (1:200 in blocking buffer) 
(Table 31) was added, subsequently incubated for one hour at RT and washed six times. 
With 100 µl of HRP-streptavidin (1:1,000 in PBS) the plate was incubated for one hour at 
RT, six times washed and developed 30 min at RT with 100 µl substrate (1 mg ABTS in 10 ml 
0.1 M NaH2PO4 pH 4, 5 µl H2O2) in the dark. Absorbance was measured at 405 nm with a 
spectrophotometer (Sunrise, Tecan).  
3.2.9 Invasion assay of S. Tm in HuTu80 cells 
Invasion assay was performed by Stefanie Walther (RKI, Wernigerode). Briefly, from 
overnight cultures a 1:31 subculture of each individual S.Tm strain was set up in LB with 
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10 mM KNO3 LB and cultured for 3.5 h in a roller drum under aerobic or microaerophilic 
conditions (0.5 % O2). HuTu80 cells (ATCC: HTB-40), a human duodenum adenocarcinoma 
cell line, were seeded 24 h prior to infection and infected with S.Tm strains with an MOI of 5 
for 10 min. Non-adherent bacteria were removed by washing and cells were incubated with 
gentamicin for 1 h to kill external bacteria. Afterwards, cells were lysed and invaded bacteria 
were quantified by plating. Invasion is presented as percentage of gentamicin-protected 
bacteria relative to the inoculum. 
3.2.10 gDNA extraction from Gram negative bacteria 
DNA was extracted following a standard phenol/chloroform/isoamylalcohol protocol. Briefly, 
bacterial pellets were resuspended in 567 µl TE buffer, 30 µl of a 10 % SDS solution and 3 µl 
of 20 mg/ml proteinaseK were added, briefly vortexed and tube was incubated for 60 min at 
55 °C. 100 µl of a 5 M NaCl solution and 80 µl of CTAB/NaCl was added, mixed and further 
incubated for 10 min at 65 °C. Equal volume of phenol:chloroform:isoamylalcohol (25:24:1) 
was added, thoroughly mixed and centrifuged (5 min, RT, 12,000 x g). The aqueous phase 
was transferred into a new tube, 0.7 x vol isopropanol and 1/10 vol. 3 M NaAcetate were 
added, the tube was inverted three times and centrifuged (30 min, 4 °C, 20.817 x g). The 
supernatant was discarded, pellet was washed with 500 µl ice-cold 70 % EtOH and 
centrifuged (15 min, 4 °C, 20,817 x g). Again, the supernatant was removed, pellet was air 
dried and resuspended in 50 µl TE buffer. DNA was stored at 4 °C for Illumina sequencing 
or stored at -20 °C. 
3.2.11 gDNA extraction from feces and cecal content 
 QIAamp Fast DNA Stool Kit (Qiagen) 
DNA extraction was performed as described in the manual of the QIAamp Fast DNA Stool 
kit with some modification. Briefly, Intestinal content was resuspended in 700 µl InhibitEx 
buffer and three small spoons of each Zirconia-beads (0.7 mm) and acid washed glass 
beads (≤ 106 µm) were added. Bacteria were lysed by bead beating (TissueLyser LT, 
Qiagen; 3 min, 50 Hz) and heating to 95 °C for 5 min followed by a second bead beating step 
(TissueLyser LT,Qiagen; 3 min, 50 Hz). After centrifugation (15,000 x g, 1 min, RT), the 
supernatant was transferred into a new tube and kept on ice. The pellet was supplemented 
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with 200 µl lysis buffer for Gram+ bacteria (Table 13) and incubated for 30 min, 37 °C. 500 µl 
InhibitEx buffer was added and stool sample was re-extracted as before (bead beating, 5 min 
95 °C, bead beating) and centrifuged. Supernatant was pooled with the one obtained earlier. 
15 µl proteinaseK were added to 400 µl supernatant and then mixed with 400 µl AL buffer, 
vortexed for 15 s and incubated for 10 min at 70 °C. Afterwards, 400 µl EtOH p. a. (96 %) 
was mixed with the lysate and applied to a QIAamp spin column (15,000 x g, 1 min, RT). 
Columns were washed with 500 µl AW1 (15,000 x g, 1 min, RT) and 500 µl AW2 (15.000 x 
g, 3 min, RT) followed by a drying step (15,000 x g, 3 min, RT) to remove residual AW2. 
DNA was eluted with 100 µl ATE buffer (preheated to 70 °C). DNA was diluted in Gibco H2O 
to a final concentration of 2 ng/µl and stored at -20 °C. 
 gDNA extraction (Turnbaugh et al., 2009) 
DNA extraction was performed as described previously (Turnbaugh et al., 2009; Ubeda et 
al., 2012). Intestinal content or feces was resuspended in 500 µl extraction buffer (Table 16) 
and 210 µl 20 % SDS, 500 µl phenol:chloroform:isoamylalcohol (25:24:1, pH 7.9) and 20 
small spoons of 0.1 mm-diameter zirconia / silica beads were added. Bacteria were lysed 
with a bead beater (TissueLyser LT, Qiagen) for 4 min, 50 Hz and afterwards spun down 
(14,000 x g, 5 min, RT). Aqueous phase was transferred into a new tube and 500 µl of 
phenol : chloroform : isoamylalcohol (25 : 24 : 1, pH 7.9) was added, gently inverted and 
again spun down (14,000 x g, 5 min, RT). After repeated transfer of aqueous phase into a 
new tube, 1 ml 96 % ethanol and 50 µl of 3 M sodium acetate were added, gently inverted 
2 - 3 times and centrifuged for 30 min (14,000 x g, 4 °C). Supernatant was discarded and 
DNA pellet was washed by inversion with 500 µl ice-cold 70 % ethanol and again centrifuged 
(14,000 x g, 4 °C; 15 min). Supernatant was discarded, pellet air-dried and DNA was 
resuspended in 150 µl 10 mM Tris-HCL pH 8. After DNA was properly dissolved, it was 
purified using the NucleoSpin gDNA clean-up kit (Macherey-Nagel, 740230). DNA was 
eluted with 100 µl of preheated (70 °C) DE buffer (11.000 x g, 30 s) and diluted to a final 
concentration of 2 ng/µl in H2O (Gibco). DNA was stored at -20 °C. 
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3.2.12 Hydrolysis-probe based quantitative real-time PCR (qPCR) 
Duplex-assays were established and optimized in a Roche LightCycler96® system by Dr. 
Markus Beutler (Brugiroux et al., 2016). Probes and primers are listed in (Table 25). Briefly, 
DNA extracted from feces or cecal content was diluted to a final concentration of 2 ng/µl and 
5 ng were used per analysis. Samples were added as duplicates in 96 well plates (Roche) 
mixed with 0.2 µl of respective primer (30 µM) and hydrolysis probe (25 µM), 10 µl 2 x 
FastStart Essential DNA Probes Master (Roche) and 5.5 µl H2O (Gibco). The following 
cycler conditions were used: preincubation for 10 min at 95 °C, followed by 45 cycles of 15 s 
95 °C and 60 s 60 °C. Fluorescence was recorded after each cycle. Data were analyzed with 
the LightCycler96® software package (Roche). 
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3.2.13 Animal experiments 
All animal experiments were performed at the Max von Pettenkofer-Institute, Munich and 
were approved by the Regierung Oberbayern (55.2-1-54-2532-13-15 and 55.2-1-54-2532-
145-14). 
 Mice used in this study 
C57BL/6J mice associated with a reduced Altered Schaedler Flora (ASF) colonized with 
three of the eight ASF members are termed ASF3 mice (Clostridium sp., ASF356; 
Lactobacillus murinus, ASF 361 and Parabacteroides goldsteinii, ASF 519) (Brugiroux et al., 
2016). 
C57BL/6J mice harboring the OligoMM12 microbiota (Clostridium innocuum I46, Bacteroides 
caecimuris I48, Lactobacillus reuteri I49, Enterococcus faecalis KB1, Acutalibacter muris 
KB18, Bifidobacterium longum subsp. animalis YL2, Muribaculum intestinale YL27, 
Flavonifractor plautii YL31, Clostridium clostridioforme YL32, Akkermansia muciniphila  
YL44, Turicimonas muris YL45, Blautia coccoides YL58) were generated as described 
(Brugiroux et al., 2016) and are termed OligoMM12 mice. 
Agr2tm1.2Erle mice were obtained from David Erle (Park et al., 2009). Germ-free mice (Agr2GF) 
mice were re-derived by Prof. Bleich and Dr. Basic at the germ-free mouse facility of the 
Hannover medical school (MHH). Mating pairs of Agr2GF from MHH were imported to the 
mouse facility of the Max von Pettenkofer-Institute in Munich. There they were colonized 
with the OligoMM12 bacteria mix as described (Brugiroux et al., 2016). From these mating 
pairs a stable OligoMM12 Agr2 mouse colony was obtained.  
All three different mouse colonies were kept and bred under sterile conditions in separate 
flexible film isolators (Harlan Laboratories) at the Max von Pettenkofer-Institute in Munich. 
Mice were supplied with autoclaved ddH2O and a standard diet (V1124-300 SSniff 
Spezialdiäten GmbH, Soest) ad libitum. 
 Handling of gnotobiotic mice 
OligoMM12, ASF3 and Agr2-OligoMM12 mice were maintained and bred in flexible film 
isolators (Harlan Laboratories). For experiments, mice were exported in gnotocages (Han, 
Bioscape) supplied with sterile ddH2O (Ampuwa), bedding, nestlet and food. All work was 
conducted under a laminar flow, disinfected for 30 min with Virkon®S, and additional 
equipment needed (gavage needles, handling cage; wrapped in sterile cloth and separately 
autoclaved) was brought under the laminar flow. Two person were needed to conduct an 
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experiment, one equipped with sterile latex surgical gloves (GAMMEX®) and sterile gown, 
able to handle mice in a germ-free manner and a second person assisting for the non-sterile 
working steps. Mice were treated according to experimental protocol. 
 Colonization of gnotobiotic mice with M. schaedleri 
M. schaedleri (ASF457) was grown under anaerobic conditions for 2 days in 10 ml AAM 
media (supplemented with 10 mM NaNO3) (3.2.1). On day of colonization, purity of culture 
was verified by Gram staining. M. schaedleri or sterile control media was administered 
rectally (100 µl) and by oral gavage (50 µl). To verify purity of culture, residual amount of 
M. schaedleri was pelleted, gDNA extracted (3.2.10) and checked by Sanger sequencing of 
the PCR amplified 16S rRNA gene (3.2.1).  
 Growth of S. Tm for mouse infections 
Three colonies of respective S. Tm strain were picked with a sterile inoculation loop, 
transferred in a glass tube containing 3 ml LB with 0.3 M NaCl (Table 3) and grown in a roller 
drum for 12 h at 37 °C without antibiotics (antibiotics were only supplemented for plasmid 
selection). After 12 h, 100 µl of overnight culture was added to 2 ml fresh LB 0.3 M NaCl 
(Table 3) and incubated for further 4 h rotating at 37 °C. Then, 1 ml of this subculture was 
taken, centrifuged (2 min at 12,000 rpm), 4 °C, supernatant was removed and pellet was 
resuspended in an equal amount of ice-cold PBS. Aliquots of 50 µl were prepared and kept 
on ice until infection.  
 Infection of mice with a single S. Tm strain 
If required, mice were pretreated with 25 mg of streptomycin by oral gavage one day prior 
to infection. S. Tm was administered by oral gavage at a dose of 107 cfu as indicated in 
section 3.2.13.4. S. Tm loads in cecal content, feces, mesenteric lymph nodes, liver and 
spleen were quantified by plating 50 µl suspension on MacConkey (Oxoid) with indicated 
antibiotics. Therefore, collected material was resuspended in PBT and disrupted with a bead 
beater (TissueLyser LT, Qiagen; 5 min 50 Hz). For mesenteric lymph nodes, spleen and liver 
a stainless steel bead (5 mm) was added for homogenization of tissue. The distal part of the 
cecum was ligated with dental floss, fixed overnight in 2 ml 4 % PFA (4 °C), incubated in 2 ml 
20 % sucrose (4 °C) overnight and embedded in tissue-tek O.C.T. (Sakura), flash frozen in 
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liquid N2 and stored at -80 °C until preparation for immunofluorescence staining or FISH. For 
haematoxylin/eosin staining, a part from liver (1/3) and spleen (1/2), one part of duodenum, 
jejunum and ileum, cecal tissue, colon and rectum were embedded in tissue-tek O.C.T. 
(Sakura) and directly flash frozen in liquid N2. 
 Competitive infection experiments  
Competitive infections were performed as described by (Maier et al., 2013) in the uninflamed 
gut. The avirulent strain (S. Tmavir) and the mutant strain in S. Tmavir background (S. Tmavir 
hyd3 or S. Tmavir ∆nr3) were grown as described in 3.2.13.4. OD600 of each strain was measured, 
if necessary adjusted and both strains were mixed in a 1:1 ratio, centrifuged 2 min at 
12000 rpm, 4 °C, supernatant was removed and pellet was resuspended in an equal amount 
of ice-cold PBS. Bacteria were kept on ice until infection. Inoculum, feces and cecum were 
plated on selective MacConkey (Oxoid) plates (all Salmonella: Strep100; mutant: 
Strep100 Cm30) and counted. The competitive index was calculated as follows: Number of 
mutant Salmonella (S. Tmavir hyd3 or S. Tmavir∆nr3) divided by the number of the avirulent strain 
(S. Tmavir) corrected by competitive index of inoculum.  
 Measuring the replicative capacity of S. Tm in vivo 
To measure the replicative index of S. Tm in vivo, S. Tmavir harboring the temperature 
sensitive plasmid pM1419 (AmpR) (Table 23), was grown and prepared as described in 
3.2.13.4 with exception that ampicillin (50 µg/ml) was added to the overnight and subculture. 
Growth was performed at 30 °C to facilitate maintenance of the plasmid. Mice were 
pretreated with 25 mg streptomycin and feces 5 h p. i. and cecum 20 h p. i. were plated on 
selective MacConkey (Oxoid) plates (all S. Tm: Strep100; S. TmavirpM1419: Strep100 Amp100) 
and counted. Replicative index was calculated as described by (Stecher et al., 2008) and is 
the number of S. TmavirpM1419+ divided by the number of total S. Tmavir. 
 Analysis of short chain fatty acids (SCFAs) in cecal content 
SCFAs in cecal content of ASF3 mice with M.schaedleri and control (n = 8 / 8) were analyzed 
by Dr. Buck Hanson (DOME, University of Vienna) using capillary electrophoresis. Cecal 
content was harvested 10 days post colonization and snap frozen in liquid N2. Samples were 
thawed on ice and 50 mg were resuspended in deionized water to a concentration of 
0.25 mg/µl. Particulate matter was pelleted at 4 °C for 10 min, supernatants were diluted 
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1:10 and 1:20 in 0.01 M NaOH, 0.5 mM CaCl2, and 0.1 mM caproate (hexanoate, internal 
standard) and each sample was screened in triplicate technical replicates. SCFA were 
quantified by capillary electrophoresis on a P/ACE MDQ Molecular Characterization System 
(Beckman Coulter) using methods previously described (Koch et al., 2015). Acetate was 
separated by using the CEofix Anions 5 kit (Analis Technologies) on a fused silica column 
(TSP075375; 75 µm ID, Polymicro Technologies). External standards of formate, succinate, 
acetate, lactate, propionate, and butyrate (50 µm, 100 µm and 250 µM) were used to quantify 
analytes with each individual run (~25 samples/run). All standards and samples were 
normalized to the 0.1 mM caproate internal standard. 
 Quantification of bile acids in cecal content 
For quantification of bile salts in cecal content, non-targeted metabolomics was performed 
using a UPLC-MS approach by Dr. Alesia Walker (Helmholtz Zentrum, München). Same 
samples were used as for SCFA analysis (3.2.13.8). 
 Transcriptome analysis 
ASF3 mice (n = 4 / 4) were pre-colonized with M. schaedleri or control for 10 days and 
infected with S. TmavirpM1419. Cecal content was harvested one day post infection, flash 
frozen in liquid N2 and stored at -80 °C until further analysis. Samples were shipped on dry 
ice to Dr. David Berry (DOME, University of Vienna) were RNA was extracted, library 
preparation and sequencing and analysis was performed. Detailed description can be found 
in (Loy et al., 2017). Briefly, RNA was extracted with a standard phenol:chloroform method, 
additionally treated with ezDNase (Invitrogen, Carlsbad, CA) and cleaned up and 
concentrated using the GeneJET RNA cleanup and Concentration Micro Kit (Thermo 
Scientific). rRNA was removed with the Ribo-Zero bacterial kit (Illumina, San Diego, CA) and 
RNA was evaluated with the RiboGreen assays (Quant-iT™ RiboGreen™ RNA Assay Kit, 
Invitrogen). Library was prepared for RNAseq on the HiSeqV4 SR100 with the NEBNext 
Ultra RNA library prep kit for Illumina (New England Biolabs, Ipswich, MA). 
The raw reads were quality filtered using Trimmomatic (Bolger et al., 2014) and mapped to 
the S. Tm reference genome (accession number: FQ312003; plasmids: HE654724, 
HE654725, HE654726) obtained from MicroScope (SALTS.1) 
(http://www.genoscope.cns.fr/agc/microscope/mage/index.php) using BWA (Li & Durbin, 
2009). Differential gene expression was analyzed using EdgeR (Robinson et al., 2010). 
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RNAseq analysis was performed by Dr. David Berry (DOME, University of Vienna) and Dr. 
Lara Jochum (MvP, Ludwig-Maximilians-University, Munich). 
3.2.14 Statistical analysis 
S. Tm loads (cfu/g), histopathological score and lipocalin-2 are displayed as median. To 
compare two groups at one time point Mann-Whitney U test was performed. For comparing 
two groups at several time points a One-way ANOVA Kruskal-Wallis test was performed and 
Dunn’s multiple comparison test was done to compare selected pairs (mock vs. 
M. schaedleri). For in vitro assays, means are shown and One-way ANOVA with Tukey post 
hoc test was performed. All analysis were performed with GraphPad Prism (version 5.01 for 
Windows, GraphPad Software, San Diego California USA).  
Diversity analysis (PCA) was performed on relative abundances from qPCR of 16S rRNA 
genes using the QIIME scripts (Caporaso et al., 2010). Different clustering was analyzed 
using the quantitative Bray Curtis dissimilarity and statistical significance was determined 
with the nonparametric Adonis method based on the permutational multivariate ANOVA 
(PERMANOVA) (Anderson, 2001).  
In all cases p < 0.05 is considered statistically significant. 
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4 Results 
4.1 Studying the effect of M. schaedleri on the development of S. Tm 
induced colitis 
4.1.1 M. schaedleri colonizes the gut of gnotobiotic mice and occupies a 
niche close to the epithelial border 
To investigate the contribution of M. schaedleri on the course of S. Tm induced 
gastroenteritis, we employed two alternative gnotobiotic mouse models with a defined 
microbiota. First, we studied the influence of M. schaedleri (ASF457) on S. Tm colitis in ASF3 
(3.2.13.1) mice, harboring three of the eight ASF members and secondly in OligoMM12 mice 
(3.2.13.1; (Brugiroux et al., 2016)), which represent a more complex microbiota with twelve 
mouse-derived strains. ASF3 mice show reduced colonization resistance to S. Tm compared 
to OligoMM12 mice, as described previously (Brugiroux et al., 2016). 
Our data reveal that M. schaedleri is able to colonize in both gnotobiotic mouse models, 
ASF3 as well as OligoMM12. By qPCR we could detect each individual strain in fecal samples 
ten days after inoculation with M. schaedleri, based on the 16S rRNA gene. The relative 
abundance of M. schaedleri in ASF3 mice ranges between 1.0 % and 15 % (Fig. 5A) whereas 
the relative abundance in OligoMM12 mice is lower, 0.1 % to 0.4 % (Fig. 5C). M. schaedleri 
was not detected in the respective control groups. To characterize the localization of 
M. schaedleri in the cecum of mice, we used a microscopy approach. With a M. schaedleri 
specific FISH probe (Loy et al., 2017), we could localize this bacterium close to the epithelial 
border in ASF3 (Fig. 5B) and OligoMM12 mice (Fig. 5D), where it forms a mesh like structure, 
but was not detected in control mice. 
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Fig. 5: M. schaedleri colonizes the intestine of gnotobiotic mice. Gnotobiotic ASF3 or OligoMM12 mice were 
colonized for 10 days with M. schaedleri by oral and rectal inoculation. A) Microbiota composition of fecal 
samples from ASF3 mice with M. schaedleri or control shown as the relative abundance of each individual strain 
(% of all 16S rRNA gene copies). Each bar represents one mouse. * under detection limit B) Localization of 
M. schaedleri by FISH analysis in PFA fixed cecum of ASF3 mice. grey, DAPI; blue, all bacteria (eub338 I:III 
probe); green, M. schaedleri (msc487_correct probe), scale bar 50 µm. White squares indicate magnified area. 
e, epithelium C) Microbiota composition of fecal samples from OligoMM12 mice with M. schaedleri or control. 
Shown is the relative abundance of each individual strain (% of all 16S rRNA gene copies). Each bar represents 
one mouse. * under detection limit D) Localization of M. schaedleri by FISH analysis in PFA fixed cecum of 
OligoMM12 mice. Grey, DAPI; blue, all bacteria (eub338 I:III probe); green, M. schaedleri (msc487_correct 
probe), scale bar 50 µm. White squares indicate magnified area. e, epithelium. 
4.1.2 M. schaedleri protects gnotobiotic ASF3 mice from S. Tm induced colitis 
To verify the role of M. schaedleri during S. Tm induced colitis we infected ASF3 mice pre-
colonized with M. schaedleri or control (n= 11 / 10) with S. Tmwt (Fig. 6A). After 24 h of 
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infection, mice were sacrificed and S. Tm loads were enumerated in the cecal content by 
plating. No differences in S. Tm colonization was detected between both groups (p > 0.05 
Mann–Whitney U test; Fig. 6B). Systemic dissemination of S. Tm could already be observed 
in mesenteric lymph nodes (Fig. 6C) but only low S. Tm loads in spleen (Fig. 6D) or liver 
(Fig. 6E). No significant differences between control and experimental group were detected 
(p > 0.05 Mann–Whitney U test). During inflammation the cecal tissue undergoes drastic 
pathological changes like formation of submucosal edema, loss of goblet cells, infiltration of 
neutrophils and epithelial damage (Stecher et al., 2007). Mice pre-colonized with 
M. schaedleri show reduced inflammation assed by histology (***p<0.001 Mann–Whitney U 
test; Fig. 6F). To confirm this observation, lipocalin-2, a marker for inflammation, was 
measured by quantitative ELISA in cecal samples. No lipocalin-2 was detected in mice pre-
colonized with M. schaedleri compared to control group (**p<0.001 Mann–Whitney U test; 
Fig. 6G). 
From this experiment we concluded that M. schaedleri does not confer colonization 
resistance but reduces S. Tm induced colitis in ASF3 mice. 
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Fig. 6: M. schaedleri protects ASF3 mice from S. Tm induced colitis. A) Experimental set up. ASF3 mice were 
pre-colonized for 10 days with M. schaedleri or control media before infection with 107 cfu of S. Tmwt and 
sacrificed one day post infection. B) S. Tm loads in cecal content, C) mesenteric lymph nodes, D) spleen and E) 
liver quantified by plating at day 1 p.i.. F) Histopathological score of cecal tissue on day 1 p. i. stained with 
hematoxylin and eosin. The degree of submucosal edema, neutrophil infiltration, loss of goblet cells and epithelial 
damage was scored in a double-blinded manner. 0-3: no pathological changes; 4-7: moderate inflammation; 
above 8: severe inflammation. G) Lipocalin-2 levels of cecal content were measured by quantitative ELISA on 
day 1 p.i.. Dashed line: detection limit. One dot represents one mouse. Mann–Whitney U test; ns, no significant 
difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. 
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4.1.3 OligoMM12 mice are protected from S. Tm induced colitis by 
M. schaedleri 
To further investigate, if the protective effect of M. schaedleri is dependent on the microbiota 
we performed an analogous experiment (4.1.2) in the OligoMM12 mice (Brugiroux et al., 
2016) which harbor a more complex microbiota than the ASF3 mice. Due to the higher 
complexity of the microbiota, onset of inflammation is delayed and starts at day 3 p.i. 
resulting in a profound colitis on day 4 p. i. (Fig. 3C) (Beutler, 2016). OligoMM12 mice were 
pre-colonized for ten days with M. schaedleri or control media, infected with S. Tmwt and 
sacrificed at day 4 p.i. (Fig. 7A). As seen in ASF3 mice, S. Tm loads in the cecal content of 
OligoMM12 mice with and without M. schaedleri show no significant difference (Fig. 7B) (p > 
0.05 Mann–Whitney U test). S. Tm dissemination to mesenteric lymph nodes (Fig. 7C), 
spleen (Fig. 7D) and liver (Fig. 7 E) was observed but no significant difference between both 
groups was detected (p > 0.05 Mann–Whitney U test). In contrast, we found a significant 
reduction (**p < 0.01) of the histopathological score (Fig. 7F) in OligoMM12 mice pre-
colonized with M. schaedleri compared to control at day 4 p.i.. To verify this result we 
measured the lipcalin-2 levels (Fig. 7G) in the cecal content day 4 p.i. and found an app. 100 
fold decrease in lipocalin-2 in mice colonized with M. schaedleri. Taken together, these 
results show a strong protective effect of M. schaedleri on S. Tm induced colitis in two 
gnotobiotic mouse models, with different microbiota complexity. This indicates that 
M. schaedleri protects in a microbiota independent way from S. Tm colitis even though it 
does not provide colonization resistance. 
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Fig. 7: M. schaedleri protects OligoMM12 mice from S. Tm induced colitis. A) Experimental set up. 
OligoMM12 mice were pre-colonized for 10 days with M. schaedleri or control media before infection with 107
cfu of S. Tmwt and sacrificed four days post infection. B) S. Tm loads in cecal content, C) mesenteric lymph 
nodes, D) spleen and E) liver quantified by plating at day 4 p.i.. F) Histopathological score of cecal tissue on 
day 4 p.i. stained with hematoxylin and eosin. The degree of submucosal edema, neutrophil infiltration, loss 
of goblet cells and epithelial damage was scored in a double-blinded manner. 0-3: no pathological changes; 
4-7: moderate inflammation; above 8: severe inflammation. G) Lipocalin-2 levels of cecal content were
measured by quantitative ELISA on day 4 p.i.. Dashed line: detection limit. One dot represents one mouse; 
Mann–Whitney U test; ns, no significant difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. 
 
Results 
56 
 
4.2 Elucidating the protective effect of M. schaedleri 
4.2.1 M. schaedleri does not inhibit the replication of S. Tm in mice 
The previous experiments left us with the question of the mechanism underlying the 
protective effect of M. schaedleri. When S. Tm enters the gut it is in need to multiply to enable 
colonization of the intestine at high numbers (≥ 108 cfu/g), which subsequently allows S. Tm 
shedding and transmission by the fecal oral route (Lawley et al., 2008; Rivera-Chávez et al., 
2016). Therefore we analyzed the influence of M. schaedleri on the replication of S. Tm in 
vivo. 
To measure the growth rate of S. Tm in vivo, an avirulent S. Tm strain harboring a 
temperature sensitive plasmid (pM1419, AmpR (Stecher et al., 2008)) was used. The plasmid 
replicates and is transferred to the daughter cell at permissive temperatures (< 30 °C), but 
at higher temperature (> 37 °C) replication of the plasmid is blocked and the plasmid is lost 
(Benjamin et al., 1990; Stecher et al., 2008). Therefore, during infection in mice, the fraction 
of bacteria harboring this plasmid will be reduced if cell division occurs. The replication rate 
of S. Tm in the uninflamed gut was calculated in OligMM12 mice and mice pre-colonized with 
M. schaedleri but was not different between both groups after 5 h p.i. in feces or 20 h p.i. 
(Fig. 8B).  
An analogous experiment was performed in ASF3 mice. Streptomycin treatment in these 
mice is not necessary as the low complex microbiota does not confer colonization resistance 
to S. Tm (Fig. 8C). The replicative index was again assessed 5 h p.i. in feces or 20 h p.i. in 
cecal content in ASF3 mice pre-colonized with M. schaedleri or control. No difference 
between both groups was observed in feces 5 h p.i.. Longer infection time (20 h p.i.) lead to 
a slight increased, but not significant, replication of S. Tm in ASF3 mice pre-colonized with 
M. schaedleri compared to control mice. 
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Fig. 8: M. schaedleri does not influence the replication rate of S. Tm. A) Experimental set up. OligoMM12 
mice were colonized with M. schaedleri or sterile control media for 10 days before treatment with 25 mg 
streptomycin by oral gavage. One day later mice were infected orally with S. TmavirpM1419 (4 x 107cfu), feces 
was collected 5 h post infection and mice were sacrificed 20 h p.i.. S. Tm loads were quantified on selective agar 
plates and B) replicative index is displayed. C) Experimental set up. ASF3 mice were colonized with M. schaedleri 
or sterile control media for 10 days. Mice were infected orally with S. TmavirpM1419 (2 x 107cfu), feces was 
collected 5 h post infection and mice were sacrificed 20 h p.i.. S. Tm loads were quantified on selective agar 
plates and D) replicative index is displayed. One dot represents one mouse. One-way ANOVA Kruskal-Wallis 
test with Dunn’s multiple comparison test compare selected pairs (mock vs. M. schaedleri); ns, no significant 
difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001 
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4.2.2 Competition between S. Tm and M. schaedleri for hydrogen or nitrate 
does not play a role in the uninflamed gut of OligoMM12 mice 
Hydrogen, generated by the microbiota is vital for growth of S. Tm in the gut (Maier et al., 
2013) and nitrate respiration plays an important role for S. Tm growth during colitis (Lopez 
et al., 2015). Genome analysis and in vitro cultures revealed that M. schaedleri is able to 
use H2 as electron donor and nitrate as electron acceptor under anaerobic conditions and 
perform full dissimilatory nitrate reduction to ammonia (DNRA) (Loy et al., 2017) (Fig. 2B). 
Thus we hypothesize, that M. schaedleri competes for H2 or NO3 with S. Tm and thereby 
inhibits growth or virulence of the pathogen. To investigate, if the availability of hydrogen 
and nitrate during the early phase of infection plays a role for S. Tm infection we performed 
competitive mouse infection experiments with a S. Tm mutant, defective in all three 
hydrogenase genes (S. Tmavir hyd3; (Maier et al., 2013)) and a S. Tm defective in three nitrate 
reductase genes (S. Tmavir∆nr3) (Table 21). First, mice were infected with a 1:1 mix of S. Tmavir 
hyd3 /S. Tmavir or S. Tmavir∆nr3/ S. Tmavir and S. Tm loads were monitored over time and the 
competitive index between mutant and S. Tmavir was calculated. In the OligoMM12 mice 
S. Tmavir does not show a growth benefit over the hydrogenase mutant S. Tmavir hyd3, 
revealing that H2 does not play a role for efficient colonization in this model. This was not 
altered in M. schaedleri pre-colonized mice or at later time points of the experiment. The 
S. Tmavir hyd3 and the hydrogenase proficient S. Tmavir colonize the gut at the same rate, 
resulting in a CI of 1 (Fig. 9 B). 
On the other hand, co-infection with S. Tmavir∆nr3/ S. Tmavir gave conflicting results. Instead of 
attenuation the S. Tmavir∆nr3 mutant showed a significant growth advantage in mice pre-
colonized with M. schaedleri compared to the control group (*p < 0.05; One-way ANOVA 
Kruskal-Wallis test with Dunn’s multiple comparison test compare selected pairs) which 
prevailed at day 3 p.i. but was reduced at day 4 p.i. in feces and cecal content (Fig. 9C).  
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Fig. 9: Competition for hydrogen or nitrate does not play a role in the uninflamed gut of OligoMM12 mice. 
A) Experimental set up. OligoMM12 mice were colonized with M. schaedleri or sterile control media for ten days 
before oral infection with a 1:1 mix of S. Tmavir hyd3/ S. Tmavir or S. Tmavir ∆nr3/ S. Tmavir (107 cfu/per strain). Feces 
was collected at day 1, day 3 and mice were sacrificed on day 4 post infection. Individual S. Tm strains were 
quantified on selective agar plates and competitive index was calculated. B) Competitive index between S. Tmavir 
hyd3 and S. Tmavir. C) Competitive index between S. Tmavir ∆nr3 and S. Tmavir. One-way ANOVA Kruskal-Wallis test 
with Dunn’s multiple comparison test compare selected pairs (mock vs. M. schaedleri); ns, no significant 
difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. 
 
 
 
 
 
 
 
Results 
60 
 
4.2.3 Colonization by M. schaedleri reduces the expression of S. Tm SPI1-
T3SS in the intestine of mice 
For inducing gastroenteritis, S. Tm needs its SPI1-T3SS which translocates effector proteins 
into epithelial cells (Collazo & Galán, 1997), mediates pathogen invasion and triggers 
inflammation (Barthel et al., 2003; Hapfelmeier et al., 2004). We studied the expression of 
SPI1-T3SS using an avirulent S. Tm strain harboring a SPI-1 reporter plasmid (pM974; 
(Ackermann et al., 2008)) with GFP fused to the promotor of sicA (S. TmavirpsicAgfp), a 
chaperone of the SPI1-T3SS translocases SipB and SipC (Tucker & Galan, 2000). Mice, 
pre-colonized with M. schaedleri or control were treated with 25 mg streptomycin to allow 
efficient colonization of S. Tm in the gut which enabled us to detect S. Tm in high numbers 
by confocal microscopy. M. schaedleri is streptomycin resistant (Fig. 20) and therefore not 
affected by this antibiotic. After 24 h post infection with the reporter strain S. TmavirpsicAgfp, the 
cecum was fixed in PFA and all S. Tm were stained with a Salmonella specific antiserum 
(Table 32). The fraction of GFP+ S. Tm of all S. Tm was determined by image analysis 
(3.2.5). Fig. 10A shows the percentage of GFP+/α-Salmonella double positive bacteria to all 
α-Salmonella positive bacteria per mouse. The SPI1-T3SS expression in mice pre-colonized 
with M. schaedleri was reduced about 2-fold compared to the control group (*p < 0.05 Mann–
Whitney U test). Fig. 10B displays the percentage of each analyzed image. Similarly, the 
median GFP expression rate between M. schaedleri and control group differs significantly 
(***p < 0.001 Mann–Whitney U test). Respective images are shown in Fig. 10C. 
Based on this data we conclude, that M.schaedleri has no impact on the replication rate of 
S. Tm nor does it compete for hydrogen or nitrate in vivo. Interestingly, it modulates 
expression of the S. Tm specific SPI1-T3SS which is important to drive intestinal 
inflammation.  
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Fig. 10: M. schaedleri modulates S. Tm SPI1-T3SS expression in vivo. OligoMM12 mice were colonized with 
M. schaedleri or sterile control media for 10 days before treatment with 25 mg streptomycin. One day later mice 
were infected with 2 x 107 cfu S. TmavirpsicAgfp and sacrificed 24 h later. Cecum was fixed in PFA and sections 
were stained with DAPI and primary rb-α-Salmonella B test serum anti-O antibody and secondary α-rabbit 
dyLight649. Per mouse 3 - 5 picture (2x zoom) close to the epithelial border were taken and counted. A) Mean 
fraction of GFP+ and Salmonella B test serum+ double positive bacteria of all images from each mouse is 
displayed. B) Percent of double positive bacteria (GFP+ and Salmonella B test serum+) is displayed per analyzed 
image. C) Representative images from cecal lumen of controls, mice colonized with M. schaedleri and infected 
with S. TmavirpsicAgfp. blue, DAPI; red, α-Salmonella; green, GFP; e, epithelium; white boxes: sections enlarged; 
scale bar, 25 µm. Dashed line indicates epithelial border. Mann–Whitney U test; ns, no significant difference p ≥ 
0.05, *p < 0.05, **p < 0.01, ***p < 0.001 
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4.2.4 Transcriptome analysis of S. Tm in vivo 
To analyze how M. schaedleri effects S.Tm in vivo we performed transcriptome analysis of 
total RNA extracted from cecal content of ASF3 mice colonized with M. schaedleri or control 
media and infected with S. Tmavir. Overall, around 100 S.Tm genes were differentially 
expressed in the presence of M. schaedleri. Interestingly, transcripts of genes associated 
with the SPI1-T3SS (sopB, sipA, prgK and invF) were downregulated in S.Tm in mice with 
M. schaedleri (Table 34), confirming our findings with a SPI1-T3SS reporter strain (Fig. 10). 
Furthermore genes involved in energy metabolism (napA, cydA, fabI, plsX and accD) and 
multiple translation associated transcripts were as well downregulated in the presence of 
M. schaedleri. On the other hand only one gene transcript is more abundant in S. Tm in the 
presence of M. schaedleri which is, malS an alpha-amylase. Recently, the 5’-UTR was linked 
to the regulation of SPI1-T3SS (Gong et al., 2015). 
Table 34. Differentially expressed genes of S. Tm between mice colonized with M. schaedleri vs. control 
mice  
Annotation logFC logCPM p-Value FDR genes 
menC -5,22 5,38 7,84E-05 1,24E-02 SALTSv1_2348 
ygaP -4,95 5,23 1,02E-04 1,41E-02 SALTSv1_2878 
rhaB -4,82 5,18 2,39E-04 2,11E-02 SALTSv1_4125 
gph -4,80 5,16 2,55E-04 2,18E-02 SALTSv1_3564 
sopB -4,72 5,12 4,95E-04 3,10E-02 SALTSv1_1052 
murA -3,67 5,63 6,68E-05 1,16E-02 SALTSv1_3394 
exbD -3,51 5,53 1,73E-04 1,89E-02 SALTSv1_3245 
purF -3,36 5,99 1,98E-04 2,05E-02 SALTSv1_2406 
sipA -3,33 5,42 7,44E-04 4,14E-02 SALTSv1_2962 
yoaE -3,30 6,61 3,57E-06 2,50E-03 SALTSv1_1800 
garR -3,12 5,81 1,36E-04 1,61E-02 SALTSv1_3334 
rplW -3,09 5,80 4,67E-04 3,03E-02 SALTSv1_3520 
prgK -3,00 6,09 7,85E-05 1,24E-02 SALTSv1_2951 
lepB -2,72 5,58 5,59E-04 3,30E-02 SALTSv1_2630 
pdxY -2,67 5,88 4,27E-04 2,92E-02 SALTSv1_1411 
ycfW -2,65 5,52 9,25E-04 4,90E-02 SALTSv1_1179 
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Annotation logFC logCPM p-Value FDR genes 
NA -2,63 6,12 2,32E-04 2,11E-02 SALTSv1_miscRNA187 
NA -2,62 5,85 6,31E-04 3,64E-02 SALTSv1_1750 
era -2,62 5,84 2,69E-04 2,18E-02 SALTSv1_2628 
tldD -2,61 5,84 4,06E-04 2,85E-02 SALTSv1_3455 
NA -2,61 10,50 3,94E-10 2,05E-06 SALTSv1_miscRNA52 
NA -2,60 7,84 2,52E-05 6,89E-03 SALTSv1_miscRNA125 
NA -2,59 6,08 1,68E-04 1,89E-02 SALTSv1_tRNA79 
napA -2,59 6,32 3,08E-05 7,27E-03 SALTSv1_2299 
tgt -2,56 6,81 4,33E-06 2,50E-03 SALTSv1_0409 
menD -2,45 6,43 2,76E-04 2,21E-02 SALTSv1_2351 
NA -2,45 6,01 3,26E-04 2,48E-02 SALTSv1_1810 
dnaX -2,42 6,70 4,04E-06 2,50E-03 SALTSv1_0486 
gudD -2,40 6,57 1,75E-04 1,89E-02 SALTSv1_3044 
NA -2,39 6,37 3,33E-04 2,48E-02 SALTSv1_tRNA83 
kdsA -2,35 5,94 9,60E-04 4,98E-02 SALTSv1_1742 
rplF -2,31 7,66 4,25E-07 5,52E-04 SALTSv1_3507 
NA -2,30 7,18 2,78E-05 7,22E-03 SALTSv1_tRNA52 
nusA -2,27 8,07 3,54E-07 5,52E-04 SALTSv1_3374 
yiaF -2,26 6,61 6,06E-05 1,09E-02 SALTSv1_3733 
NA -2,20 7,29 1,28E-04 1,55E-02 SALTSv1_4534 
proS -2,15 6,37 3,99E-04 2,85E-02 SALTSv1_0246 
rpsI -2,15 8,21 7,71E-09 2,00E-05 SALTSv1_3431 
melA -2,12 7,55 7,36E-04 4,14E-02 SALTSv1_4367 
glyS -2,12 6,63 5,96E-05 1,09E-02 SALTSv1_3741 
rplD -2,11 6,84 1,66E-05 5,73E-03 SALTSv1_3521 
fabI -2,09 6,33 2,34E-04 2,11E-02 SALTSv1_1671 
oxyR -2,07 6,48 7,40E-04 4,14E-02 SALTSv1_4203 
dinG -2,04 6,30 3,34E-04 2,48E-02 SALTSv1_0815 
speF -2,02 6,44 4,52E-04 2,97E-02 SALTSv1_0699 
NA -2,01 6,42 5,75E-04 3,35E-02 SALTSv1_tRNA2 
rplC -2,00 7,69 7,72E-06 3,34E-03 SALTSv1_3522 
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Annotation logFC logCPM p-Value FDR genes 
infB -1,99 7,98 2,51E-05 6,89E-03 SALTSv1_3373 
iscR -1,98 7,11 2,18E-05 6,89E-03 SALTSv1_2592 
rplI -1,97 6,94 2,36E-05 6,89E-03 SALTSv1_4463 
tsf -1,94 7,33 3,00E-05 7,27E-03 SALTSv1_0221 
plsX -1,93 6,51 5,43E-04 3,28E-02 SALTSv1_1152 
rplO -1,92 7,31 5,32E-05 1,06E-02 SALTSv1_3503 
accD -1,83 6,43 9,44E-04 4,95E-02 SALTSv1_2411 
invF -1,81 6,64 3,11E-04 2,43E-02 SALTSv1_2980 
NA -1,76 8,31 1,16E-04 1,51E-02 SALTSv1_tRNA28 
rpoC -1,76 8,87 2,58E-04 2,18E-02 SALTSv1_4222 
NA -1,75 8,65 8,53E-05 1,30E-02 SALTSv1_tRNA23 
cydA -1,75 7,36 9,67E-05 1,40E-02 SALTSv1_0737 
pitA -1,74 6,70 2,66E-04 2,18E-02 SALTSv1_3673 
rpoA -1,74 8,47 4,89E-05 1,02E-02 SALTSv1_3498 
yaeT -1,73 7,61 1,02E-05 4,09E-03 SALTSv1_0228 
NA -1,72 6,87 7,63E-04 4,17E-02 SALTSv1_miscRNA128 
recA -1,72 7,76 3,48E-04 2,55E-02 SALTSv1_2908 
eno -1,70 8,35 4,17E-04 2,88E-02 SALTSv1_3035 
NA -1,68 8,60 4,94E-04 3,10E-02 SALTSv1_tRNA62 
lysS -1,67 6,92 7,50E-04 4,14E-02 SALTSv1_3123 
sspB -1,67 6,55 5,28E-04 3,26E-02 SALTSv1_3428 
pflB -1,66 8,65 3,13E-04 2,43E-02 SALTSv1_0928 
NA -1,64 11,04 4,77E-04 3,06E-02 SALTSv1_miscRNA229 
hybA -1,64 7,80 3,41E-05 7,70E-03 SALTSv1_3236 
tufB -1,63 8,61 4,18E-05 9,05E-03 SALTSv1_3527 
rpsB -1,62 8,40 9,32E-05 1,38E-02 SALTSv1_0220 
pta -1,60 7,14 4,44E-04 2,96E-02 SALTSv1_2382 
secA -1,54 7,40 1,82E-04 1,93E-02 SALTSv1_0137 
fusA -1,52 8,97 1,28E-04 1,55E-02 SALTSv1_3528 
tufB -1,51 8,13 1,22E-06 1,27E-03 SALTSv1_4214 
rplA -1,51 8,59 5,90E-06 2,79E-03 SALTSv1_4218 
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Annotation logFC logCPM p-Value FDR genes 
rplE -1,50 8,04 2,21E-04 2,09E-02 SALTSv1_3510 
sspA -1,50 7,77 1,46E-04 1,69E-02 SALTSv1_3429 
cpxP -1,48 10,70 3,13E-06 2,50E-03 SALTSv1_4138 
rimM -1,47 7,86 5,59E-05 1,07E-02 SALTSv1_2739 
rplX -1,45 7,77 2,21E-04 2,09E-02 SALTSv1_3511 
rpsD -1,43 8,08 4,01E-04 2,85E-02 SALTSv1_3499 
rplN -1,43 9,01 7,16E-05 1,20E-02 SALTSv1_3512 
rpmA -1,41 8,15 2,61E-04 2,18E-02 SALTSv1_3390 
groL -1,40 8,67 1,26E-04 1,55E-02 SALTSv1_4402 
NA -1,38 7,13 8,78E-04 4,75E-02 SALTSv1_tRNA60 
lexA -1,37 7,68 2,20E-04 2,09E-02 SALTSv1_4304 
rne -1,37 8,03 1,03E-04 1,41E-02 SALTSv1_1145 
rpsA -1,37 9,63 5,91E-06 2,79E-03 SALTSv1_0936 
ftsH -1,31 8,49 1,32E-05 4,90E-03 SALTSv1_3383 
secY -1,31 9,65 9,24E-04 4,90E-02 SALTSv1_3502 
tig -1,28 7,83 2,11E-04 2,09E-02 SALTSv1_0451 
rpoB -1,27 8,40 2,01E-04 2,05E-02 SALTSv1_4221 
rpoH -1,19 9,25 4,45E-04 2,96E-02 SALTSv1_3652 
rplL -0,95 8,88 5,35E-04 3,27E-02 SALTSv1_4220 
sulII -0,94 8,92 2,37E-04 2,11E-02 SALTSv1_p30001 
NA 0,97 12,18 1,14E-04 1,51E-02 SALTSv1_16s_rRNA_2 
malS 2,67 5,22 5,54E-04 3,30E-02 SALTSv1_3750 
NA, not annotated; logFC, log2-transformed fold change; logCPM, average log-transformed counts 
per million reads; P-values were adjusted using the FalseDiscoveryRate method. 
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4.3 Nitrate drives expression of SPI1-T3SS in vitro, but is negligible for 
protection from colitis by M. schaedleri in vivo 
4.3.1 Expression of SPI1-T3SS is elevated with nitrate under anaerobic 
conditions in an in vitro assay  
Taken together the above mentioned results, we found that M. schaedleri does not compete 
for nitrate with S. Tm to promote a growth advantage. However, we hypothesized that 
depletion of nitrate by M.schaedleri by DNRA could influence expression of the SPI1-T3SS 
of S. Tm. 
To test this, we first analyzed the effect of NO3 on S. Tm SPI1-T3SS expression. For this we 
used luciferase reporter strains harboring the firefly luciferase fused to the sicA promoter 
(S. TmsicA-luc) (Häberli, 2005). In S. TmsicA-luc, light emission can be correlated with SPI1-T3SS 
expression. The plasmid was inserted into the pagC locus of the chromosome of S. Tmwt 
(Häberli, 2005). By P22 transduction, the construct was transferred in recipient strains 
S. Tmavir and S. Tmavir∆nr3. Culturing the reporter strains under aerobic conditions in LB, LB 
supplemented with 0.3 M NaCl or different concentrations of NaNO3 did not have any effect 
on SPI1-T3SS expression (Fig. 11A). Under microaerophilic conditions (0.8 % O2) with high 
salt (0.3 M NaCl), SPI1-T3SS was significantly increased to app. 3-fold in the S. Tmavir and 
S. Tmavir∆nr3 reporter (*p < 0.05 One-way ANOVA with Tukey’s multiple comparison test) and 
slightly elevated in S. Tmwt, which was expected as high salt and low oxygen levels have 
been described as SPI-1 inducing (Bajaj et al., 1996). No upregulation was observed when 
different concentrations of NaNO3 were supplemented (Fig. 11A). When bacteria were 
cultured under anaerobic conditions we saw a strong induction (5 - 6 fold) of SPI1-T3SS in 
S. Tmwt and S. Tmavir with 10 mM and 40 mM NaNO3 (***p < 0.001 One-way ANOVA with 
Tukey’s multiple comparison test). This effect was absent in the nitrate reductase triple 
mutant S. Tmavir∆nr3 and was not seen with lower nitrate concentrations (1 mM), as NaNO3 is 
probably rapidly consumed by S. Tm under anaerobic conditions. No induction in either 
strain was observed with 0.3 M NaCl under anaerobic conditions. This experiment revealed, 
that nitrate can lead to increased SPI1-T3SS expression in vitro but only under anaerobic 
conditions. 
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Fig. 11: The ability of nitrate respiration enhances SPI1-T3SS expression and is important for S. Tm to 
invade epithelial cells. A) Luciferase activity was measured in cell extracts of indicated S. Tm reporter strains 
grown for 4 h under aerobic, microaerophilic (0.8 % O2) and anaerobic conditions in LB media with indicated 
supplements and normalized to OD600. Graph shows the fold-change to cultures grown in plain LB under the 
indicated oxygen concentration; each bar shows the mean of two cultures and the SEM. The experiment was 
repeated three times and one representative experiment is displayed. One-way ANOVA with Tukey’s multiple 
comparison test; ns, no significant difference p ≥ 0.05; *p < 0.05, **p < 0.01, ***p < 0.001 B) Invasion of indicated 
S. Tm strains under aerobic or microaerophilic conditions in the presence of 10 mM KNO3 into HuTu80 cells. 
Experiment was repeated three times (Stefanie Walter, RKI Wernigerode), each dot represents one experiment. 
One-way ANOVA with Tukey’s multiple comparison test; ns, no significant difference p ≥ 0.05, *p < 0.05, **p < 
0.01, ***p < 0.001. bar: mean. 
 
 
Results 
68 
 
4.3.2 S. Tm∆nr3 shows reduced invasion of HuTu80 cells under anaerobic 
conditions 
To further investigate if nitrate respiration plays a role for invasion, we performed invasion 
assays in cooperation with the Robert Koch Institute in Wernigerode (Stefanie Walter). 
S. Tmwt as positive control, S. Tm∆narZ, S. Tm∆narG, S. Tm∆napA, the triple mutant S. Tm∆nr3 and 
a SPI-1 mutant, S.TmSPI1, as a negative control, which is unable to invade epithelial cells, 
were cultured under aerobic and microaerophilic (0.5 % O2) conditions in the presence of 
10 mM NaNO3 in LB. Invasion of the single nitrate reductase mutants and the triple mutant 
into HuTu80 cells was determined by invasion assay (3.2.9). We observed, that S. Tmwt 
invades epithelial cells at the same efficiency and S. Tm SPI1 is unable to invade under both 
aerobic and microaerophilic conditions (p > 0.05 unpaired t test; Fig. 11B). On the other 
hand, the single mutants S. Tm∆narZ, S. Tm∆narG and S. Tm∆napA show decreased invasion 
under anaerobic condition and the triple mutant S. Tm∆nr3 is even more inhibited (*p < 0.05; 
*p < 0.05; ***p < 0.001 and ***p<0.001  respectively, One-way ANOVA with Tukey’s multiple 
comparison test). From this we conclude that under microaerophilic conditions, nitrate 
respiration is vital to induce the full invasive capacity of S. Tm.  
4.3.3 S.Tm∆nr3 shows reduced colonization in M. schaedleri pre-colonized 
OligoMM12 mice 
With respect to the previous results, genome based predictions for DNRA in M. schaedleri 
and verification in vitro (Loy et al., 2017) (Fig. 2), we hypothesized that M. schaedleri, 
localized close to the epithelial border (Fig. 5B & D), can limit the available nitrate in the 
mucus layer. This may then lead to reduced expression of S. Tm SPI1-T3SS and ultimately 
inflammation. Therefore, we designed the following experiment: if this hypothesis was true, 
a nitrate respiration defective S. Tm strain (S. Tm∆nr3) would be attenuated in control mice 
and exhibit the same level of inflammation as M. schaedleri colonized mice. Therefore, we 
infected OligoMM12 mice colonized with M. schaedleri or control with the nitrate reductase 
triple mutant S. Tm∆nr3 in wild type background. This time we found that S. Tm∆nr3 has a slight 
but not significant growth disadvantage (p > 0.05 One-way ANOVA Kruskal-Wallis test with 
Dunn’s multiple comparison test compare selected pairs) in mice pre-colonized with 
M. schaedleri compared to control mice on day 1 p.i. as well as on day 4 p.i. in feces and 
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cecum (Fig. 12B). Moreover, we observed a reduced inflammation in M. schaedleri 
colonized mice evaluated by cecal histology day 4 p.i. (Fig. 12F) (*p < 0.05 Mann–Whitney 
U test) and lipocalin-2 levels (Fig. 12G) in feces and cecum day 4 p.i. (*p < 0.05 and 
**p < 0.01 respectively; One-way ANOVA Kruskal-Wallis test with Dunn’s multiple 
comparison test compare selected pairs). No difference was seen in the colonization of 
mesenteric lymph nodes (Fig. 12C), spleen (Fig. 12D), and liver (Fig. 12E) (p > 0.05 Mann–
Whitney U test). Overall this experiment yielded inconclusive data. The protective effect may 
either indeed be independent of nitrate or, on the other hand, decreased inflammation could 
be also due to reduced colonization levels of S. Tm in mice pre-colonized with M. schaedleri. 
Therefore we performed an additional experiment in streptomycin treated OligoMM12 mice 
which lack colonization resistance and therefore should exhibit equal colonization of S. Tm 
in both groups.  
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Fig. 12: S. Tm∆nr3 colonization is reduced in M. schaedleri pre-colonized OligoMM12 mice. A) Experimental 
set up. OligoMM12 mice were pre-colonized for 10 days with M. schaedleri or control media before infection with 
107 cfu of S. Tm∆nr3 and sacrificed four days post infection. B) S. Tm loads in feces and cecal content over time 
of infection quantified by selective plating. S. Tm loads in C) mesenteric lymph nodes, D) spleen and E) liver at 
day 4 p.i.. F) Histopathological score of cecal tissue on day 4 p.i. stained with hematoxylin and eosin. The degree 
of submucosal edema, neutrophil infiltration, loss of goblet cells and epithelial damage was scored in a double-
blinded manner. 0-3: no pathological changes; 4-7: moderate inflammation; above 8: severe inflammation. G) 
Lipocalin-2 levels of feces and cecal content were measured by quantitative ELISA. Dashed line: detection limit. 
Mann–Whitney U test; B) & G) One-way ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test 
compare selected pairs (mock vs. M. schaedleri); ns, no significant difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p 
< 0.001. 
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4.3.4 Anaerobic electron acceptors are negligible for protection from S. Tm 
induced colitis by M. schaedleri 
OligoMM12 mice were pre-colonized with M. schaedleri or control media and treated with a 
single dose of streptomycin one day prior infection with S. Tm∆nr3 or S. Tmwt. Equal 
colonization of both strains was observed at day 1 p. i. and day 2 p. i. in feces and cecal 
content irrespective of M. schaedleri (Fig. 13B). Mesenteric lymph nodes and spleen showed 
as well no differences in S. Tm loads (Fig. 13C & D). In contrast, the liver exhibited increased 
S. Tmwt loads in M. schaedleri colonized mice (Fig. 13E) (*p < 0.05 One-way ANOVA 
Kruskal-Wallis test with Dunn’s multiple comparison test to compare selected pairs) and also 
to some extend for S. Tm∆nr3 (Fig. 13E). The histopathological score of cecal tissue on day 
2 p.i. is clearly but not significantly lower in streptomycin treated mice pre-colonized with 
M.schaedleri and infected with either S. Tm∆nr3 or S. Tmwt (Fig. 13F) (p > 0.05 One-way 
ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test to compare selected pairs). 
Further, lipocalin-2 was measured over time in fecal pellets and cecal content (Fig. 13G). 
Mice pre-colonized with M. schaedleri exhibited reduced, but not significant, lipocalin-2 
levels during S. Tm∆nr3 or S. Tmwt infection compared to control group (Fig. 13G) (p > 0.05 
One-way ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test to compare 
selected pairs). With S. Tmwt we see a 20 fold increase of lipocalin-2 in feces of control mice 
at day 1 p.i. which is still present in feces at day 2 p.i. but is slightly decreased in cecum at 
day 2 p.i. (10 fold) compared to mice associated with M. schaedleri. Regarding S. Tm∆nr3 
infected mice, we see a reduction in lipocalin-2 levels of app. 100 fold in feces of 
M. schaedleri pre-colonized mice at day 2 p.i. which is slightly reduced in cecum (app. 50 
fold) compared to control mice. 
Besides genes for DNRA, genome analysis of M. schaedleri ASF457 also predicted further 
genes involved in anaerobic respiration like a reductase system with homology to dimethyl 
sulfoxide (DMSO) reductase, a tetrathionate reductase and trimethylamine-N-oxide (TMAO) 
reductase (Loy et al., 2017). The alternative electron acceptors DMSO, TMAO, tetrathionate 
and nitrate can also be utilized by S.Tm (Harel et al., 2016) and are important for growth in 
the inflamed gut (Winter, Lopez, et al., 2013). One common feature of these reductases is 
that they all contain a molybdopterin co-factor (Hille, 1996). By deleting moaA, a crucial gene 
in molybdopterin biosynthesis (Mehta et al., 2014), anaerobic respiration is disabled in 
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Enterobacteriaceae (Winter, Winter, et al., 2013). Besides S. Tm∆nr3 and S. Tmwt (as control) 
we additionally infected mice with S. Tm∆moaA. After treatment with streptomycin, all mice 
(control and pre-colonized with M. schaedleri) show equal colonization of S. Tm∆moaA at all 
time points (feces day 1 p.i.; feces and cecum day 2 p.i.) (p > 0.05 One-way ANOVA Kruskal-
Wallis test with Dunn’s multiple comparison test) (Fig. 13B). Also no difference in 
colonization of mesenteric lymph nodes (Fig. 13C) and spleen was seen (Fig. 13D) (p > 0.05 
One-way ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test compare 
selected pairs). Histopathology score at day 2 p.i. show reduced inflammation in mice pre-
colonized with M. schaedleri and infected with S. Tm∆moaA compared to control mice (Fig. 
13F). Though, the differences are not significant (p > 0.05 One-way ANOVA Kruskal-Wallis 
test with Dunn’s multiple comparison test to compare selected pairs). Still, the protective 
effect is present in mice associated with M. schaedleri. We also monitored the lipocalin-2 
levels (Fig. 13G) on day 1 and day 2 p.i.. Even though statistical analysis does not yield 
significant differences (p > 0.05 One-way ANOVA Kruskal-Wallis test with Dunn’s multiple 
comparison test compare selected pairs) we can clearly see protection from colitis with 
M. schaedleri in the infection with S. Tm∆moaA. Lipocalin-2 is decreased in mice colonized 
with M. schaedleri and infected with S.Tm∆moaA around 70 fold in feces day 1 p.i., 8 fold and 
20 fold in feces and cecum day 2 p.i., respectively. Overall, this experiment shows that 
nitrate respiration and also the utilization of other sources for anaerobic respiration by S. Tm 
are likely not involved in vivo in M. schaedleri dependent reduction of S.Tm SPI1-T3SS 
expression. 
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Fig. 13: Competition for anaerobic electron acceptors is not responsible for protection from S. Tm colitis 
by M. schaedleri. A) Experimental set up. OligoMM12 mice were pre-colonized for 10 days with M. schaedleri or 
control media. Mice were treated with 25 mg streptomycin by oral gavage one day before infection with 107 cfu 
of S. Tmwt, S. Tm∆nr3 or S. Tm∆moaA and were sacrificed two days post infection. B) S. Tm loads in feces and cecal 
content were quantified by selective plating over time. S. Tm loads in C) mesenteric lymph nodes, D) spleen and 
E) liver were quantified at day 4 p.i.. F) Histopathological score of cecal tissue on day 4 p.i. stained with 
hematoxylin and eosin. The degree of submucosal edema, neutrophil infiltration, loss of goblet cells and epithelial 
damage was scored in a double-blinded manner. 0-3: no pathological changes; 4-7: moderate inflammation; 
above 8: severe inflammation. G) Lipocalin-2 levels of feces and cecal content were measured by quantitative 
ELISA. Dashed line: detection limit. One-way ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test 
compare selected pairs (mock vs. M. schaedleri); ns, no significant difference p ≥ 0.05; *p < 0.05, **p < 0.01, ***p 
< 0.001. 
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4.4 Does M. schaedleri have a protective effect against S. Tm in a 
gnotobiotic Agr2-/-/Agr2+/- mouse model? 
4.4.1 M. schaedleri colonizes the cecum of mucus deficient Agr2-/- mice 
Previous research in our lab by Dr. Sandrine Brugiroux showed that conventional 
streptomycin treated Agr2-/- mice (colonized with a complex microbiota) are protected from 
S. Tm colitis compared to Agr2+/- mice or ampicillin treated Agr2-/-/Agr2+/- mice (Fig. 4A). 
Microbiome analysis showed that the abundance of Deferribacteres (M. schaedleri) was 
increased in these protected mice (Fig. 4B) (Brugiroux, 2016). To investigate if this protective 
effect is dependent on the Agr2-/- genotype we generated gnotobiotic Agr2-/- mice colonized 
with the defined OligoMM12 microbiota (Beutler, 2016). OligoMM12 associated Agr2-/- and 
Agr2+/- mice were colonized with M. schaedleri or control media for 10 days. By FISH 
analysis (Fig. 14A) we could localize M. schaedleri in the cecum of OligoMM12 Agr2+/- and 
OligoMM12 Agr2-/- mice. Interestingly, the latter does not harbor an intact mucus layer, stating 
that M. schaedleri does not require mucus for successful colonization. OligoMM12 
composition of these mice was analyzed by quantitative PCR assay (3.2.12) (Fig. 14B). 
M. schaedleri was detected in the colonized groups but not in control mice. To get a closer 
look on differences between the microbiota of OligoMM12 Agr2-/-, Agr2+/- with and without 
M. schaedleri, cluster analysis (based on Bray-Curtis distance matrices) was performed. 
OligoMM12 Agr2-/- mice colonized with M. schaedleri show a distinct microbiota composition 
compared to all other three groups (Fig. 15A; according to Adonis ***p < 0.001 with 35.7 % 
of variation explained). Only slight differences were found between genotype (Agr2-/- vs. 
Agr2+/- Fig. 15B; according to Adonis *p < 0.024 with 13.5 % of variation explained) and 
between colonization (M. schaedleri vs. mock Fig. 15C; according to Adonis **p < 0.004, with 
20.99 % of variation explained). 
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Fig. 14: M. schaedleri colonizes in Agr2+/- as well as in mucus deficient Agr2-/- mice. A) Localization of 
M. schaedleri by FISH analysis in PFA fixed cecum of Agr2+/- and Agr2-/- mice pre-colonized with M. schaedleri 
or control for 10 days. grey, DAPI; blue, all bacteria (eub338 I:III probe); green, M. schaedleri (msc487_correct 
probe), scale bar 50 µm. White squares indicate enlarged area. Dashed line indicates epithelial border. B) 
Microbiota composition of cecal content from Agr2+/- and Agr2-/- mice with M. schaedleri or control. Shown is the 
relative abundance of each individual strain (% of all 16S rRNA gene copies). Each bar represents one mouse. 
* below detection limit. 
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Fig. 15: Cluster analysis of OligoMM12 Agr2-/- and Agr2+/- mice pre-colonized with M. schaedleri or control. 
Cluster analysis is based on Bray-Curtis distance matrices and visualized as PCoA plots. A) 2D PCoA plot of 
cecal microbiota from OligoMM12 Agr2-/- and Agr2+/- mice pre-colonized with M. schaedleri or control for 10 days 
colored by genotype & colonization (M. schaedleri or control); significant for Bray-Curtis (***p < 0.001, Adonis) 
with 35.7 % of variation explained. B) Coloring by genotype (Agr2-/- vs. Agr2+/-); significant for Bray-Curtis 
(*p < 0.024, Adonis) with 13.5 % of variation explained or C) colonization (M. schaedleri vs. mock); significant for 
Bray-Curtis (**p < 0.004, Adonis) with 20.99 % of variation explained. 
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4.4.2 Protection from S. Tm induced colitis by M. schaedleri is independent of 
the Agr2 genotype  
First we analyzed in uninfected mice (Fig. 14) if OligoMM12 Agr2-/- mice showed already 
signs of inflammation in cecal tissue before infection. We observed no pathological changes 
(Fig. 16F) and no increased lipocalin-2 levels (Fig. 16G). Therefore, OligoMM12 Agr2-/- and 
Agr2+/- littermates were colonized with M. schaedleri or control media for 10 days and 
subsequently infected with wildtype S.Tm. Fecal colonization of S. Tm was slightly but not 
significantly elevated (app. 2 log10 levels) at day 1 p.i. in Agr2-/- mice with and without 
M. schaedleri compared to Agr2+/- control groups; this difference was absent at day 3 p.i. (p 
> 0.05 One-way ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test compare 
selected pairs; Fig. 16B). No difference was seen in colonization of mesenteric lymph nodes 
(Fig. 16C), spleen (Fig. 16D) and liver (Fig. 16E) (p > 0.05 One-way ANOVA Kruskal-Wallis 
test with Dunn’s multiple comparison test compare selected pairs). S. Tm infected Agr2+/- 
mice colonized with M. schaedleri show a significantly reduced cecal histopathological score 
(Fig. 16F) and significantly reduced lipocalin-2 levels (Fig. 16G) (**p < 0.01 One-way 
ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test compare selected pairs) 3 
days p.i.. In the same way, Agr2-/- mice colonized with M. schaedleri show a reduced 
histopathological score (Fig. 16F) and decreased lipocalin-2 levels (Fig. 16G) (p > 0.05 One-
way ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test compare selected 
pairs). We conclude that M. schaedleri protects both OligoMM12 Agr2-/- and Agr2+/- mice 
independent of the genotype in a gnotobiotic setting. Thus we conclude that the protective 
effect observed in conventional Agr2-/- but not Agr2+/- mice (Fig. 4A) is probably dependent 
on other commensal bacteria or due to the treatment with streptomycin. To investigate this 
further, we conducted a follow-up experiment in OligoMM12 Agr2-/- and Agr2+/- mice with 
foregoing streptomycin treatment. 
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Fig. 16: M. schaedleri protects mice independent of the Agr2 genotype. A) Experimental set up. Agr2-/- and 
Agr2+/- associated with the OligoMM12 microbiota were pre-colonized for 10 days with M. schaedleri or control 
media before infection with 107 cfu of S. Tmwt and were sacrificed three days post infection. B) S. Tm loads in 
feces and cecal content were quantified over time by plating. S. Tm loads in C) mesenteric lymph nodes, D) 
spleen and E) liver were quantified by plating at day 3 p.i..F) Histopathological score of cecal tissue on day 3 p.i. 
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stained with hematoxylin and eosin. The degree of submucosal edema, neutrophil infiltration and epithelial 
damage was scored in a double-blinded manner. 0-3: no pathological changes; 4-7: moderate inflammation; 
above 8: severe inflammation. Pathological score is displayed without loss of goblet cells. G) Lipocalin-2 levels 
of cecal content were measured by quantitative ELISA on day 3 p.i.. Cecal content from uninfected Agr2-/- and 
Agr2+/- mice with and without M. schaedleri (Fig. 14) was used as negative control. Dashed line: detection limit. 
One dot represents one mouse. One-way ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test 
compare selected pairs (mock Agr2+/- vs. M. schaedleri Agr2+/- /  mock Agr2-/- vs. M. schaedleri Agr2-/-); ns, no 
significant difference p ≥ 0.05; *p < 0.05, **p < 0.01, ***p < 0.001. From one  
Agr2-/- control mouse treated with S.Tm, histopathological analysis was not possible (F). 
 
4.4.3 M. schaedleri protects streptomycin pretreated OligoMM12 Agr2-/-/Agr2+/- 
mice 
OligoMM12 Agr2-/-/Agr2+/- mice were pre-colonized for 10 days with M. schaedleri or control 
media, treated with streptomycin and infected with S. Tmwt. Colonization of S. Tmwt in cecum 
(Fig. 17A), mesenteric lymph nodes (Fig. 17B), spleen (Fig. 17C) and liver (Fig. 17D) was 
equal between all four groups (Agr2+/-/Agr2-/- +/- M. schaedleri) one day p.i.. As in the 
previous experiment, we see protection from colitis in Agr2+/- and Agr2-/- mice pre-colonized 
with M. schaedleri compared to control mice, indicated by reduced histopathological score 
(Fig. 17F) and lipocalin-2 levels (Fig. 17G). Microbiota analysis by a quantitative PCR assay 
(3.2.12) showed slight microbiota alterations in all groups one day after streptomycin 
treatment (Fig. 17H). M. schaedleri (ASF457) and B. caecimuris (I48) are increased in their 
relative abundances, whereas M. intestinale (YL27) and T. muris (YL45) are reduced (Fig. 
17H). Cluster analysis (based on Bray-Curtis distance matrices) was performed and 
samples were grouped by genotype & colonization & streptomycin treatment (Fig. 18A; 
according to Adonis ***p < 0.001 with 65.2 % of variation explained), genotype (Fig. 18B), 
colonization (Fig. 18C) and streptomycin treatment (Fig. 18D) alone. No clear separation 
was seen for genotype (Fig. 18B according to Adonis *p = 0.038 with 13.2 % of variation 
explained) or colonization (Fig. 18C according to Adonis p > 0.05), but clearly all samples 
show a distinct pattern after streptomycin treatment, independent of their Agr2 genotype or 
their colonization with or without M. schaedleri (Fig. 18D according to Adonis ***p < 0.001 
with 38.8 % of variation explained).  
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Fig. 17: Streptomycin does not influence protection by M. schaedleri in OligoMM12 Agr2-/-/Agr2+/- mice. A) 
Experimental set up. OligoMM12 Agr2+/- and Agr2-/- mice were pre-colonized for 10 days with M. schaedleri or 
control media. Mice were treated with 25 mg streptomycin by oral gavage one day before infection with 107 cfu 
of S. Tmwt and were sacrificed one day post infection. B) S. Tm loads in cecal content, C) mesenteric lymph 
nodes, D) spleen and E) liver were quantified by plating day 1 p.i.. F) Histopathological score of cecal tissue on 
day 1 p.i. stained with hematoxylin and eosin. The degree of submucosal edema, neutrophil infiltration and 
epithelial damage was scored in a double-blinded manner. 0-3: no pathological changes; 4-7: moderate 
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inflammation; above 8: severe inflammation. Pathological score is displayed without loss of goblet cells. G) 
Lipocalin-2 levels in cecal content were measured by quantitative ELISA day 1 p.i.. Dashed line: detection limit. 
One dot represents one mouse. One-way ANOVA Kruskal-Wallis test with Dunn’s multiple comparison test 
compare selected pairs (mock Agr2+/- vs. M. schaedleri Agr2+/- /  mock Agr2-/- vs. M. schaedleri Agr2-/-); ns, no 
significant difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. H) Microbiota composition of feces from Agr2+/- 
and Agr2-/- mice with M. schaedleri or control before and one day post streptomycin treatment. Shown is the 
relative abundance of each individual strain (% of all 16S rRNA gene copies). Each bar represents one mouse. 
On the right axis, black dots show the absolute number of 16S rRNA gene copies per 5 ng DNA quantified by a 
universal primer/probe combination. 
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Fig. 18: Cluster analysis of streptomycin pretreated OligoMM12 Agr2-/- and Agr2+/- mice pre-colonized with 
M. schaedleri or control. Cluster analysis is based on Bray Curtis distance matrices and visualized as PCoA 
plots. A) 2D PCoA plot of fecal microbiota from OligoMM12 Agr2-/- and Agr2+/- mice pre-colonized with 
M. schaedleri or control for 10 days colored by genotype & colonization (M. schaedleri or control) & streptomycin 
treatment; significant for Bray Curtis (***p < 0.001, Adonis) with 65.2 % of variation explained. B) Coloring by 
genotype (Agr2-/- vs. Agr2+/-); significant for Bray Curtis (*p < 0.038, Adonis) with 13.2 % of variation explained or 
C) colonization (M. schaedleri vs. mock); not significant for Bray Curtis (p > 0.05, Adonis) and D) streptomycin 
treatment (untreated vs. streptomycin); significant for Bray Curtis (***p <0.001, Adonis) with  38.8 % of variation 
explained. 
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4.5 Influence of M. schaedleri on gut metabolites and pathogenicity of 
C. rodentium 
4.5.1 M. schaedleri does not protect mice from C. rodentium induced 
intestinal inflammation and colonization 
We asked whether the protective effect of M. schaedleri is unique to S. Tm infection or also 
applies to other pathogens. Therefore we chose C. rodentium, a common mouse pathogen 
and model for human Enteropathogenic Escherichia coli (EPEC) infection, to study the effect 
of M. schaedleri on colonization and colon hyperplasia in the OligoMM12 model. In SPF mice, 
C. rodentium induces a self-limiting disease with peak colonization at day 7 p.i. which 
resolves after approximately 20 days p.i.(Wiles et al., 2004). Previous experiments in 
OligoMM12 mice showed, that C. rodentium was still detectable after 42 days of infection at 
107 cfu/g (Beutler, 2016). We infected OligoMM12 mice pre-colonized with M.schaedleri or 
control for 10 days with 108 cfu C. rodentium DBS100. C. rodentium loads in the feces 
increased to mean 4*107 cfu / g within 4 - 7 days and remained high for the entire duration of 
the experiment. M. schaedleri did not reduce colonization of C. rodentium in the feces of 
infected mice at the beginning nor did it facilitate clearance of the pathogen (Fig. 19B) as 
seen by high levels of colonization of 107 cfu / g until day 30 p.i. (data up to day 23 is shown 
as there were no further changes of C. rodentium loads). Furthermore, in OligoMM12 mice 
C. rodentium only elicits a mild inflammation, as determined by fecal lipocalin-2, starting at 
day 8 p.i., reaching its maximum from day 10 - 15 p.i., and then decreasing steadily until day 
23 p.i. when no lipocalin-2 was detectable in the feces (Fig. 19C). No difference in lipocalin-
2 between the control group and mice colonized with M. schaedleri was seen at any time 
point. We can conclude that M. schaedleri, while blocking S. Tm induced colitis, does not 
attenuate C. rodentium induced inflammation. This is in accordance with the idea that 
M. schaedleri specifically interferes with the expression of the SPI1-T3SS of S. Tm. 
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Fig. 19: The course of C. rodentium infection is not influenced by M. schaedleri. A) Experimental set up. 
OligoMM12 mice were pre-colonized with M. schaedleri or sterile control media 10 days prior to infection with 
C. rodentium (108 cfu/mouse), fecal samples were taken on a regular base day 0 until day 30 (day of termination). 
B) C. rodentium loads quantified over time by plating of fecal pellets. C) Lipocalin-2 levels in feces measured by 
ELISA. One dot represents one mouse, dashed line: detection limit. One-way ANOVA Kruskal-Wallis test with 
Dunn’s multiple comparison test; ns, no significant difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. Data 
points from day 23 onwards are not shown, as no further changes were observed. 
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4.5.2 M. schaedleri is streptomycin resistant but sensitive to ampicillin 
As M. schaedleri was enriched in streptomycin treated Agr2-/- mice but not in ampicillin 
treated mice (Brugiroux, 2016), we tested whether M. schaedleri was resistant to the 
aminoglycoside streptomycin but not to the beta-lactam antibiotic ampicillin. Indeed, when 
M. schaedleri was cultured in the presence of standard concentrations of 100 µg/ml or 
50 µg/ml of streptomycin or ampicillin, or media without antibiotic, we observed no growth of 
the cultures with both concentrations of ampicillin, but normal growth in the presence of 
streptomycin compared to control without antibiotics at 48 h and 72 h after inoculation (Two-
way ANOVA with Bonferroni multiple comparison test; ***p < 0.001) (Fig. 20). 
 
 
 
 
Fig. 20: M. schaedleri is streptomycin resistant but sensitive to ampicillin. M. schaedleri was grown in AAM 
(10 mM NaNO3) in the presence of 50 or 100 µg/ml streptomycin or ampicillin or as a control without antibiotics 
for 72 h. OD600 was measured every 24 h. Displayed is the mean of three replicates and SEM. Two-way ANOVA 
test with Bonferroni multiple comparison test; ns, no significant difference p ≥ 0.05, *p < 0.05, **p < 0.01, ***p < 
0.001. 
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4.5.3 M. schaedleri leads to alterations of the primary bile acid pool and 
SCFAs in the cecum of mice 
Bile acids are produced in the liver and released into the intestine where they are modified 
by the microbiota (Wahlstrom et al., 2016). A study by Prouty & Gunn showed, that SPI1-
T3SS was repressed in the presence of bile acids (Prouty & Gunn, 2000). On the other hand, 
short-chain fatty acids (SCFAs) such as acetate, propionate and butyrate are produced by 
the microbiota via fermentation of dietary fibers and play an important role for gut 
homeostasis (e.g. as energy source for colonocytes (Donohoe et al., 2011), anti-
inflammatory response (Tedelind et al., 2007)). An effect of butyrate and acetate on SPI1-
T3SS was previously shown (Durant et al., 2000; Lawhon et al., 2002). Thus, we 
hypothesized that alterations of SCFAs or bile acids by M. schaedleri could lead to 
repression of SPI1-T3SS expression. We analyzed changes of bile acid and SCFA levels in 
the cecum of ASF3 mice colonized with M. schaedleri or control for 10 days. Interestingly, 
the primary bile acids β-MCA, TCA, α-TMCA and β-TMCA were increased in mice colonized 
with M. schaedleri (Mann–Whitney U test; **p < 0.01, *p < 0.05, **p < 0.01; Fig. 21A). No 
secondary bile acids were detectable (data not shown). On the other hand, the SCFAs 
succinate, acetate, propionate and the total amount of SCFAs were slightly decreased in 
M. schaedleri colonized ASF3 mice (Mann–Whitney U test; *p < 0.05), whereas formate, 
lactate and butyrate levels did not show a significant difference (Fig. 21B). 
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Fig. 21: M. schaedleri increases taurine conjugated primary bile acids and alters the SCFA pool in the 
cecal content of mice. A) Quantification of bile acids in cecal content by non-targeted metabolomics using 
UPLC-MS (Dr. Alesia Walker) from ASF3 mice colonized for 10 days with M. schaedleri or mock. Secondary bile 
acids were not detectable (data not shown) B) SCFAs quantification (Dr. Buck Hanson) by capillary 
electrophoresis from same samples as used for bile acid quantification. Shown is the mean concentration with 
SD from 8 mice per group. nd, not detected; Mann–Whitney U test; ns, no significant difference p ≥ 0.05, *p < 
0.05, **p < 0.01, ***p < 0.001 
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5 Discussion 
In the last few years the field of microbiome research has extremely expanded. The 
importance of the microbiota on the human health has been acknowledged and dysbiosis is 
associated to a wide range of diseases. A higher susceptibility of a disrupted microbiota to 
enteric pathogens is of significant importance for human health (Buffie et al., 2012; Ubeda 
et al., 2010). A small number of intestinal microbiota species were already identified which 
protect the host from pathogenic bacteria. Among them are Clostridium scindens, 
Escherichia coli Nissle 1917, Bifidobacterium spp. and Ruminococcus obeum which were 
shown to confer resistance to major intestinal pathogens like Clostridium difficile, S. Tm, 
Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 and Vibrio cholerae respectively 
(Buffie et al., 2015; Deriu et al., 2013; Fukuda et al., 2011; Hsiao et al., 2014; Studer et al., 
2016). Those bacteria employ distinct mechanisms to confer colonization resistance. 
C. scindens produces secondary bile acids which prevent germination of C. difficile spores, 
whereas E. coli Nissle competes with S.Tm for iron (Buffie et al., 2015; Deriu et al., 2013; 
Studer et al., 2016). Specific Bifidobacterium spp. are able to produce acetate which 
promotes an anti-inflammatory response preventing translocation of shiga toxin type 2 to the 
bloodstream (Fukuda et al., 2011). On the other hand, R. obeum interferes with the 
V. cholerae quorum-sensing and therefore represses major colonization factors of 
V. cholerae (Hsiao et al., 2014). To date, no bacterium has been identified which influences 
the expression of a major virulence factor but does not confer colonization resistance. In my 
thesis I was able to demonstrate a causal role of M. schaedleri in protection from S. Tm 
colitis by employing different gnotobiotic mouse models, S. Tm mutants and RNAseq. This 
protective effect is achieved by downregulation of the S.Tm SPI1-T3SS, its major virulence 
factor.  
5.1 M.schaedleri delays the onset of S.Tm colitis in mice 
S.Tm is a major cause of gastroenteritis in humans and leads to high mortality in 
immunocompromised people (Gordon, 2008; Uche et al., 2017). Further, antibiotic-resistant 
strains are emerging (Okoro et al., 2012). Therefore, it is necessary to develop protective 
strategies. One future strategy could be the precise manipulation of the microbiota 
(“precision editing”, (Zhu et al., 2018)) to increase protection against disease in high risk 
populations. A complex microbiota precludes the analysis of the contribution of single 
bacterial species to the outcome of disease. S.Tm infection in the mucus deficient Agr2-/- 
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mouse model identified a potential protective role of M. schaedleri in S. Tm colitis (Fig. 4) 
(Brugiroux, 2016). By utilizing two distinct gnotobiotic mouse models (ASF3 and OligoMM12) 
I confirmed causality of M. schaedleri in protection from S.Tm colitis by selectively adding 
this species only. Due to the low complex microbiota no streptomycin pretreatment is needed 
to breach colonization resistance in both types of mice (Beutler, 2016; Brugiroux, 2016; 
Stecher et al., 2010). Indeed, M.schaedleri reduced colitis in gnotobiotic ASF3 and as well 
OligoMM12 mice infected with wildtype S. Tm (Fig. 6F & G; Fig. 7F & G). In contrast, 
M.schaedleri is not able to confer colonization resistance to S. Tm (Fig. 6B; Fig. 7B). This 
observation indicates that M.schaedleri is a beneficial bacterium in respect to protection of 
mice from S.Tm colitis and that this effect is independent of the microbial context. The 
microbiota produces diverse metabolites and generates a complex environment. Recently it 
was shown that protection from vancomycin-resistant Enterococcus (VRE) in mice is 
mediated in a cooperative manner by four different species (Caballero et al., 2017). A niche 
is created by members of this consortium to allow efficient colonization of the protective 
strain Blautia producta (Caballero et al., 2017). Furthermore, the E. coli strain Mt1B1 was 
only able to confer colonization resistance to S. Tm in gnotobiotic mice colonized with the 
OligoMM12 microbiota but not in the very low complex ASF mice (Brugiroux et al., 2016), 
showing the importance of the microbiota composition on protection. Cross feeding is an 
important interaction between different species in the gut. In vitro, Parabacteroides 
goldsteinii ASF519 was reported to produce multiple amino acids, among them methionine, 
threonine and tryptophan (Biggs et al., 2017) which are in contrast not synthesized by 
M. schaedleri (Loy et al., 2017). Further M. schaedleri utilizes H2 as electron donor to 
perform dissimilatory nitrate reduction to ammonia (DNRA) (Loy et al., 2017). The ceca of 
germ-free mice are devoid of H2 and the resident microbiota is responsible for H2 production 
(Maier et al., 2013). Therefore, M. schaedleri could rely on amino acids and H2 produced by 
the intestinal microbiota. Infection experiments in germ-free mice mono-colonized with 
M. schaedleri could show if colonization of M. schaedleri and the protective effect is 
completely microbiota independent. 
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5.2 S.Tm SPI1-T3SS expression is reduced in the presence of 
M.schaedleri 
Elucidating the mechanism underlying the protective effect of M. schaedleri in S. Tm colitis 
proofed to be rather difficult. Until now, genetic manipulation of M. schaedleri is not possible 
and therefore mutants are not available. Furthermore, M. schaedleri is a fastidious bacterium 
growing slowly in liquid culture under anaerobic conditions. It was isolated on agar plates 
but does not readily form single colonies (Robertson et al., 2005). In our lab, we were so far 
unable to obtain reproducible growth on agar plates which would be a prerequisite for in vitro 
studies. Therefore we relied so far on S.Tm reporter and S.Tm mutant strains as well as 
transcriptome analysis to identify the mechanism of protection indirectly.  
The SPI1-T3SS is the major virulence factor of S.Tm which is employed to invade intestinal 
epithelial cells and trigger inflammation (Barthel et al., 2003). S.Tm colitis is drastically 
reduced by M. schaedleri in gnotobiotic mice and invasion of S.Tm into the cecal tissue of 
protected streptomycin treated Agr2-/- mice was reduced (Brugiroux, 2016). Therefore, we 
analyzed SPI1-T3SS expression in vivo using an avirulent S.Tm harboring a SPI1 reporter 
plasmid (Ackermann et al., 2008). In control mice, approximately 8 % of the S.Tm population 
expresses SPI1-T3SS. This is significantly reduced about 2-fold to approximately 4 % in the 
presence of M.schaedleri (Fig. 10). SPI1-T3SS was shown to be expressed in a bistable 
manner (Ackermann et al., 2008). It was stated that only approximately 15 % of the total 
S.Tm population express SPI1-T3SS (Ackermann et al., 2008). Those SPI1+ bacteria can 
invade the tissue and trigger inflammation. In contrast, SPI1- bacteria can benefit of the 
inflammatory milieu in the gut and acquire nutrients released by the inflamed mucosa and 
expand in the gut (Ackermann et al., 2008; Diard et al., 2013). This strategy is known as 
phenotypic heterogeneity (Ackermann et al., 2008; Diard et al., 2013). Further, it was 
reported that inflammation is enhanced proportional to increasing numbers of SPI1+ bacteria 
(Ackermann et al., 2008). Therefore, a reduction of about half of SPI1+ bacteria seen in mice 
colonized with M. schaedleri will have a strong impact on inflammation.  
RNAseq data from S.Tm infection in vivo confirmed the downregulation of SPI1-T3SS in the 
presence of M. schaedleri (Table 34). InvF, a main positive regulator of SPI1-T3SS effector 
protein genes, is ~ 2-fold downregulated. Further, SPI1-T3SS genes like sipA and prgK are 
also downregulated 3 - 5-fold. SipA effects the rearrangement of actin filaments and 
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mediates the uptake of S.Tm in host cells (Galkin et al., 2002) whereas PrgK forms together 
with PrgH the inner ring of the SPI1-T3SS apparatus (Bergeron et al., 2015). In addition the 
expression of the effector protein SopB is also negatively influenced by the presence of 
M. schaedleri. SopB is not encoded on the SPI-1 locus but is translocated via the SPI1-T3SS 
and leads to disruption of the tight junctions of epithelial cells (Boyle et al., 2006). This 
argues that the expression of the entire S.Tm SPI1-T3SS and some effector proteins is 
seriously affected by M. schaedleri and therefore SPI1-T3SS mediated invasion and 
induction of inflammation is severly reduced. Utilizing two distinct methods, a gfp-reporter 
strain and RNAseq, I could confirm that M. schaedleri influences the expression of S.Tm 
SPI1-T3SS which results in a significantly decreased S.Tm colitis in vivo.  
On the other hand, M.schaedleri does not confer protection to mice against infection with 
the common mouse pathogen Citrobacter rodentium (Fig. 19B&C). This bacterium is used 
as a model for human Enteropathogenic Escherichia coli infection (EPEC) (Wiles et al., 
2004). C. rodentium elicits a milder inflammation compared to S.Tm which sets in 6-10 days 
post infection and is usually cleared from the intestine 20 days post infection (Wiles et al., 
2004). In OligoMM12 mice C. rodentium colonizes the gut for at least 42 days (Beutler, 2016). 
Mice pre-colonized with M. schaedleri show a slight but not significant reduction of 
C. rodentium loads (Fig. 19BC). This could indicate that M. schaedleri contributes to some 
extend to the clearance of C. rodentium in OligoMM12 mice. Like S. Tm, C. rodentium harbors 
a T3SS encoded on the locus of enterocyte effacement (LEE) (Jarvis et al., 1995). 
Expression of LEE is tightly regulated by environmental factors like fucose, butyrate, pH, 
NO, epinephrine/norepinephrine and bacterially derived auto-inducer 3 signaling molecule 
(AI-3) or acyl-homoserine lactones (Branchu et al., 2014; Connolly et al., 2015; Hughes et 
al., 2010; Kanamaru et al., 2000; Nakanishi et al., 2009; Pacheco et al., 2012; Walters & 
Sperandio, 2006). It is essential for injection of effector proteins which lead to cytoskeletal 
rearrangement and inflammation (Hueck, 1998; Kaper et al., 2004). We suppose that the 
inhibition of virulence of S.Tm by M.schaedleri is specific for S.Tm and not the T3SS. 
Experiments with other pathogens harboring a T3SS like Shigella flexneri or Yersinia 
enterocolitica (Notti & Stebbins, 2016) will help further to analyze this aspect. 
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5.3 Nitrate induces S.Tm SPI1-T3SS expression under anaerobic 
conditions in vitro 
The SPI1-T3SS system is controlled by a complex regulatory network. Little is known on the 
environmental cues stimulating SPI1-T3SS expression. During inflammation the 
environment of the gut changes dramatically. Cells of the innate immune response release 
ROS as a first line of defense against invading pathogens and thereby creating a hostile 
environment (Rivera-Chavez & Baumler, 2015). On the other hand, growth of S. Tm is 
promoted in the presence of alternative electron acceptors (Price-Carter et al., 2001; Unden 
& Dunnwald, 2008). For S.Tm, nitrate is the most preferred alternative electron acceptor 
directly after oxygen (Unden & Dunnwald, 2008). Nitrate concentrations are low (0.03 mM) 
in the uninflamed gut but increase during inflammation (0.3 mM) in the cecal mucus layer 
(Lopez et al., 2015). It was shown that the periplasmic nitrate reductase plays an important 
role for S.Tm colonization in the gut, highlighting its importance in S.Tm infection (Lopez et 
al., 2015). M. schaedleri performs full dissimilatory nitrate reduction to ammonia (DNRA) and 
could therefore limit available nitrate in the gut and compete with S. Tm (Fig. 2B) (Loy et al., 
2017). Data from an in vitro SPI1-luciferase reporter assay show that under anaerobic 
conditions in the presence of nitrate (10 mM or 40 mM) SPI1-T3SS expression is enhanced 
app. 5-fold (Fig. 11A). This stimulatory effect is abolished in a nitrate respiration deficient 
S.Tm mutant (S.TmΔnr3) (Fig. 11A), suggesting that functional nitrate respiration is needed 
for SPI1-T3SS induction under anaerobic conditions. Further, published SPI1-T3SS 
inducing factors like microaerobic conditions and high osmolarity (Lee & Falkow, 1990; Song 
et al., 2004) were also able to enhance SPI1-T3SS in our assay (Fig. 11A). Nitrate 
dependent induction of SPI1-T3SS was only observed under anaerobic conditions (Fig. 
11A). Further, induction was not observed with low nitrate concentrations (1 mM). The three 
different nitrate reductases are induced under different nitrate concentrations. The high 
affinity periplasmic nitrate reductase NapABCGH is induced at low nitrate concentrations 
(1 mM) whereas the low affinity NarGHI is maximally synthesized at nitrate concentrations 
of 10 mM (Wang et al., 1999). Nitrate is consumed rapidly by S. Tm during anaerobic growth, 
therefore high concentrations of nitrate (> 10 mM) are needed to sustain constant supply of 
nitrate over the 4 h growth period (DeMoss & Hsu, 1991). It would be of interest to analyze 
the minimal nitrate concentration needed to induce S. Tm SPI1-T3SS in vitro and whether 
this concentration is comparable to conditions found in vivo. Therefore, growth in a 
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chemostat with constant supply of nitrate would be mandatory. An invasion assay confirmed 
that under low oxygen conditions (0.5 %) functional nitrate respiration is needed to enable 
full invasion into HuTu80 cells (Fig. 11B). In conclusion, I identified nitrate as a new inducer 
of SPI1-T3SS under anaerobic conditions which could play an important role in vivo for S.Tm 
invasion into epithelial cells. Other alternative electron acceptors (DMSO, TMAO) were also 
tested using the SPI1-luciferase reporter assay. Both, DMSO and TMAO respiration induce 
SPI1-T3SS under anaerobic conditions (unpublished, Master Thesis R. Götz). Those 
alternative electron acceptors are as well metabolized by M.schaedleri as predicted by 
genome analysis (Loy et al., 2017) and first in vitro culture experiments (preliminary data, 
not shown). 
5.4 How does M.schaedleri influence the regulation of S.Tm SPI1-T3SS 
in vivo? 
In vitro, nitrate was found to be a potent S. Tm SPI1-T3SS inducer. We hypothesized that 
M. schaedleri limits available nitrate in the gut by performing dissimilatory nitrate reduction 
to ammonia (DNRA) (Loy et al., 2017). Therefore, SPI1-T3SS expression should be reduced 
and hence inflammation dampened. Due to the lack of a genetic system for M. schaedleri I 
employed a S. Tm mutant defective in nitrate respiration (S.TmΔnr3) for infection experiments. 
Assuming that M. schaedleri limits nitrate, control mice without M. schaedleri should exhibit 
higher intestinal nitrate concentrations. If nitrate plays a role as SPI1-T3SS inducer in vivo, 
a S.TmΔnr3 mutant unable to utilize nitrate should induce less inflammation in control mice 
even if nitrate is present. The inflammation should be as low as in mice colonized with 
M. schaedleri and infected with wildtype S.Tm or S.TmΔnr3. 
In contrast to our expectations, S.TmΔnr3 still elicits a profound inflammation in control mice, 
comparable to wildtype S.Tm infection (Fig. 13F & G). Mice colonized with M. schaedleri are 
still protected from colitis during S.TmΔnr3 infection (Fig. 13F & G). This indicates that nitrate 
is negligible in vivo for protection from S.Tm colitis by M. schaedleri. 
During inflammation in the intestine, an altered environmental condition is established that 
boost growth of enteric pathogens (Winter, Lopez, et al., 2013). However, also other 
metabolites besides nitrate like TMAO, DMSO and tetrathionate are released which can be 
used as alternative electron acceptors by S.Tm under anaerobic conditions (Unden & 
Dunnwald, 2008). This leads to a growth advantage of S.Tm over the resident microbiota in 
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the intestine (Winter, Lopez, et al., 2013; Winter et al., 2010). Infection experiments with 
S.TmΔmoaA, a mutant unable to utilize nitrate, TMAO, DMSO, tetrathionate and fumarate, 
showed that this mutant still elicits profound inflammation in control mice, resembling 
wildtype S.Tm infection. 
These results show that the protective effect of M.schaedleri is not dependent on the 
alternative electron acceptors nitrate, DMSO, TMAO, tetrathionate and fumarate. Both 
mutants, S.TmΔnr3 and S.TmΔmoaA, could still acquire nitrite and convert nitrite to ammonia by 
its nitrite reductases (NirBD, NrfA) (Einsle, 2011; Einsle et al., 1999; Gilberthorpe & Poole, 
2008; Rycovska-Blume et al., 2015). Further, three nitrite transporters (NarK, NarU and 
NirC) are described to import environmental nitrite into S.Tm (Jia et al., 2009; Rycovska et 
al., 2012). Nitrite is an intermediate in nitrate reduction and is the most preferred anaerobic 
electron acceptor after nitrate under anoxic conditions (Unden & Dunnwald, 2008). The 
SPI1-T3SS inducing effect observed in vitro could be accounted to nitrite respiration rather 
than nitrate respiration. If this is the case, SPI1-T3SS should be inducible by nitrite in 
S.TmΔnr3, S.TmΔmoaA and wildtype S.Tm but not in a nitrite reductase mutant S.TmΔnrfAΔnirB. 
This can be analyzed by an in vitro luciferase-assay. Further the nitrite respiration mutant 
S.TmΔnrfAΔnirB and a S.Tm mutant completely unable of anaerobic respiration 
S.TmΔmoaAΔnrfAΔnirB could be used for infection experiments in OligoMM12 mice colonized with 
M. schaedleri or control to study the effect in vivo. Complete abrogation of anaerobic 
respiration could lead to a severe growth defect of S.Tm in the gut, especially as nrfA plays 
as well a role in detoxification of NO (Mills et al., 2008). This has to be experimentally tested. 
S.TmΔnirC, defective in a nitrite transporter, showed reduced dissemination into the spleen of 
mice (Das et al., 2009) indicating a role in S.Tm pathogenesis.  
Measurement of nitrate and nitrite concentrations in the intestinal mucus would give 
important information about environmental available nitrate / nitrite and changes in the 
presence of M.schaedleri. Due to inhibitors and probably low amounts of nitrate / nitrite in 
mucus scrapings a colorimetric assay (Lopez et al., 2015) and a commercial fluorometric 
nitric oxide kit failed to measure accurate nitrate concentrations.  
A second important factor is the presence of oxygen in the usually hypoxic intestine. In the 
in vitro luciferase assay we showed that oxygen is a potent inducer of S. Tm SPI1-T3SS 
which was already described (Ibarra et al., 2010; Lee & Falkow, 1990). Further, oxygen 
induces the T3SS of the pathogen Shigella flexneri (Marteyn et al., 2010). Therefore oxygen, 
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present at the epithelial border could influence the expression of SPI1-T3SS in vivo. 
Streptomycin treatment disturbs the resident microbiota and depletes especially members 
of the Clostridia (Rivera-Chávez et al., 2016). This leads to an increase of available oxygen 
which is readily consumed by facultative anaerobic bacteria like S.Tm and results in 
expansion of S.Tm (Rivera-Chávez et al., 2016). It was shown that the post-antibiotic 
expansion of S.Tm relies on its cytochrome bd-II oxidase (CyxA) (Rivera-Chávez et al., 
2016). Therefore, a S.TmΔcyxA mutant could contribute to understand the potential role of 
oxygen for the protective effect of M.schaedleri. The protective effect of M. schaedleri was 
also observed in the unperturbed gut of OligoMM12 and ASF3 mice (Fig. 6 & Fig. 7). Due to 
the low complexity of the microbiota and under – representation of butyrate producing 
Clostridia it could be possible that oxygen is present at low levels in the gut. M. schaedleri 
could compete with S.Tm for oxygen using a cytochrome c oxidase (Loy et al., 2017) and 
thereby decrease SPI1-T3SS in S.Tm. Intestinal oxygen quantification is a challenging task. 
Several techniques are published but are not easy to perform (Espey, 2013). In contrast, O2 
microsensors were recently used in cockroaches and honeybees to measure O2 
concentrations in the gut (Tegtmeier et al., 2016; Zheng et al., 2017). To the best of my 
knowledge there are so far no studies in the mouse gut. If this method is applicable to mice 
has to be shown. Further, hypoxia staining with pimonidazol was recently used to visualize 
hypoxia of the intestinal epithelium (Byndloss et al., 2017; Rivera-Chávez et al., 2016). 
However, as preliminary experiments suggested this method is not sensitive enough for our 
needs. 
Transcriptome analysis revealed that in the presence of M. schaedleri S. Tm downregulates 
the genes for the periplasmic nitrate reductase napA, hydrogenases as well as cytochrome 
d oxidase subunit I cydA (Table 34). This points at efficient competition for nitrate, hydrogen 
and oxygen of M. schaedleri with S. Tm. Competition for nutrients was already shown to be 
an essential mechanism in conferring colonization resistance to S. Tm (Deriu et al., 2013). 
It was also demonstrated that commensal E. coli reduces colonization of pathogenic E. coli 
probably by competing for the same nutrients (Leatham et al., 2009). H2 and nitrate are 
known to be factors important for S. Tm colonization of the mouse intestine (Lopez et al., 
2015; Maier et al., 2013). Initial competition experiments indicate that in the OligoMM12 mice 
H2 as well as nitrate utilization are negligible for efficient colonization (Fig. 9).  The impact of 
available oxygen has to be evaluated as discussed above. 
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Fig. 22. Hypothetical mechanism of protection by M. schaedleri from S.Tm colitis. During inflammation 
several eletron acceptors become available, especially in close proximity of the epithelial border. Those can be 
sensed by S. Tm and used as signal for SPI1-T3SS expression which leads to cell invasion and triggering of the 
innate immune response (left). M. schaedleri has the capacity to utilize those electron acceptors as well, 
suggesting competition between M. schaedleri and S. Tm. By depletion of the complex pool of electron acceptors 
by M. schaedleri S. Tm respiration and SPI1-T3SS expression is reduced which leads to decreased epithelial 
cell invasion and subsequently to lower inflammation. 
Further, transcriptome data showed that several genes involved in translation are as well 
downregulated implying reduced growth of S.Tm in the presence of M.schaedleri (Klumpp 
et al., 2013; Zhu et al., 2016). This could not be substantiated by experiments where we 
measured the replication rate of S. Tm harboring a temperature sensitive plasmid (Stecher 
et al., 2008) (Fig. 8). In ASF3 mice colonized with M.schaedleri we actually observed a higher 
replication rate (Fig. 8B). On the other side, in OligoMM12 mice we rather saw a slightly 
reduced growth rate with M.schaedleri which would be in line with the transcriptome data. 
This discrepancy has to be addressed further. 
A genetic system for M. schaedleri would be highly useful to further entangle the mechanistic 
details underlying S. Tm antagonism. M.schaedleri is a vastly unexplored bacterium. This is 
also due to its fastidious lifestyle and its inability to form single colonies on agar plates 
(Robertson et al., 2005). So far reproducible growth is only obtained in liquid culture. We 
suppose that M. schaedleri has even more requirements for growth on solid media and the 
media have to be adjusted. The genome analysis revealed that M.schaedleri is unable to 
synthesize several amino acids like methionine and tryptophan (Loy et al., 2017), therefore 
supplementation of these could yield in growth. Recently it was reported that fastidious 
bacteria were able to grow in the presence of another bacterium, a so called helper strain. 
Those helper strains produce nutrients vital for recipient strains (Fenn et al., 2017; Nichols 
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et al., 2008; Ohno et al., 1999). Growth in the presence of E.coli, the OligoMM12 or ASF 
strains will be tested.  
In respect to S.Tm colitis M.schaedleri fulfills definitely a protective role. On the other hand 
it was indicated as a potential pathobiont (Loy et al., 2017). It is increased in its abundance 
in the context of inflammation in several studies performed in mice (Berry et al., 2012; Rooks 
et al., 2014; Selvanantham et al., 2016; Song et al., 2018). Further it is also elevated in 
obese mice where a dysbiotic microbiota changed the intestinal environment (Ravussin et 
al., 2012; Serino et al., 2012). During inflammation, alternative electron acceptors like 
DMSO, TMAO, nitrate, tetrathionate and oxygen become available (Rivera-Chavez & 
Baumler, 2015).  M. schaedleri can perform full DNRA and possesses genes for potential 
DMSO, TMAO and tetrathionate reductases (Loy et al., 2017). Therefore it is not surprising 
that M. schaedleri is increased in experimental colitis models (Berry et al., 2012; Rooks et 
al., 2014; Selvanantham et al., 2016; Song et al., 2018; Vereecke et al., 2014). Further, the 
presence of genes encoding cytochrome c oxidase, catalase, superoxide reductase, 
cytochrome c peroxidase and rubrerythrin allows it to withstand efficiently neutrophil 
oxidative burst (Loy et al., 2017). If M.schaedleri is a true pathobiont and actually promotes 
colitis or just benefits from released nutrients has to be experimentally tested in the future 
using gnotobiotic mice.  
5.5 M. schaedleri is a natural member of the murine microbiota  
M. schaedleri is part of the minimal consortium Altered Schaedler Flora (ASF) (Orcutt et al., 
1987). It was isolated from mice and is predominant in wild living mice (Linnenbrink et al., 
2013; Robertson et al., 2005; Rosshart et al., 2017). Records of M. schaedleri in human are 
scarce and it is so far only detected in samples from colonic biopsies at low levels (Bik et 
al., 2006; Harrell et al., 2012; Rausch et al., 2011). It was stated that Mucispirillum is an 
exclusive genus in mice compared to human (Krych et al., 2013). Limiting sequencing depth, 
the low abundance of M. schaedleri even in mice and its localization at the epithelial border 
could account for its rare detection in human. Further, M. schaedleri is not present in each 
laboratory mouse strain. In mice from Taconic and Charles River, M. schaedleri is highly 
abundant, whereas it is not detected in mice from Jackson (Rosshart et al., 2017). In the 
context of the protective effect of M. schaedleri on S.Tm infection found in this study the 
choice of vendor should be carefully reconsidered in future experiments when using mice 
for infection studies.  
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M. schaedleri inhabits a distinct niche close to the epithelium, which was shown by FISH 
analysis in gnotobiotic ASF3 and OligoMM12 mice (Fig. 5B & D) (Loy et al., 2017). Genome 
analysis of M.schaedleri predicts a cytochrome c oxidase, catalase, superoxide reductase, 
cytochrome c peroxidase and rubrerythrin to fend off oxidative stress which is likely 
encountered in close proximity to the epithelial border (Fig. 2A) (Loy et al., 2017). This is 
also in accordance with observations in our lab which showed that M. schaedleri is oxygen 
tolerant. M.schaedleri is described as a mucus dwelling bacterium (Loy et al., 2017; 
Robertson et al., 2005). Surprisingly, M. schaedleri is also abundant in MUC2 deficient 
OligoMM12 Agr2-/- mice and is localized close to the epithelial border (Fig. 14A). Together 
with the genome prediction of Loy et al. which found no evidence for mucus degrading 
enzymes we can conclude that MUC2 is dispensable for successful M. schaedleri 
colonization in mice (Loy et al., 2017). At the epithelial border, M.schaedleri forms a dense, 
mesh like biofilm (Fig. 5B & D; Fig. 14A) (Loy et al., 2017). In combination with its oxygen 
detoxifying enzymes, M. schaedleri could contribute to the anoxic conditions found in the 
intestinal lumen. M. schaedleri is fully adapted to its life close at the epithelial border, where 
it is exposed to harsh environmental conditions. 
5.6 M. schaedleri changes the intestinal metabolome 
SCFAs and bile acids were shown to be important environmental cues for SPI1-T3SS 
expression as their concentrations and compositions differ along the gastrointestinal tract 
(Durant et al., 2000; Eade et al., 2016; Lawhon et al., 2002; Prouty & Gunn, 2000). SCFAs 
play a pivotal role in gut homeostasis and are mainly produced by the microbiota (den 
Besten et al., 2013; Donohoe et al., 2011; Furusawa et al., 2013; Macfarlane et al., 
1998).The ileum exhibits high concentrations of acetate which induce SPI1-T3SS in vitro 
(Lawhon et al., 2002). In contrast, the cecum and colon are rich in butyrate and propionate 
which were shown to have an inhibitory effect on SPI1-T3SS (Lawhon et al., 2002). 
M.schaedleri slightly alters SCFA concentrations in the cecum of mice (Fig. 21B). The 
differences observed are only subtle and an effect on S. Tm SPI1-T3SS expression is 
unclear. M. schaedleri does not only colonize the cecum of mice but is distributed along the 
whole gastrointestinal tract (Sarma-Rupavtarm et al., 2004). The distal ileum was reported 
to be the preferred site of S. Tm invasion (Carter & Collins, 1974). Therefore M. schaedleri 
could change the SCFA composition in the ileum rather than the cecum. This has to be 
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followed up by analyzing the SCFAs in the ileum of mice colonized with M. schaedleri or 
control.  
Primary bile acids are produced by the host and metabolized by the gut microbiota (de 
Aguiar Vallim et al., 2013; Sayin et al., 2013). Only few intestinal bacteria like Clostridium 
scindens and Clostridium hylemonae are capable to produce secondary bile acids (Ridlon 
et al., 2016; Ridlon et al., 2006). As none of these bacteria are a member of the ASF3 
consortium it is not surprising that ASF3 mice lack secondary bile acids (Fig. 21A). 
Additionally, we can conclude that M.schaedleri is not a secondary bile acid producer. 
Further, taurine-conjugated primary bile acids are decreased by bile salt hydrolase (BSH) 
activity of taurine deconjugating bacteria (Sayin et al., 2013). Interestingly, taurine 
conjugated bile acids like TCA, α-TMCA and β-TMCA are increased in the cecal content of 
ASF3 mice with M. schaedleri compared to control (Fig. 21A). BSH are widely distributed 
among bacteria and are required for taurine deconjugation (Begley et al., 2006; Jones et al., 
2008; Tanaka et al., 1999). We suspect that M. schaedleri may inhibit the BSHs of L. murinus 
(ASF361) and P. goldsteinii (ASF519) which could explain the increased concentrations of 
TCA, α-TMCA and β-TMCA. 
5.7 Agr2-/- and Agr2+/- mice are protected by M. schaedleri independent 
of their genotype or streptomycin treatment 
The intestinal mucus layer protects the host from invading pathogens and serves as a 
nutrient source for the microbiota (Derrien et al., 2004; Johansson et al., 2008; Sonnenburg 
et al., 2005). The mucus layer is intensely studied and it was shown that mucus deficient 
(Agr2-/-) mice are more susceptible to chemically induced DSS colitis (Park et al., 2009). 
Recently, its role in S. Tm infection was addressed. Interestingly, Agr2-/- mice pretreated with 
streptomycin were resistant to S. Tm colitis at day one post infection (Fig. 4A) (Brugiroux, 
2016). In contrast, littermate control Agr2+/- mice and ampicillin pretreated Agr2+/- and Agr2-
/- mice developed severe colitis (Fig. 4A) (Brugiroux, 2016). A microbiota mediated effect 
was assumed and 16S rRNA gene sequencing combined with indicator taxa analysis 
revealed that M.schaedleri is highly enriched in protected Agr2-/- mice (Fig. 4B) (Brugiroux, 
2016). In this respect, resistance of M. schaedleri ASF457 to the aminoglycoside 
streptomycin and beta-lactam ampicillin was tested in an in vitro culture assay (Fig. 20). 
Indeed, M. schaedleri is resistant to streptomycin but sensitive to ampicillin. This explains 
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the observation that protection from S.Tm colitis in streptomycin treated Agr2-/- mice is lost 
in ampicillin pretreated Agr2-/- mice (Fig. 4A) (Brugiroux, 2016). To investigate the impact of 
the microbiota composition on protection of Agr2-/- mice, germ-free Agr2-/- mice were 
associated with the defined OligoMM12 consortium (Beutler, 2016). Those mice were used 
to investigate the role of M. schaedleri on S. Tm colitis in the mucus deficient Agr2-/- model. 
The benefit of a low complex microbiota is that antibiotic treatment is dispensable to elicit 
S.Tm colitis in mice. Both OligoMM12 Agr2-/- and OligoMM12 Agr2+/- mice developed colitis 3 
days p. i. with S.Tm (Fig. 16F & G). On the other hand, OligoMM12 Agr2-/- and OligoMM12 
Agr2+/- pre-colonized with M. schaedleri were both protected from colitis (Fig. 16F & G). This 
is in contrast to the observations in conventional Agr2-/- mice (Fig. 4) (Brugiroux, 2016) and 
shows that M. schaedleri confers protection independent of the host genotype. OligoMM12 
Agr2-/- mice with and without M. schaedleri show higher S. Tm loads on day 1 p. i. in feces 
of app. 2 log10 levels compared to OligoMM12 Agr2+/- mice (Fig. 16B). This could indicate a 
potential role of the mucus layer in colonization resistance to S.Tm. Furthermore, Agr2-/- 
mice exhibit low-grade inflammation in the distal part of the intestine as LCN2 levels in feces 
of untreated mice were elevated compared to Agr2+/- (data not shown) but not in cecal 
content (Fig. 16). Inflammation can promote S. Tm growth in the lower intestine which could 
explain the increased S. Tm loads in feces day 1 p. i.. The microbiota composition of 
untreated OligoMM12 Agr2-/- and OligoMM12 Agr2+/- with and without M.schaedleri was 
analyzed. Cluster analysis based on Bray-Curtis distance matrices revealed only minor 
differences in microbiota composition (Fig. 15). OligoMM12 Agr2-/- mice with M.schaedleri 
show a distinct microbiota composition compared to all the three other groups (Fig. 15 A). 
Conventional Agr2-/- and Agr2+/- mice harbor a divergent microbial composition of the cecum 
(Brugiroux, 2016). Therefore, in the case of protected conventional Agr2-/- mice, the 
microbiota could mediate a context dependent effect where M. schaedleri is repressed by 
the community or that M. schaedleri is dependent on other bacteria present only in Agr2-/- 
mice. 
Besides the defined microbiota composition, streptomycin treatment should be taken into 
account. Streptomycin dramatically changes the composition and complexity of the gut 
microbiota of conventional mice (Lichtman et al., 2016; Sekirov et al., 2008). The cecal tissue 
of streptomycin treated mice reveals no histopathological changes compared to mock 
treated mice, which excludes obvious adverse effects on cecal tissue (Barthel et al., 2003). 
However, the cecum itself is increased in size in streptomycin treated mice, probably due to 
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water influx and osmoregulation (Barthel et al., 2003; Savage & Dubos, 1968). M. schaedleri 
is still able to protect both OligoMM12 Agr2-/- and Agr2+/- mice from S.Tm colitis even if they 
are pretreated with streptomycin (Fig. 17F & G). Streptomycin has an immense impact on 
the microbiota composition independent of M.schaedleri colonization or host genotype (Fig. 
17H & Fig. 18). Especially M. schaedleri and B. caecimuris are increased whereas T. muris 
and M. intestinale are reduced by streptomycin. The increase of M. schaedleri after 
streptomycin treatment is not surprising as it is resistant to streptomycin (Fig. 20). Further it 
can probably benefit from the changed environment in regard to available nutrients and 
oxygen (Rivera-Chávez et al., 2016). Until now it was not possible to unravel the discrepancy 
observed between conventional and gnotobiotic OligoMM12 Agr2+/- and Agr2-/- mice in S.Tm 
colitis.   
Conventional Agr2-/- mice where described to exhibit normal growth and body weight up to 
four month after birth (Park et al., 2009). In contrast, germ-free and OligoMM12 Agr2-/- mice 
show already from 5 weeks on tremendous growth defects compared to littermate controls 
(data not shown) but no spontaneous inflammation was observed in the cecum of mice (Fig. 
16F & G). This indicates that a complex microbiota sustains a healthy environment which is 
needed in the Agr2-/- mice. The OligoMM12 microbiota is not able to provide this benefit.  
5.8 Can M. schaedleri be used as a probiotic to prevent S.Tm colitis? 
In order to answer this question, more research has to be conducted. First of all it has to be 
confirmed that M. schaedleri is able to colonize the human intestine. As discussed above 
(5.5) observations of M. schaedleri in human samples are scarce and only reported in 
samples obtained by colonoscopy (Harrell et al., 2012; Rausch et al., 2011). Therefore deep 
sequencing of colonic samples could reveal if M. schaedleri is commonly distributed among 
the population. If one can proof that M. schaedleri is a common member of the human 
microbiota, further studies have to be performed to rule out negative health effects of 
M. schaedleri on humans. Recently, M. schaedleri was implicated in the development of 
arteriosclerosis in mice (Qiu et al., 2018). Further, we need to investigate its impact on 
chronic inflammatory diseases like Chron’s disease and ulcerative colitis where it was found 
to be an indicator species for colitis mouse models (Berry et al., 2015; Rooks et al., 2014). 
We need to reveal if it is a true pathobiont promoting colitis or only benefits from the changed 
intestinal environment. In addition we have to address if M. schaedleri ameliorates the 
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outcome of infections with other intestinal pathogens like Clostridium difficile, Vibrio 
cholerae, Shigella flexneri or vancomycin resistant Enterococcus or in contrast leads to 
deterioration. Eventually, we need to establish a genetic system for M. schaedleri. We hope 
to be able to perform site directed mutagenesis in M. schaedleri and utilize transposon 
mutagenesis to unravel the mechanism behind the protection from S. Tm colitis in the near 
future. 
In conclusion, I was able to proof that M.schaedleri, a low abundant member of the gut 
microbiota, delays significantly the onset of S.Tm colitis. This was reproducible in two 
gnotobiotic mouse models with distinct defined microbiota (ASF3 and OligoMM12). Further I 
could show that protection of Agr2-/- mice in S.Tm colitis is microbiota dependent by using 
gnotobiotic OligoMM12 Agr2-/- mice. Expression of SPI1-T3SS, the major virulent factor of 
S. Tm, is markedly reduced in the presence of M.schaedleri, shown by RNAseq data and 
infection experiments with a SPI1-T3SS gfp-reporter strain. This is probably achieved by 
changing the intestinal environment and availability of nutrients (Fig. 22). I could show a 
strong inducing effect of nitrate on SPI1-T3SS under anaerobic conditions in vitro which 
contributes for the further understanding of the SPI1 regulation in vivo. Overall this suggests, 
although not formally confirmed, that M. schaedleri inhibits S.Tm virulence by competition 
for respiratory electron acceptors (Fig. 22). 
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